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Zusammenfassung 
Das kleine G-Protein Ran ist an elementaren zellulären Prozessen wie dem 
nukleozytoplasmatischen Transport sowie dem Aufbau der Kernhülle und der 
mitotischen Spindeln beteiligt. Die zwei nukleotidabhängigen Zustände, GTP- 
und GDP-gebunden, zeichnen sich durch unterschiedliche Konformationen 
zweier regulatorischer Schleifen (Switch I und Switch II) aus, welche 
maßgeblich die Effektor-Bindung beeinflussen. Der Übergang zwischen den 
zwei Zuständen wird durch regulatorische Proteine unterstützt, welche die 
Hydrolyse und den Austausch des Nukleotides beschleunigen. Die 
unterschiedliche zelluläre Lokalisation  dieser Proteine führt zur Ausbildung 
eines RanGDP/GTP-Gradienten. Eine umfangreiche massenspektrometrische 
Studie im Jahr 2009 identifizierte fünf Acetylierungsstellen in humanem Ran, 
welche mittlerweile auch durch Folgestudien in anderen Organismen bestätigt 
wurden. Ziel dieser Arbeit war es, die Auswirkungen der Ran-Acetylierung auf 
die Funktion von Ran zu untersuchen. Des Weiteren sollten Einblicke in die 
Stöchiometrie und Regulation dieser post-translationalen Modifikation von Ran 
gewonnen werden um eine Einschätzung der physiologische Relevanz zu 
ermöglichen. 
 
Im Zuge der Arbeit wurde mittels Erweiterung des genetischen Codes von E.coli 
stellen-spezifisch acetyliertes Ran (an den Lysinen 37, 60, 71, 99 und 159) 
hergestellt. Die Proteine wurden gereinigt und hinsichtlich ihrer intrinsischen 
Eigenschaften sowie der Interaktion mit dem Nukleotid-Austauschfaktor RCC1, 
dem wichtigsten Import-Rezeptor Importin-β und dem Ran-bindenden Protein 
NTF2 untersucht. Die umfangreiche in vitro Charakterisierung zeigt, dass die 
Acetylierung einzelner Lysine die RCC1-Interaktion und Nukleotid-
Austauschrate, sowie die Ran-Lokalisierung und die Bildung von Import-
Komplexen beeinflusst. Ran-Acetylierung an den Lysinen 37, 99 oder 159 hat 
eine höhere Importin-β-Affinität zur Folge. Acetyliertes Lysin 71 hat einen 
dominant negativen Effekt bezüglich RCC1 welcher mit dem der T24N-Mutante 
vergleichbar ist: die Bindungsaffinität ist erhöht, während die Nukleotid-
Austauschrate herabgesetzt ist. Weiterhin verhindert diese Acetylierung die 
Interaktion mit NTF2, was wiederum die Ausbildung des Ran-Gradienten bzw. 
die Lokalisation von Ran beeinträchtigt. Für Lysin 99-acetyliertes Ran war ein 
überwiegender Verlust der RCC1-Regulation zu beobachten, basierend auf einer 
verringerten Affinität und einem drastisch verringerten Nukleotid-Austausch. 
Die durchgeführten Untersuchungen zur Regulation der Ran-Acetylierung 
führten zur Identifikation Ran-spezifischer Acetyltransferasen und Deacetylasen 
in vitro und in vivo. Sirt1, -2 und -3 wirken als Deacetylasen auf Acetyl-Lysin 
37, wohingegen Acetylierung an Lysin 71 spezifisch von Sirt2 entfernt wird. 
Immunoblotting und massenspektrometrische Untersuchungen identifizierten 
Tip60, p300 und CBP als Ran-spezifische Acetyltransferasen und die Lysine 37, 
134 und 142 als hauptsächliche Acetyl-Akzeptoren. Zusammengefasst deutet die 
vorliegende Arbeit auf ein hohes regulatorische Potential für die Acetylierung 
von Ran in Abhängigkeit vom zellulären Kontext hin. 
“Absence of evidence is not evidence of absence.”
Carl Edward Sagan, Astronomer
Abstract
The small GTP-binding protein Ran regulates fundamental cellular processes such
as nucleocytoplasmic transport, nuclear envelope formation and mitotic spindle
assembly. The two nucleotide states of Ran, GTP- and GDP-bound, are charac-
terized by distinct conformations of two regulatory regions (switch I and switch
II) which determine effector binding. The interconversion of these two states is
facilitated by regulatory proteins (RanGAP, RCC1). The differential localiza-
tion of these proteins leads to the formation of a Ran∗GDP/GTP gradient. A
mass-spectrometrical screen of the acetylome of human cell lines in 2009 iden-
tified five acetylation sites in Ran, which were confirmed by subsequent screens
in different organisms. The aim of this thesis was to study the impact of Ran-
acetylation on Ran-function. Furthermore, the abundance and regulation of this
post-translational modification was investigated to judge the physiological rele-
vance of Ran-acetylation.
In this study, recombinant Ran was site-specifically acetylated at lysines 37, 60, 71,
99 and 159 using the genetic-code expansion concept in E.coli. The proteins were
purified and characterized regarding their intrinsic properties and the interaction
with the nucleotide exchange factor RCC1, the major import receptor Importin-β
and the Ran-shuttling protein NTF2 (nuclear transport factor 2). The compre-
hensive in vitro characterization revealed that acetylation of single lysines impacts
on RCC1-interaction and -catalysis, Ran-localization and import-complex forma-
tion. Ran acetylated at lysines 37, 99 or 159 exhibits a higher binding affinity
for Importin-β. Acetylation of lysine 71 (in switch II) has a dominant negative
effect on RCC1 analogous to the T24N-mutant of Ran. Furthermore, it abolishes
NTF2-interaction, which consequently affects Ran-localization and the formation
of the Ran-gradient. Moreover, Ran acetylated at lysine 99 resembles a loss-of-
function mutant regarding RCC1, lowering affinity and nucleotide exchange rates.
Regulatory enzymes for Ran-specific de-/acetylation were identified in vitro and
in vivo. Sirt1, -2 and -3 are deacetylating enzymes for lysine 37 of Ran, whereas
lysine 71 is specifically deacetylated by Sirt2. The enzymatic acetylation of Ran
by the acetyltransferases Tip60, p300 and CBP was shown by immunoblotting
and mass-spectrometrical analysis and lysines 37, 134 and 142 were identified as
the major acetyl-acceptors of Ran. Taken together, these results suggest a strong
regulatory potential of Ran-acetylation depending on the cellular context.
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Chapter 1
Introduction
1.1 The Ras superfamily
Cellular signal transduction enables prokaryotic and eukaryotic cells to react to ex-
tracellular stimuli- a prerequisite for survival. G-proteins (guanine nucleotide bind-
ing proteins, GNBPs) are key players in signal transduction. Based on sequence-
and structure-similarities, GNBPs are divided into two major classes: the TRAFAC
(translation factors) and the SIMIBI (signal recognition particle, MinD and BioD)
class. More than twenty families are organized in both classes together, which
are further subdivided into 57 subfamilies (Leipe et al., 2002). TRAFAC-GNBPs
are involved in signal transduction, translation, cell migration and intracellular
transport processes. The translation factor superfamily (e.g. EF-Tu), the Ras su-
perfamily (e.g. Ras, Rho, Ran) and the myosin-kinesin superfamily (e.g. myosin)
are well known examples. SIMIBI proteins are involved in protein targeting and
-localization and their biological function is associated with homo- or heterodimer-
ization. The signal recognition-associated GTPase superfamily (SRP and its re-
ceptor) is one example for the SIMIBI class. Based on their biological function
GNBPs can be divided into:
1. α-subunits of heterotrimeric G-proteins (Gαs)
2. Translation factors (e.g. EF-Tu, IF-2)
3. Ras superfamily (e.g. Ras, Rho, Ran)
4. SRP and SRP-receptor
5. Large GNBPs (e.g. Dynamin, GBP)
1
Introduction 2
Table 1.1: Subfamilies of the Ras superfamily (after (Rojas et al., 2012))
Ras Rho Rab Arf Ran
Members 39 22 65 30 1
Function differentiation cytoskeleton vesicle transport vesicle transport nucleocytoplasmic transport
proliferation cell growth mitotic spindle formation
apoptosis nuclear envelope formation
Examples (H/K/N)-Ras Rho(A/B/C) Rab1A Arf1-6 Ran
Rap1A Rnd(1/2/3) Rab1B Arl1-10
Rap1B Rac(1/2) Rab2
RalA CDC42 Rab3A
Rit1/2 TC10 Rab3B
Rhes Rif Rab10
The Ras superfamily comprises more than 150 human small GNBPs with a molec-
ular weight of 20 to 25 kDa. The prototypical member of the superfamily, Ras (rat
sarcoma), was first identified in 1979 as the product of a gene later characterized
as a proto-oncogene (Chien et al., 1979; Langbeheim et al., 1980; Shih et al., 1979).
20 - 30 % of all human tumors carry mutations in the RAS proto-oncogene (Prior
et al., 2012). Based on functional- and sequence similarity the Ras superfamily
is further subdivided into five main-families: Ras, Rho, Rab, Arf and Ran (Ro-
jas et al., 2012). Ras family proteins play important roles in cell differentiation,
-proliferation and apoptosis. Rho-proteins (ras-homologous) are involved in cy-
toskeleton organization, cell growth and regulation of gene expression. Members
of the Rab (ras-like proteins from brain) and Arf (ADP-ribosylation factor) fam-
ilies regulate the generation and transport of vesicles. Ran (ras-related nuclear)
is crucial for nucleocytoplasmic transport, mitosis and formation of the nuclear
envelope.
The importance of G-proteins in signal transduction is based on the ability to
adopt two different states: the GTP-bound ”on”-state and the GDP-bound ”off”-
state. The two states differ in the conformation of the highly conserved core
domain of the G-proteins, the G-domain. Downstream targets, so called effector
proteins, are only able to bind to the GTP-bound conformation, defining this as
the active state. The fact that both conformational states are interconvertible
by nucleotide exchange, predestines G-proteins to act as molecular switches. The
hydrolysis of GTP to GDP results in the inactivation of the G-protein, which
terminates the signal transduction and prevents permanent ”on”-signaling.
With the exception of the Ran and Rad subfamilies, all small G-proteins are
post-translationally modified by lipidation. This lipid anchor is crucial for tar-
geting specific subcellular membranes and, consequently, for regulation of the bi-
ological activity of the GNBPs. Ras- and Rho-proteins are farnesylated and/or
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geranylgeranylated by specific farnesyltransferses and geranylgeranylases, respec-
tively (Lowy and Willumsen, 1989). The lipid-anchor is attached to the C-
terminal CaaX-consensus sequence (C: Cysteine, a: aliphatic, X: any amino acid)
by thioetherbond-formation with the cysteine side chain (Hancock et al., 1989).
Following lipidation, the farnesyltransferase catalyzes the proteolytic cleavage af-
ter the cysteine and methylation thereof (Dai et al., 1998; Schmidt et al., 1998).
For N- and H-Ras additional palmitoylation was reported. In that case, one or two
cysteines N-terminal to the CaaX-Box are modified by a reversible thioesterbond.
A constant cycle of palmitoylation/depalmitoylation drives the rapid exchange of
Ras between the plasma membrane and the golgi (Rocks et al., 2005). K-Ras, in
contrast, is not palmitoylated. Instead, a polybasic domain consisting of multi-
ple lysines targets K-Ras to the plasma membrane independent of the secretory
pathway (Hancock et al., 1990). Furthermore, Rab-proteins are geranylgerany-
lated and Arf-proteins were found to be N-terminally myristoylated. For lipi-
dated Rho- and Rab-proteins additional regulatory proteins were identified. The
guanine-nucleotide dissociation inhibitors (GDIs) bind to the switch regions of the
GDP-state and accommodate the lipid-anchor in a hydrophobic pocket (Figure
1.2). Thereby the activation by GEF-action is prevented and the protein is sol-
ubilized from biomembranes. Moreover, PDEδ (Phosphodiesterase 6 subunit δ)
solubilizes a broad spectrum of farnesylated cargoes (Chandra et al., 2012; Ismail
et al., 2011).
1.1.1 The G-domain
The G-domain of Ras, with 166 residues and a mass of approximately 20 kDa,
can be regarded as the minimal signaling unit in all G-proteins (Vetter and Wit-
tinghofer, 2001). It is characterized by a mixed six-stranded β-sheet flanked by five
helices (Figure 1.1). This α, β protein fold is typical for nucleotide binding pro-
teins, although variations in the number of sheets and helices are possible. Four to
five conserved sequence elements (Table 1.2), all located in loop domains, are lined
up along the nucleotide binding pocket and mediate the high-affinity binding of
guanine nucleotides (Figure 1.4.a) (Bourne et al., 1991; John et al., 1990; Schmidt
et al., 1996; Via et al., 2000). The P-loop contacts the β- and γ-phosphate of the
nucleotide and, hence, makes the major contribution to high-affinity nucleotide
binding (Saraste et al., 1990). Mutations of S/T to N result in dominant negative
small GTPases with a drastically reduced nucleotide affinity (Farnsworth and Feig,
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a. b.
Figure 1.1: Structure of the G-domain of GNBPs. Superimposition
of several GNBPs of the Ras superfamily on the G-domain in the GTP- (a)
and GDP-conformation (b). The switch regions adopt a rigid conformation in
the GTP-form and exhibit a high degree of exibility in the GDP-form. Extra
elements in the structures of Rho (insert helix, magenta), Ran (C-terminal
extension, red) and Arf (N-terminal helix, blue) are highlighted. Taken from
(Vetter and Wittinghofer, 2001)
1991; Feig, 1999; John et al., 1993; Klebe et al., 1995a). The switch I and II re-
gions primarily contact the -phosphate of the bound nucleotide. Removal of this
phosphate during GTP-hydrolysis leads to conformational changes in both loops
and consequently controls e ector binding (Spoerner et al., 2001; Wittinghofer
and Pal, 1991). The bifurcated H bond between an Asp side chain in G4 and the
nucleotide base as well as a main chain interaction between an invariant Ala in
G5 (SAK motif) and the guanine oxygen are the determinants of the speci city
for guanine.
Table 1.2: Motifs of the G-domain
Motif Sequence Function Ras Ran
G1 , P-loop GxxxxGK(S/T) - contacts - and -Phosphate 10GAGGVGKS17 17GDGGTGKT24
- coordinates Mg2+
G2, switch I T - hydrogen bond to -Phosphate 30DEYDPTIE37 32TGEFEKKYVATLG44
- hydrogen bond to Mg2+
G3, switch II DxxG - contacts -Phosphate (G) 57DTAGQEEYSAM67 65DTAGQEKFGGLRDG78
- coordinates Mg2+ (D)
G4 NKxD - contacts guanine base (speci city) 116NKCD119 122NKVD125
G5 SAK - contacts guanine base (speci city) 145SAK147 150SAK152
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1.1.2 Regulatory cycle
The existence of two nucleotide-dependent interconvertible conformational states
is the basis for the relevance of small GNBPs as molecular switches. The GTP-
bound state adopts a rigid conformation (Figure 1.1.a) which is recognized by
effector proteins and activates downstream signaling cascades. Hydrolysis of the
bound GTP releases switch I and switch II from this conformation, since the
interactions to the γ-phosphate are lost. In the GDP-bound state the switch
regions are highly flexible and, thus, not recognized by effector proteins or, if so,
only with very low affinity. This ”inactive” protein state is, however, interacting
with regulatory proteins such as exchange factors. This cycle of activation and
inactivation is depicted in scheme 1.2.
GAP
GEF
GTP
Rho
GDP
Rho
GTP GDP
H2OPi
EffectorsRho
GDP
GDI
Figure 1.2: Regulatory cycle of GNBPs of the Ras superfamily.
Small G-proteins (e.g. Rho) are regulated by guanine-nucleotide exchange
factors (GEF) and GTPase-activating proteins (GAPs). Lipidated Rho- and
Rab-proteins are, furthermore, regulated by guanine-nucleotide dissociation in-
hibitors (GDIs).
The basic machinery for interconversion of both states, by nucleotide hydrolysis
and nucleotide exchange, is provided by the G-protein itself. However, intrinsic
rates for GTP-hydrolysis as well as nucleotide exchange are too slow to be of
physiological relevance. Hence, both processes are accelerated 105-fold by GTPase-
activating proteins (GAPs) and guanine-nucleotide exchange factors (GEFs).
GAPs of small GNBPs are not conserved and they often approach the catalytic site
from different directions. Furthermore, different catalytic mechanisms are utilized
to accelerate GTP-hydrolysis (Scheffzek et al., 1997; Seewald et al., 2002). In most
cases, the insertion of a positively charged residue by the GAP (either arginine
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. . .
Figure 1.3: Molecular basis for GAP-accelerated GTP-hydrolysis.
(a)Insertion of an arginine of RasGAP into the active site of Ras to position
the catalytic glutamine. (b) RanGAP provides an asparagine to disrupt an
inhibitory state created by tyrosine 39. Modified after (Rehmann and Bos,
2004)
or asparagine) stabilizes the catalytic machinery and lowers the activating energy
of the catalytic step. Ras- and Rho proteins contain a conserved glutamine in
switch II (Glu61 Ras/Rac/CDC42, Glu63 Rho) which positions a catalytic water
molecule for nucleophilic attack on the the γ-phosphate of GTP (Resat et al.,
2001). Ras- and RhoGAPs insert an arginine residue into the active site, the so
called arginine-finger, to position the catalytic glutamine and to neutralize the
developing negative charge in the hydrolysis step (Figure 1.3.a) (Ahmadian et al.,
1997).
RanGAP provides an asparagine instead of the arginine-finger to accelerate the
intrinsic GTP-hydrolysis. Furthermore, tyrosine 39 of Ran holds the catalytic
glutamine (Glu69) and the water in an anti-catalytic position. Asparagine 131
of RanGAP displaces Tyr39 and allows for rapid hydrolysis by disruption of the
inhibitory state (Figure 1.3.b) (Brucker et al., 2010). The GTP-hydrolysis of Rap
is based on, yet, another mechanism, independent of a catalytic glutamine and the
arginine-finger. In fact, a threonine residue without a detectable role in catalysis is
found in the position of the catalytic glutamine. However, the missing glutamine
in Rap is replaced by an asparagine in trans, the Asn-thumb, which is inserted
into the active site by RapGAP and occupies exactly the same position as the
catalytic glutamine in the other G-proteins (Scrima et al., 2008).
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b.a.
Figure 1.4: Schematic presentation of nucleotide binding and
GEF-mechanism.(a) Schematic presentation of molecular contacts between
GppNHp (a GTP-analogon) and residues of Ras (Wittinghofer and Waldmann,
2000). (b) Schematic diagram of the push-and-pull mechanism for GEF-induced
nucleotide dissociation. Insertion of GEF-residues into/close to the magnesium-
binding site and the P-loop disturbs nucleotide binding and reduces the nu-
cleotide affinity. Switch I is pushed out and switch II pulled towards the nu-
cleotide binding site (Vetter and Wittinghofer, 2001).
G-proteins bind GDP/GTP with low nanomolar to picomolar affinities and con-
sequently exhibit very slow intrinsic nucleotide dissociation rates. GEFs accel-
erate these rates by several orders of magnitude by reducing the affinity for the
nucleotide. The catalytic domains of various GEFs and also the specific bind-
ing sites differ throughout the Ras superfamily. However, GEF-binding always
induces conformational changes in the switch regions and the P-loop, which steri-
cally perturb the magnesium binding site (Lenzen et al., 1998). This mechanism is
referred to as ”push-and-pull mechanism”, since switch I is pushed out of its nor-
mal position, whereas switch II is pulled toward the nucleotide binding site (Figure
1.4.b)(Vetter et al., 1999). Insertion of GEF-residues close to or into the P-loop
and Mg2+-binding area disturbs the nucleotide binding and drastically reduces
the nucleotide affinity. The fact that the P-loop lysine (Lys16 in Ras), formerly
contacting negative charges of the phosphates, is reoriented and interacts with
either the invariant Asp (Asp57 in Ras) or the conserved Glu (Glu62 in Ras) of
switch II, furthermore favors nucleotide release (Gasper et al., 2008). The stable
nucleotide-free complex of GTPase and GEF is dissociated by subsequent rebind-
ing of nucleotide. Noteworthy, the GEF-activity does not influence the binding
selectivity regarding GDP or GTP. Rebinding of GTP, instead of GDP, is simply
favored by a higher cellular GTP-concentration.
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1.2 The small GTPase Ran
Ran was originally isolated with a Ras-like sequence from a human teratocar-
cinoma cell line (Drivas et al., 1990). Ran is a highly abundant and strongly
conserved small GNBP, which is ubiquitously expressed in all eukaryotic cells
(Ren et al., 1993). During interphase it shows predominantly nuclear localization,
whereas it is widely distributed throughout the cell during mitosis. As a family
member of the Ras superfamily, Ran features the characteristic G-domain and
passes through the regulatory cycle (Scheffzek et al., 1995). In addition to the G-
domain, Ran exhibits a C-terminal extension consisting of an unstructured linker
followed by a 16 residue α-helix. In the GDP-bound state this extension contacts
the protein core opposite of the switch I. In the GTP-bound state the unstructured
C-terminus is extending away from the core, exposing the switch region for effec-
tor recognition and -binding. In contrast to the majority of small GTPases, Ran
does not bind to biomembranes and, thus, is not post-translationally modified by
prenylation. Ran carries an acidic C-terminus (-DEDDDL) which stabilizes the
GDP-bound state and mediates interactions with RCC1, RanGAP, and RanBP1
(Richards et al., 1995).
Ran is involved in a variety of essential cellular processes. It is a key player in the
transport of proteins in and out of the nucleus and also RNA is exported from the
nucleus in a Ran-dependent process (Ko¨hler and Hurt, 2007; Weis, 2002). Ran,
furthermore, controls the cell cycle in yeast, regulates several mitotic processes and
is involved in nuclear envelope formation (reviewed in (Clarke and Zhang, 2008)).
Most of the functions of Ran are based on a gradient of Ran∗GDP/Ran∗GTP
which is established by differential localization of the two regulating proteins Ran-
GAP (cytosolic) and RCC1 (nuclear).
1.2.1 Nucleocytoplasmic transport
The nucleus of eukaryotic cells is delimited by the nuclear envelope, consisting of
an inner nuclear membrane and an outer nuclear membrane. The outer nuclear
membrane is continuous with the endoplasmatic reticulum. The inner nuclear
membrane is lined by the nuclear lamina, a fibrillar network out of intermediate
filaments and membrane associated proteins. The exchange of proteins, RNA and
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small molecules between the cytosolic and the nuclear compartment is a prereq-
uisite for survival of every eukaryotic cell. The translocation processes of these
molecules are regulated with varying stringency. To this end, the nuclear envelope
is perforated by nuclear pores - channels connecting inner and outer membrane and
harboring the nuclear pore complexes (NPCs). NPCs are large multimeric protein
assemblies out of 30 - 60 different proteins (nucleoporins) reaching a size of around
120 MDa in mammalian cells (Grossman et al., 2012; Reichelt et al., 1990; Rout and
Aitchison, 2000). Phenylalanine-Glycine-(FG)-rich repeats (consensus sequence:
FG, FxFG or GLFG) of nuclear pore proteins form a three-dimensional meshwork
with hydrogel-like properties, which enables passive diffusion of molecules smaller
than 25 - 40 kDa (Frey and Go¨rlich, 2009; Frey et al., 2006). Larger molecules
either possess the intrinsic capacity to interact with the NPC or the transloca-
tion is facilitated by association with specific transport receptors. These import-
(importins) and export-receptors (exportins) recognize specific nuclear localiza-
tion signals (NLS) and nuclear export signals (NES), respectively. From in vitro
studies and single-molecule imaging experiments, an import rate capacity of 1000
molecules per second and NPC was estimated (Ribbeck and Go¨rlich, 2001; Yang
et al., 2004). Only facilitated, energy-dependent transport permits such an ef-
ficient translocation. However, the translocation process itself does not require
energy. Rather, the energy consumption enables a directed transport against a
concentration gradient. And in fact, transport-associated GTP-hydrolysis takes
place after translocation trough the nuclear pore.
The cycling of Ran between its GDP- and GTP-bound state is crucial for nucle-
ocytoplasmic transport (reviewed in (Cautain et al., 2014)). The spatial separa-
tion of Ran∗GTP-generation in the nucleus and GTP-hydrolysis in the cytosol
generates the Ran∗GDP/GTP-gradient, which provides directionality to the nu-
cleocytoplasmic transport (Kala´b et al., 2006). RCC1, the GEF of Ran, binds
to chromatin and catalyzes the nucleotide exchange to generate Ran∗GTP in the
nucleus. The mechanism of action of Ran∗GTP with transport receptors is differ-
ent for import- and export processes (Figure 1.5). In the case of protein import,
binding of Ran∗GTP dissociates import-complexes in the nucleus (Go¨rlich et al.,
1996). These complexes are formed in the cytosol and consist of a cargo molecule,
an adaptor protein (e.g. Importin-α) and the import-receptor (e.g. Importin-β).
The cargo protein carries a specific nuclear localization signal (one or two short
stretches of positively charges amino acids) which is recognized and bound by
Importin-α. Importin-β, the actual transport receptor, binds to the complex and
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Figure 1.5: The nucleocytoplasmic transport cycle.Schematic presen-
tation of the Ran-mediated nucleocytoplasmic transport cycle. Ran∗GTP is
generated by the RanGEF (RCC1) at the chromatin, whereas hydrolysis of
Ran∗GTP is accelerated by RanGAP at the cytosolic side of the nuclear pore
complex. Protein export by export receptors (Exp.) as well as the classical
import pathway, involving Importin-α (Imp-α) and Importin-α, are depicted.
facilitates translocation trough the NPC. The binding of Ran∗GTP to Importin-
β in the nucleoplasm results in the dissociation of the import-complex and the
release of the cargo molecule. Subsequently, the Importin-β-Ran∗GTP-complex
passes the NPC and dissociates as a consequence of RanGAP-catalyzed GTP-
hydrolysis in the cytosol.
In contrast to import processes, nuclear Ran∗GTP-binding to an exportin (e.g.
Crm1) initiates export-complex formation by enhancing cargo binding. The ternary
complex is exported through the NPC and dissociates upon GTP-hydrolysis by
RanGAP. The cytosolic Ran-binding proteins (RanBPs) RanBP1 and RanBP2
co-stimulate the GAP-reaction. Both transport cycles, import and export, are
closed by re-import of Ran∗GDP into the nucleus. This process is mediated by
Introduction 11
the nuclear transport factor 2 (NTF2), which binds specifically to GDP-bound
Ran.
1.2.2 Mitotic spindle assembly
Several observations suggested a participation of Ran and Ran-interacting pro-
teins in mitosis. Expression of dominant mutants of Ran disrupted cell cycle pro-
gression and cell cycle defects were also observed when other components of the
Ran-system were perturbed (Ren et al., 1994; Sazer and Nurse, 1994). Premature
chromatin condensation after loss of RCC1 in a temperature-sensitive hamster cell
line (tsBN2), furthermore, suggested a pivotal role for RCC1 during mitosis (Nishi-
moto et al., 1978; Uchida et al., 1990). Ran influences many different processes
during mitosis. It promotes the nucleation of microtubuli at the centrosomes and
plays a role in chromatin-directed nucleation (Carazo-Salas et al., 1999; Kalab
et al., 1999; Ohba et al., 1999; Zhang et al., 1999). Moreover, Ran affects mi-
totic motor proteins involved in spindle assembly, regulates the microtubulin-flux
during mitosis and stabilizes microtubuli (Carazo-Salas et al., 2001; Wilde et al.,
2001).
In most cases, Ran acts by releasing mitotic spindle assembly factors (SAFs) from
inhibitory complexes with Importin-α and/or Importin-β. Since Ran∗GTP is the
active species, able to bind to importins, the detachment of SAFs is linked to the
Ran∗GDP/GTP-gradient and, consequently, to Ran∗GTP-generation by RCC1
a. b.
Figure 1.6: Ran is involved in mitotic spindle formation. (a) Re-
lease of spindle assembly factors (SAFs) from inhibitory complexes is coupled
to Ran∗GTP-generation by RCC1. (b) Localization of SAFs via their NES
by a Crm1-Ran∗GTP-dependent pathway. (modified after (Clarke and Zhang,
2008))
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close to the chromatin. For example, the inactivation of TPX2 (target protein for
Xklp2) by association of Importin-α is abolished by Ran∗GTP-mediated complex
dissociation. TPX2 is a microtubuli-associated protein targeting motor proteins to
the minus-ends of microtubuli (Wittmann et al., 2000). It, furthermore, activates
the Aurora A kinase which is crucial for proper centrosome separation after the
mitotic spindle has been formed (Eyers and Maller, 2004). On the other hand,
NuMA (nuclear mitotic apparatus protein) is released from an inhibitory complex
with Importin-β to regulate microtubuli organization in the spindle.
Table 1.3: Mitotic targets of RanGTP in spindle assembly
SAF Mitotic function Exp. system Karyopherin References
Direct targets
TPX2 MAP, MT bundling XEE, CMCs Importin-α (Gruss et al., 2001)
(Trieselmann et al., 2003)
NuMA MAP XEE Importinβ (Nachury et al., 2001)
(Wiese et al., 2001)
Kid Chromokinesin HCE, CMCs Importin-α, -β (Trieselmann et al., 2003)
(Tahara et al., 2008)
XCTK2 Kinesin, MAP XEE Importin-α, -β (Ems-McClung et al., 2004)
RAE1 MAP, RNA binding XEE Importin-β (Blower et al., 2005)
NuSAP MAP, MT stabilization/bundling XEE, CMCs Importin-α, -β, -7 (Ribbeck et al., 2006)
HURP MAP, k-fibre stabilization/tension XEE, CMCs Importin-β (Koffa et al., 2006)
(Sillje´ et al., 2006)
Lamin B Mitotic matrix formation XEE Unknown (Tsai et al., 2006)
CDK11 MT stalibization XEE Importin-α, -β (Yokoyama et al., 2008)
CRB3-CLPI Polarized membrane targeting Epithelial cells Importin-β (Fan et al., 2007)
Indirect targets
TACC/Maskin MT stabilization XEE Importin-α? (Albee et al., 2006)
(Sato and Toda, 2007)
XMAP215 MAP XEE Unknown (Wilde et al., 2001)
(Koffa et al., 2006)
Aurora A Mitotic kinase CEE, HCE Importin-α, -β (Trieselmann et al., 2003)
(Tsai et al., 2003)
XRHAMM MT nucleation XEE Unknown (Groen et al., 2004)
BRCA1-BARD1 Mitotic spindle assembly XEE, CMCs Unknown (Joukov et al., 2006)
Crm1-dependent
RanBP2 K-fibre formation CMCs Crm1 (Arnaoutov et al., 2005)
RanGAP1 K-fibre formation CMCs Crm1 (Arnaoutov et al., 2005)
CPC K-fibre attachment, CMCs Crm1 (Knauer et al., 2006)
checkpoint signaling
Abbreviations: XEE (Xenopus laevis egg extract), CMC (cultured mammalian cells), HCE (human cell extract), MT
(microtubuli), MAP (microtubuli-associated protein), K-fibre (kinetochore-fibre), Kid (kinesin-like DNA binding protein),
XCTK2 (Xenopus carboxy-terminal kinesin 2), RAE1 (ribonucleic acid export 1), NuSAP (nucleolar- and spindle-associated
protein), HURP (hepatoma upregulated protein), CDK11 (cyclin-dependent kinase-11), CRB3-CLPI (Crumbs homolog 3 ending
in CLPI), TACC (transforming acidic coiled-coil-containing protein 1), XMAP215 (X microtubuli-associated protein 215),
XRHAMM (Xenopus receptor for hyaluronic acid-mediated motility), BRCA-1 (breast cancer type-1 susceptibility protein),
BARD-1 (BRCA-associated RING domain protein), CPC (chromosome passenger complex); Table modified after (Clarke and
Zhang, 2008)
Apart from the Importin-dependent recruitment of factors, some proteins are also
localized via their NES by a Crm1-Ran∗GTP-dependent pathway, analogous to
the protein export during interphase. Another way of regulatory influence of Ran
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on mitotic processes, especially mitotic spindle assembly, involves the APC/C
(anaphase-promoting complex). APC/C promotes the ubiquitination and subse-
quent degradation of several SAFs, namely BARD1, HMMMR, HURP and NuSAP
(Song and Rape, 2010). Importin-β was shown to inhibit the APC/C-dependent
ubiquitination of these factors. Thus, the interplay of APC/C and the Importin-β-
Ran∗GTP pathway regulates mitotic spindle assembly by controlling the amount
of SAFs. Table 1.2.2 lists mitotic targets of Ran∗GTP in the process of spindle
assembly.
1.2.3 Nuclear envelope formation
Besides its importance for nucleocytoplasmic transport and regulation of mitotic
spindle assembly, Ran is required for nuclear envelope reformation at the end of
mitosis and for post-mitotic NPC assembly (Hetzer et al., 2000; Ryan et al., 2003;
Zhang and Clarke, 2000). Bead-immobilized Ran was able to induce the formation
of nuclear envelope-like structures in cell-free Xenopus egg extracts. Surprisingly,
these structures contained NPCs. Furthermore, Hetzer et al. showed the ne-
cessity of RCC1 and Ran for the early stages of nuclear envelope formation. The
molecular mechanisms of post-mitotic NPC-assembly are not yet fully understood,
however, the involvement of Ran, Importin-β and the Nup107-Nup160-complex is
clear (Harel et al., 2003; Walther et al., 2003). While an excess of Importin-β
inhibits nuclear membrane fusion and NPC-assembly, Ran∗GTP stimulates these
processes. Most likely, Importin-β acts as a negative regulator by refraining the
nucleoporins Nup107-Nup160 from the chromatin surface. In analogy to the releas-
ing effect on SAFs, Ran∗GTP overcomes this effect of Importin-β by dissociating
the inhibitory complexes.
1.2.4 Ran-interacting proteins
Guanine-nucleotide exchange factor (GEF)
RCC1 (regulator of chromosome condensation 1) localizes to chromatin and is the
only GEF acting on the small GNBP Ran (Bischoff and Ponstingl, 1991a,b; Oht-
subo et al., 1989). The yeast protein Mog1 stabilizes the nucleotide-free conforma-
tion of Ran, however, true GEF-activity could not be shown, therefore Mog1 was
postulated to be a nucleotide-release factor (Steggerda and Paschal, 2000, 2001).
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The exible N-terminal region (NTR) of RCC1 is responsible for chromatin binding
(Moore et al., 2002). Deletion thereof disperses RCC1 from mitotic chromosomes,
resulting in spindle abnormalities due to the disturbance of the Ran  GTP localiza-
tion. The NTR, furthermore, carries a bipartite NLS recognized by Importin- / 3
and is subject to post-translational modi cation. The N-terminal methionine is
removed and serine two is mono-, di- or tri-methylated (Chen et al., 2007a). This
methylation is required for chromatin interaction but is not regulated during the
cell cycle. In contrast to the stable methylation, phosphorylation at serine two
and eleven by CDK1/cyclin B1 is restricted to mitosis. Phosphorylation disrupts
the binding of Importin- / 3 to the N-terminal NLS and thereby preserves the
mobility of RCC1 during metaphase (Hutchins et al., 2004; Li and Zheng, 2004).
Ran
Chromatin
90°
a. b.
Ran•GDPT
Ran•GDPT•RCC1L
Ran•GDPL•RCC1T
Ran•RCC1T
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Figure 1.7: Crystal structure and mechanism of action of RCC1.
(a) Cartoon-presentation of the -propeller-fold of RCC1 from two di erent
angles (PDB:1I2M). Secondary structure elements are colored in grey (sheets),
green (helices) and orange (loops) and the Ran- (yellow) and chromatin-binding
site (light-blue) are indicated. (b) Multi-step mechanism of RCC1-catalyzed
nucleotide exchange on Ran. The observed ternary complex comprises two
intermediates, which change from tight (T) to loose (L) binding of RCC1 or
nucleotide and vice versa.
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Alternative splicing of the single RCC1-gene in animal cells results in three RCC1
isoforms (RCC1α/ β/ γ) which exhibit different expression levels in specific tis-
sues (Hood and Clarke, 2007). The β- and γ-isoforms contain short inserts in the
NTR, resulting in altered chromatin binding properties, molecular interactions
and slightly different regulation by phosphorylation.
The crystal structure of RCC1 revealed a seven bladed β-propeller with seven 51 -
68 residue repeats (Figure 1.7.a) (Renault et al., 1998). Ran-interaction buries
a large solvent-accessible surface area but otherwise entails only minor structural
alterations (Renault et al., 2001). Ran contacts all seven propeller blades of RCC1.
The binding-interface is relatively flat, except for a protruding β-sheet in blade
three (residues 146 - 153 of RCC1), the so called β-wedge. Structural changes in
the Ran structure upon binding of RCC1 involve switch II, the helices α3 and α4,
as well as the region around the NKxD base-binding motif. Ran, furthermore,
adopts the GDP-conformation - with an extra β-strand in the switch I region.
The C-terminal extension is not visible in the complex-structure, indicating a
high degree of flexibility.
RCC1 has the highest binding affinity for nucleotide-free Ran but binds to both
nucleotide-states of Ran with similar (lower) affinity (Ran∗GDP 1.3·105M−1; Ran∗GTP
1.8·105M−1)(Klebe et al., 1995a). In the course of RCC1-catalyzed nucleotide ex-
change a ternary complex Ran∗GXP∗RCC1 is formed, which indicates that GXP
and RCC1 claim spatially distinct or partially overlapping binding sites. A simple
mechanism of facilitated dissociation is accepted for the reaction meaning that
the high-affinity binding is the product of several low-affinity interactions (Klebe
et al., 1995a; Prinz and Striessnig, 1993). In other words, the low-affinity binding
of RCC1 to Ran∗GXP is followed by a competition between RCC1 and GXP for
weak interactions and results in a number of small conformational changes. As
a result of this process, a ternary complex with low nucleotide affinity and high
RCC1 affinity is formed, which allows fast dissociation of GXP and formation of
a tight binary Ran∗RCC1 complex. The rebinding of nucleotide, in turn, dis-
places RCC1 in an analogous manner - via the formation of a ternary complex
(Figure 1.7). Notably, RCC1-action does not influence the binding characteris-
tics (affinities or on/off-rates) of GDP or GTP on Ran. The net generation of
Ran∗GTP is solely due to a 10-fold higher concentration of GTP over GDP in
the cell. The RCC1-mediated catalysis of nucleotide exchange on Ran results in
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a 105-fold increased nucleotide exchange rate (from 1.8x10−5 s−1 to 2.1 s−1)(Klebe
et al., 1995a).
Ran GTPase activation protein (RanGAP)
The Ran GTPase-activating protein (RanGAP) was first reported as rna1, a mu-
tant defective in mRNA processing and -transport in S.cerevisiae (Hartwell, 1967;
Hopper et al., 1978). RanGAP is exclusively cytosolic during interphase, however,
a fraction is tethered to the cytosolic face of the NPC. The localization to the
nuclear pore is mediated by SUMO-1-modification at the C-terminus and binding
to the Ran binding protein 2 (RanBP2) and the E2-conjugating enzyme Ubc9
(Mahajan et al., 1997; Matunis et al., 1996, 1998; Werner et al., 2012).RanGAP
stimulates the GTP-hydrolysis on Ran 105-fold from 1.5x10−5 s−1 to 5.0 s−1 (Klebe
et al., 1995a). RanBPs are able to co-stimulate the GAP-reaction (Bischoff et al.,
1995; Villa Braslavsky et al., 2000). RanGAP-catalyzed hydrolysis either takes
place in the cytosol or on the cytoplasmic fibrils of the NPC and is independent of
the translocation process trough the nuclear pore (Ribbeck and Go¨rlich, 2001). In
contrast to RasGAPs and RhoGAPs, RanGAP does not utilize an arginine finger
to complement and stabilize the catalytic machinery of the G-protein (Seewald
et al., 2002). In fact, the catalytic machinery is exclusively provided by Ran it-
self. However, RanGAP assists in positioning the catalytic glutamine Q69 and by
shielding the active site from the solvent. Please refer to section 4.2 for mechanistic
details.
Importin-β
Importin-β belongs to the karyopherin-β superfamily, which is also named Importin-
β superfamily after the first receptor identified. The karyopherins are subdivided
into importins and exportins to specify the direction of transport. The superfam-
ily counts 14 members in yeast and more than 20 in humans. Proteins carrying an
NLS or NES are bound by the respective karyopherin and transported through the
NPC. A small number of proteins is able to pass the NPC directly (e.g. β-catenin)
and also mRNAs use a different pathway (Ko¨hler and Hurt, 2007).
Importin-β is the most prominent member of the family, which is also reflected by
a high intracellular concentration of approximately 3µM (Kutay et al., 1997). Im-
port cargo recognition and protein import is mediated by adaptor proteins, which
bind the cargo-NLS and Importin-β simultaneously. Up to eleven adaptor pro-
teins are known so far and each heterodimer exhibits a different cargo specificity
(Fried and Kutay, 2003; Ja¨kel et al., 2002). In the classical import pathway the
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NLS of cytoplasmic cargoes is rst recognized and bound by Importin- , which
then associates with Importin- via its N-terminal Importin- -binding (IBB) do-
main. The ternary complex (NLS/Importin- / ) translocates trough the NPC
and dissociates upon Ran  GTP binding to Importin- in the nucleus.
Importin- is the typical structure of the superfamily (Figure 1.8). Two anti-
parallel -helices joined by a turn form the basic HEAT-repeat (Huntingtin, elon-
gation factor 3, protein phosphatase 2A, and the yeast kinase TOR1) element. The
overall protein consists of 19 such HEAT-repeats forming a short superhelix with
an N-terminal Ran-binding domain (Cingolani et al., 1999; Vetter et al., 1999).
Comparison of the seven available crystal structures of Importin- complexes
(Importin- , 1QGK; Ran, 1IBR; FxFG-Nucleoporin, 1F59; SREBP-2, 1UKL;
Nup1P, 1BPT; Snurportin, 2P8Q; Snail1, 3W5K) reveals individual binding sites
and modes of interaction for every interaction partner. The Importin exhibits a
high degree of exibility, creating binding sites by opening up repeats or wrapping
the superhelix around the binding partner (Stewart, 2003).
The passage through the nuclear pore is regulated by the NPC, which prevents
passive di usion of proteins larger than 40 kDa. The central tunnel of the NPC
is lined by FG (phenylalanine-glycine)-rich repeat-containing nucleoporins. Mem-
bers of the Importin- superfamily interact with these FG-repeats and facilitate
translocation without direct energy consumption. One transport model suggests
a gradient of increasing a nity through the pore, with the highest a nity of the
transport complex for the last nucleoporin (Ben-Efraim and Gerace, 2001; Py-
htila and Rexach, 2003). The identi cation of two FG-repeat-binding regions on
Figure 1.8: Crystal structre of Importin- .Stereo-view of the -helical
structure of Importin- , forming a superhelix.
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Importin-β initiated speculations about a multistep translocation process (Bed-
nenko et al., 2003). The importin could step from one nucleoporin to the adjacent
one by alternating detachment of one FG-binding site.
Apart from nucleocytoplasmic transport processes, Importin-β is involved in mi-
totic spindle assembly and nuclear envelope formation (refer to subsections 1.2.2,
1.2.3). Furthermore, Importinβ/α were reported to be part of the second, delayed
signaling wave after axonal injury (Guzik and Goldstein, 2004; Hanz et al., 2003).
Jakel et al. also assigned a cytoplasmic chaperone function to the Importin-β/-7-
complex (Ja¨kel et al., 2002) which, by shielding basic domains, prevents aggrega-
tion of certain proteins (e.g. histone 1) in the cytosol.
Nuclear transport factor 2 (NTF2)
The Ran-binding protein NTF2 was identified as an essential protein in yeast
(Corbett and Silver, 1996; Nehrbass and Blobel, 1996; Paschal et al., 1996). It is
a homodimer able to bind to Ran and FG-repeat-containing nucleoporins (Isgro
and Schulten, 2007). Since NTF2 transports Ran∗GDP back into the nucleus, it
is crucial for Ran-dependent nucleocytoplasmic transport (Ribbeck et al., 1998;
Smith et al., 1998). Mutants defective in Ran-binding disrupt protein-transport
and proper cell-cycle progression (Clarkson et al., 1997; Stewart et al., 1998).
The crystal structure of NTF2 shows a cone-shaped fold forming a distinctive
hydrophobic cavity surrounded by negatively charged residues (Bullock et al.,
1996). This specific fold is common to the members of the NTF2-like superfamily.
Due to the fact that this fold can accommodate many different sequences, this
superfamily comprises proteins without a common sequence motif and with or
without enzymatic activity. Examples for the NTF2-like superfamily are SnoaL
polyketide cyclase, scytalone dehydratase and Mba1 (multi-copy Bypass of AFG3).
NTF2 specifically binds Ran∗GDP and the interaction primarily involves the
switch II region (residues 65 - 78 of Ran), to a lesser extend switch I (39 - 43)(Stewart
et al., 1998). The binding to the switch region explains the nucleotide-specificity
of NTF2. The aromatic ring of Phe72 of Ran is buried in the hydrophobic cavity
of NTF2. This corresponds to 22% of the buried binding surface and is a major
contribution to complex formation. Furthermore, three salt bridges have been re-
ported to be essential for the interaction: Glu42NTF2 - Arg76Ran and D92/94NTF2 -
Lys71Ran. Mutation of these residues results in the loss of interaction between
NTF2 and Ran (Kent et al., 1999; Stewart et al., 1998).
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1.3 Protein lysine acetylation
Post-translational modification of proteins is a diverse and powerful regulatory
tool of living cells. The spectrum includes anorganic (e.g. phosphorylation) and
organic functional groups (e.g. acylation, glycosylation), proteins (e.g. ubiquity-
lation, SUMOylation), lipids (e.g. prenylation) and alterations of bonds or con-
formations (e.g. disulfide bonds, peptidy-prolyl-cis/trans-isomerization). Protein
acetylation is a kind of acylation taking place at the -amino group of lysines or
at the α-amino group of the N-terminal amino acid. Most eukaryotic proteins are
co-translationally acetylated at the N-terminus by a family of N-terminal acetyl-
transferases (NATs) (Arnesen et al., 2009; Brown and Roberts, 1976). In contrast
to lysine acetylation, N-terminal acetylation is an irreversible PTM. It is involved
in the regulation of protein degradation via the N-end rule (Scott, 2011), protein
targeting (Hwang 2010), metabolism and apoptotic processes (Hwang et al., 2010;
Scott et al., 2011).
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Figure 1.9: Impact of lysine acetylation.Comparison of chemical charac-
teristics of lysine and acetyl-lysine regarding (a) solvent remodeling, (b) elec-
trostatic and (c) hydrophobic interactions and (d) surface complementarity.
Reversible acetylation at the -amino group of lysines was first identified on his-
tones by Allfrey et al. in 1964 (Allfrey et al., 1964). It took more than twenty
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years until the first non-histone target of acetylation was discovered: the cytosolic
α-tubulin (L’Hernault and Rosenbaum, 1983). The tumor suppressor p53 and the
HIV transcriptional regulator Tat followed another decade later (Gu and Roeder,
1997; Ott et al., 1999). By now the existence of lysine acetylation in all organ-
isms, from bacteria to humans, is established knowledge (Kim and Yang, 2011;
Soufi et al., 2012).
The molecular effects of this relatively small modification on the lysine side chain
are diverse and provide a broad spectrum of regulatory modes of action (Figure
1.9). The effect of electrostatic quenching might be the most dominant effect.
Acetylation of the lysine side chain neutralizes the prominent positive charge,
which can entail drastic consequences for protein structure or protein-protein in-
teractions, e.g. by disrupting an essential salt bridge. The altered spacial de-
mand of acetyl-lysine is, furthermore, relevant for the surface complementarity
of two interaction partners, e.g. enzymes and substrate. The modification can
either create or disrupt a complementary interaction surface and consequently fa-
cilitate/strengthen or disrupt/weaken binding, respectively. The acetylation also
changes chemical characteristics of the side chain and thereby affects the hydropho-
bicity and the solvent-interaction (solvent remodeling) of the lysine residue.
1.3.1 Characteristics and regulation of lysine acetylation
Lysine acetylation is a reversible post-translational modification (PTM). The dy-
namics of this system originate from the existence of enzymes which generate
(writers) and remove (erasers) the modification in a regulated manner. The recog-
nition of the lysine acetylation by specific proteins (readers) allows for the signaling
function in several cellular processes.
Lysine deacetylases
The removal of the acetyl-moiety by hydrolysis is catalyzed by lysine deacety-
lases (KDACs). There are 18 human KDACs, subdivided into four classes (KDAC
I - IV): classes I, II and IV utilize a Zn2+-dependent mechanism, whereas KDAC
class III uses nicotinamide adenine dinucleotide (NAD+) as a cofactor. Enzymes
of KDAC class III are referred to as sirtuins- named after the yeast homolog Sir2
(silent information regulator), which was originally identified as a regulator of
transcriptional silencing of mating-type loci, telomeres and ribosomal DNA (Shore
et al., 1984). Based on sequence-based phylogenetic analysis mammalian sirtuins
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can be further subdivided into four classes (I - IV)(Table 1.4). Despite their
function as transcriptional regulators, sirtuins are also regarded as energy sen-
sors, since their NAD+-dependence establishes a direct link to the cell metabolism
(Imai et al., 2000). The activation of sirtuins was reported to be bene cial for
metabolism-related diseases (e.g. diabetes 2, obesity), neurodegenerative diseases
(Alzheimers, Parkinsons) and the stimulation of mitochondrial activity (reviewed
in (Houtkooper et al., 2012)). Of the seven human sirtuins only three (sirtuins
1, 2 and 3) exhibit a decent deacetylase activity, whereas the other members of
Table 1.4: Sirtuins
Sirtuin Class Localization Activity Target Refs.
Sirt1 I Nucleus, Deacetylation FOXO1, p53, (Daitoku et al., 2011; Lee and Gu, 2013)
cytosol Notch, NF- B, (Guarani et al., 2011; Kauppinen et al., 2013)
SREBP-1c (Ponugoti et al., 2010)
Sirt2 I Cytosol Deacetylation Tubulin, PEPCK, (Jiang et al., 2011; North et al., 2003)
FOXO1, PAR3 (Beirowski et al., 2011; Daitoku et al., 2011)
Sirt3 I Mitochindria Deacetylation GDH (Lombard et al., 2007)
SOD2, IDH2 (Qiu et al., 2010; Someya et al., 2010)
Sirt4 II Mitochondria ADP-ribosylation GDH (Haigis et al., 2006)
Sirt5 III Mitochondria Deglutarylation, (Park et al., 2013)
demalonylation,
desuccinylation
Sirt6 IV Nucleus Deacetylation, H3K9, H3K56 (Pan et al., 2011)
demyristoylation
Sirt7 IV Nucleolus Deacetylation H3K18 (Barber et al., 2012)
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the family have to be regarded as deacylating enzymes catalyzing demalonylation,
desuccinylation, deglutarylation or demyristoylation and ADP-ribosylation (Table
1.4)(Choudhary et al., 2014).
Lysine acetyltransferases
Lysine acetyltransferases (KATs) are ”writers” of lysine acetylation by transfer-
ring an acetyl-group from the co-factor acetyl-CoA to the -amino group of the
target lysine. So far, 22 different KATs were identified in human and mouse
(reviewed in (Lee and Workman, 2007; Roth et al., 2001)). Based on sequence-
and structural divergence these can be subdivided into five subfamilies: HAT1,
Gcn5/PCAF, MYST (MOZ, Ybf2, Sas2, Tip60), p300/CBP and Rtt109 (Fried-
mann and Marmorstein, 2013). All subfamilies share a structurally conserved
core region comprised of a three-stranded β-sheet and a helix, which is flanked by
divergent regions.
Interestingly, little to no sequence homology is present between the subfamilies
and, in conformity with this fact, all subfamilies employ different chemical strate-
gies for catalysis (Yuan and Marmorstein, 2013). However, they all need acetyl-
CoA as a cofactor to act as acetyl-donor and to stabilize the fold of the acetyl-
transferase domain (Yuan and Marmorstein, 2013). Figure 1.11 depicts the basic
mechanisms of the Gcn5-related- and the MYST-family KATs. Both families uti-
lize a conserved glutamate as general base to either directly (MYST) or indirectly
(via catalytic water, Gcn5-related KATs) activate the target lysine for the nucle-
ophilic attack on the thioester bond. In the case of MYST family KATs, this step
is preceded by the formation of an acetylated cysteine as a covalent intermediate.
Whereas no general base/acid was identified for Rtt109-transferases, p300/CBP
use a tyrosine as general acid.
KATs are regulated by a variety of different mechanisms. Changes of the subcel-
lular localization can shift the substrate spectrum without affecting the molecular
substrate specificity. The ubiquitin-dependent degradation of KATs is another
way of controlling KAT-levels and -activities. Furthermore, acetyltransferases are
often active in multiprotein-complexes and activity as well as substrate speci-
ficity has been observed to be influenced by the associated subunits (Shahbazian
and Grunstein, 2007). KATs are also subject to regulation by post-translational
modifications such as acetylation, phosphorylation or SUMOylation. Especially
activation by autoacetylation is a common phenomenon in the KAT superfamily.
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Figure 1.11: KATs utilize a direct attack mechanism of acetylation.
The catalytic mechanism is depicted for (a) Gcn5-related and (b) MYST family
acetyltransferases. Both families utilize a general base to catalyze the nucle-
ophilic attack of the lysine amine on the thioester bond. MYST KATs form
a covalent cysteine-intermediate before the acetyl-moiety is transferred to the
lysine side chain.
Bromodomain-containing proteins
Acetylated lysines are specifically recognized and bound by bromodomain-containing
proteins, also referred to as ”readers” of this PTM. The bromodomain was named
after the Drosophila protein brahma (Haynes et al., 1992; Tamkun et al., 1992).
The conserved domain consist of around 120 amino acids arranged in an all-α-
protein fold: a bundle of α-helices forming a hydrophobic pocket (Figure .1.12).
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Bromodomains are often found in KATs and proteins involved in gene transcrip-
tion (Jeanmougin et al., 1997). 46 acetyl-lysine-binding, bromodomain-containing
proteins are predicted to be encoded in the human genome (Filippakopoulos et al.,
2012).
a. b.
Figure 1.12: Structure and acetyl-lysine recognition of the PCAF
bromodomain. (a) Cartoon presentation of the PCAF bromodomain bound
to a lysine-acetylated peptide derived from histone H3 lysine 36. (b) The three
main ligand contact sites, important for the recognition of the acetyl-lysine, are
color-coded in red, blue and green. Modified after (Mujtaba et al., 2007)
1.3.2 Lysine acetylation as an emerging PTM
The rapid advances in high-resolution mass spectrometry (MS)-based proteomics
result in an overwhelming amount of acetylome data sets, screening a broad spec-
trum of organisms and conditions and identifying an increasing number of acety-
lated proteins and acetylation sites. The regulatory potential of lysine acetylation
in combination with the increasing number of identified acetylation sites prompted
the hypothesis of acetylation as a PTM with a relevance rivaling that of phospho-
rylation (Kouzarides, 2000). While the functions of histone-acetylation are well
studied, the roles of lysine acetylation are unclear for the majority of non-histone
proteins identified in the acetylome screens (Khan and Khan, 2010). However,
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due to the large number of analyzed organisms and conditions, several general
conclusions can be drawn by now.
The comparison of the acetylome of different organisms reveals, that acetylation
sites are frequently conserved across diverse organisms (Beltrao et al., 2012; Wein-
ert et al., 2011; Zhang et al., 2009). Despite the fact, that histone-acetylation is
well characterized, the majority of acetylation events occur on non-nuclear proteins
(Choudhary et al., 2009; Kim et al., 2006; Zhao et al., 2010). Although quantifi-
cation by MS-based proteomics is challenging, recent studies suggest a low overall
stoichiometry for the majority of sites under the conditions tested (Baeza et al.,
2014; Weinert et al., 2014). Interestingly, particularly mitochondrial proteins com-
prise a large proportion of the identified acetylation sites. The fact that this also
applies to bacterial proteins is in agreement with the endosymbiotic theory (van
Noort et al., 2012; Zhang et al., 2009).
An emerging body of evidence supports the theory of strong non-enzymatic protein
acetylation in mitochondria and bacteria (Guan and Xiong, 2011; Newman et al.,
2012). In mitochondria no acetyltransferase was identified so far, rather, does the
higher pH of the mitochondrial matrix increase the reactivity of lysine side chains.
Since the mitochondrial matrix is the primary site of acetyl-CoA metabolism, the
highly reactive lysines come in contact with high levels of reactive acetyl-donors,
such as acetyl-CoA. Mitochondrial levels of acetyl-CoA were reported to be 20- to
30-fold higher than cytosolic levels in yeast and rat, reaching up to millimolar levels
in mitochondria (Garland et al., 1965; Weinert et al., 2014). Non-enzymatic lysine
acetylation under these conditions is very likely. In fact, reproducing mitochon-
drial conditions in vitro resulted in non-enzymatic acetylation of mitochondrial
and non-mitochondrial proteins (Wagner and Payne, 2013). The observation that
mitochondrial acetylation always exerts an inhibitory effect led to the hypothesis
of acetylation being a response to carbon stress and mitochondrial sirtuins (es-
pecially Sirt3) acting as detoxifying enzymes in protein-quality control (Wagner
and Hirschey, 2014). Similar conditions were observed in bacteria (Weinert et al.,
2013). Protein acetylation correlates with the abundance of the reactive metabolic
intermediate acetyl-phosphate, e.g. increases in growth-arrested cells. The acety-
lation seems to be independent of the only E.coli acetyltransferase YfiQ (Pat in
Salmonella enterica) and the sole sirtuin-class deacetylase, CobB, regulates only
a small subset of sites (Lima et al., 2011; Starai and Escalante-Semerena, 2004).
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Furthermore, incubation of proteins under the bacterial conditions in vitro also
resulted in the acetylation of all sites identified in vivo.
Functional roles of lysine acetylation include:
1. Regulation of nucleic acid binding and protein-protein-interactions
2. Crosstalk with other PTMs
3. Regulation of enzymatic activity
4. Regulation of subcellular localization
1. Nucleic-acid binding and protein-protein interactions
The acetylation of histone-tails regulates the compaction of chromatin and, conse-
quently, transcription (Tse et al., 1998). While histone-tails are hyperacetylated
in euchromatin, they were found to be hypoacetylated in heterochromatin. The
interplay of (reversible) histone acetylation and -methylation regulates transcrip-
tional activation/inactivation. Another well established example is the acetyla-
tion of Tat by the acetyltransferase p300, which functions as a molecular switch
between two Tat-activities and is the rate-limiting step for viral replication (Fig-
ure 1.13.a). Non-acetylated Tat binds to TAR (transactivating response element)
Degradation
a.
b.
c. d.
cytosolic
nuclearActivation
            loop
TAR
pTEFb complex
Bromodomain
RNA Pol II
b.
Figure 1.13: Functional roles of lysine acetylation. (a) Tat-acetylation
regulates protein-protein interactions and functions as a molecular switch. (b)
Crosstalk between acetylation and ubiquitylation regulates SMAD7 (Mothers
against decapentaplegic homolog 7) stability. (c) Autoacetylation of p300 stim-
ulates its catalytic activity. (d) The subcellular localization of the E3-ubiquitin
ligase SKP2 (S-phase kinase associated protein 2) is controlled by acetyla-
tion/deacetylation of the NLS by p300/Sirt3. (modified after (Choudhary et al.,
2014)
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RNA, whereas acetylated Tat (on K50) binds the transcriptional coactivator PCAF
via its bromodomain which promotes association with the elongating RNA poly-
merase II and HIV gene transcription elongation (Dorr et al., 2002; Mujtaba et al.,
2002).
2. Cross-talk with other PTMs
The combination of several PTMs in one protein provides a different level of regu-
lation. The cross-talk between two modifications can either be competitive, due to
mutually exclusive modification sites, or non-competitive, if independent residues
are modified. In the case of ubiquitylation or SUMOylation a competitive crosstalk
is possible, since both modifications target lysine side chains. And actually one
third of all acetylation sites in human cells were also found to be ubiquitylated
(Wagner et al., 2011).
One example for the competitive cross-talk of acetylation and ubiquitylation is
the protein SMAD7 (Mothers against decapentaplegic homolog 7). Acetylation
of lysines 64 and 70 of SMAD7 by p300 prevents ubiquitylation (by SMURF
1) and subsequent proteasomal degradation (Figure 1.13.b). Deacetylation by
HDAC1, however, makes the lysines accessible for ubiquitylation and initiates the
degradation process (Gro¨nroos et al., 2002; Simonsson et al., 2005). The well
characterized tumor suppressor p53 provides two examples of non-competitive
cross-talk between two different kinds of PTMs. Firstly, acetylation of p53 prevents
the C-terminus from ubiquitylation and thereby stabilizes the protein. Secondly,
methylation of lysine 372, in response to DNA damage, promotes acetylation of the
adjacent lysine 373 and leads to transcription of p21 and cell cycle arrest (Ivanov
et al., 2007).
3. Regulation of enzymatic activity
Lysine residues are often found in catalytic sites of enzymes. Taking into account,
that lysine acetylation impacts drastically on the chemical characteristics of the
lysine side chain, this modification can easily regulate enzymatic activities. The
stimulation of catalytic activity by autoacetylation is known for several members
of the KAT-family, including Tip60, CBP, PCAF and Rtt109. P300, for example,
exhibits a low basal activity in the hypoacetylated state. Autoacetylation at five
lysines within the activation loop motif ( K1499/1549/1554/1558/1560) stimulates
the catalytic activity (Figure 1.13.c)(Thompson et al., 2004). This process is
probably induced by dimerization and reversed by Sirt2 (Black et al., 2008).
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4. Regulation of subcellular localization
Acetylation can also impact on the subcellular localization of proteins, since pos-
itively charged lysine residues are often part of subcellular localization signal do-
mains, e.g. monopartite NLS with a loose consensus sequence of K(K/R)X(K/R)
(Conti and Kuriyan, 2000; Fontes et al., 2000). The S-phase kinase associated
protein 2 (SKP2) is a E3 ubiquitin ligase involved in cell survival and tumori-
genesis. Acetylation of lysines in the NLS by p300 results in nuclear export and
cytoplasmic retention of SKP2. The ubiquitylation of E-cadherin in the cytoplasm
enhances cell migration. Deacetylation of the NLS by Sirt3 restores the original
nuclear localization of SKP2 (Figure 1.13.d).
1.3.3 Tools to study lysine acetylation
Quantitative mass spectrometry to study lysine acetylation
The increased interest in lysine acetylation of non-histone proteins is primarily
owing to major advances in high-resolution MS-based proteomics. Over the last
decade high-throughput analyses of different species/conditions identified thou-
sands of new acetylation sites and acetylated proteins. In contrast to serine- or
threonine phosphorylation, lysine-acetylated peptides are stable during MALDI-
and ESI-ionization and can be reliably identified by their specific marker ions at
m/z 126.1 and 143.1 (Trelle and Jensen, 2008). Most studies utilize the bottom-
up, or ”shotgun”, approach to analyze a complex mixture of proteins, e.g. cell
lysates. This method is based on the digestion of all proteins in the complex mix-
ture (cell- or tissue lysate) and subsequent, mostly antibody-based, enrichment
of modified peptides, followed by liquid chromatography and tandem MS. In con-
trast to the top-down approach, which analyzes intact proteins, the peptide-based
shotgun-method makes the assignment of protein isoforms and modification pat-
terns difficult. The predominant use of trypsin as a protease, furthermore, limits
the detection to trypsin-accessible acetylation sites. However, due to the lack of
efficient protein fractionation techniques the top-down approach was so far not
feasible for high-throughput acetylomics. Technical advances in the field, such as
the four-dimensional separation system by Tran et al. will close this gap in the
near future (Tran et al., 2011).
The generally low stoichiometry of lysine acetylation poses a high technical chal-
lenge for the identification of this PTM in complex protein mixtures. One way to
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Figure 1.14: MS-based global analysis of lysine acetylation. Scheme
of a typical bottom-up (shotgun) approach for large-scale acetylome studies.
The procedure involves enzymatic digestion, peptide fractionation and liq-
uid chromatography coupled to tandem MS. Software such as MaxQuant or
ProteomeDiscoverer are used for the computational analysis. (modified after
(Choudhary et al., 2014))
overcome this problem is the enrichment of acetylated peptides with acetyllysine-
specific antibodies. This procedure is an inherent part of the described bottom-up
approach, which drastically increases the number of identified acetylation sites.
However, the dependence on specific antibodies also limits the reproducibility
and complicates the interpretation of data, since target specificity, enrichment
efficiency and batch-to-batch variations of the antibody directly influence the ex-
perimental outcome (Shaw et al., 2011). The reduction of sample complexity
and increase of the dynamic range by fractionation also allows detection of low-
abundant proteins/modifications at the expense of increased input material and
measurement time. Fractionation is typically achieved by separating different
cellular compartments, electrophoresis of proteins and/or chromatographic sep-
aration of proteins/peptides. The increased speed and sensitivity of new mass
spectrometers reduces the importance of peptide enrichment and fractionation for
the detection of low-abundance proteins or modification.
Quantification
The quantification of detected PTMs is crucial for the interpretation of the bi-
ological relevance, especially against the background of increasing evidence for
non-enzymatic acetylation. The determination of absolute quantities is possible
by comparing the amount of modified peptide to an injected labeled peptide stan-
dard (e.g. AQUA-method). Due to the label the standard peak can be distin-
guished from the peptide peak and absolute quantity can be calculated from the
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peak ratios (Gerber et al., 2003). For high-throughput acetylome studies, relative
quantification techniques such as metabolic or chemical labeling are used as routine
in most labs. This approach can identify regulated acetylation sites by comparing
the peptide intensities under two or more distinct condition, without providing
an absolute stoichiometry. A schematic overview of the different quantification
methods is shown in Figure 1.15.
Using metabolic labeling, or SILAC (stable isotope labeling by aminoacids in cell
culture), up to three different conditions can be analyzed in parallel. The dif-
ferent cell populations are cultured in normal (light) medium and in medium
containing amino acids (lysine or arginine) labeled with stable, non-radioactive
isotopes (heavy). The incorporation of the isotopes results in chemically identi-
cal protein/peptides which can be attributed to the respective growth condition
by the detected mass difference. Thus, lysates of the conditions are combined
and analyzed together which reduces quantitative variability due to subsequent
biochemical manipulation/sample handling. This principle can also be used to
analyze de novo protein production. In that case, heavy medium is only added
for a short period of time (pulsed SILAC).
SILAC Chemical labeling Internal peptide
standard
Cells/tissue
Protein
Peptides
MS sample
Figure 1.15: Comparison of quantification strategies. Comparison of
quantification strategies based on labeling techniques or external standards.
The reference (label or standard) can be introduced at different stages of the
procedure.
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The major advantage of chemical isobaric labeling compared to metabolic labeling,
is the higher number of conditions/samples which can be analyzed in parallel. The
different isobaric labeling techniques (TMT,Tandem mass tag; iTRAQ, isobaric
tags for relative and absolute quantification) are based on isobaric mass tags, which
are chromatographically indistinguishable but fragment into reporter ions with
different masses during tandem MS. The number of analyzed conditions is merely
limited by the number of available isobaric tags (currently 8-plex for iTRAQ).
The samples are chemically labeled after proteolytic digestion and then combined
to be measured and analyzed together. This procedure is more susceptible to
variability and manipulations since the samples are combined much later than
in the case of SILAC. Label-free quantification uses peptide intensities (and less
often peptide counts) of two or more samples to determine relative abundances of
modified peptides.
Acetylation mimics as tools
To study the molecular effects of lysine acetylation in vitro, site-specifically acety-
lated proteins are important tools. However, these are difficult to obtain. Chemical
acetylation of recombinant proteins is not site-specific and does in most cases result
in a mixture of acetylated species if several acetyl-donors are available. The use of
recombinant acetyltransferases is an alternative to chemical acetylation. However,
the enzyme-specific sites often unknown and the degree of modification is difficult
to control and in most cases far from quantitative. Furthermore, the problem of
site-specificity also applies to in vitro KAT-catalyzed acetylation, since the target
specificity of KATs often depends on the formation of multi-protein complexes in
vivo. Thus, often more than one lysine is targeted by the enzyme in vitro. Na-
tive chemical ligation introduces the acetyl-lysine by ligating a modified synthetic
peptide with the recombinant protein core carrying an engineered N-terminus (re-
active cysteine at the end) (Figure 1.16) (He et al., 2003). This strategy is not
suitable to introduce acetyl-lysine in the core of the protein.
Acetylation mimics, such as glutamine and arginine, are often used to study the
effects of lysine acetylation in vivo and in vitro. Usually, glutamine is regarded as
the residue representing the acetylated lysine, whereas arginine mimics the non-
acetylated/acetylatable lysine. In terms of charge characteristics, this assignment
might be appropriate, however, with respect to the steric properties arginine is
the better mimic for acetyllysine.
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Figure 1.16: Chemical ligation for the modification of C- or N-
terminal domains. The acetyl-lysine is incorporated into the synthetic termi-
nal peptide, which is then ligated to the (recombinant) globular domain of the
protein by transthioesterification. Thioester rearrangement followed by desul-
furization results in the acetylated protein. (modified after (He et al., 2003))
Huang et al. presented MTCTK (methylthiocarbonyl-thiaLys) as an acetyl-lysine
analog (Huang et al., 2010). To create this analog, the lysine of interest is re-
placed by cysteine, which is then used as reactive nucleophile for the subsequent
alkylation (Figure 1.17). MTCTK, which was used for the functional characteriza-
tion of acetylated CK2 protein kinase, was shown to be recognized by site-specific
anti-acetyl-lysine antibodies and a bromodomain (Huang et al., 2010). A clear dis-
advantage of this technique is the need for removal of all additional cysteines from
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Figure 1.17: Acetyl-lysine-analog by alkylation of cysteines.(a)The
alkylation of cysteine with Methylthiocarbonyl-aziridine yiels an acetyl-lysine
analog. (b) In comparison to acetyl-lysine several chemical properties of the
analog are altered by the carbon-sulphur-exchange.
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the sequence. The replacement of one carbon by sulphur, furthermore, changes
several chemical properties compared to acetyl-lysine (bond-length and -angle, pKa
of amine). At this point trifluoro-acetyl-lysine- and thio-acetyl-lysine-analogs of
acetyl-lysines have to be mentioned, since they are valuable tools for deacetylase-
structure determination and for the development of deacetylase inhibitors. How-
ever, the problem of site-specific incorporation into proteins remains.
1.3.4 Genetic code expansion concept
The co-translational incorporation of modified amino acids is an elegant method
to study post-translationally modified proteins, such as acetylated proteins, in
vitro. In contrast to the techniques described above (chemical ligation, mimics
and cysteine-based analogs, chemical and enzymatic acetylation) the genetic code
expansion concept (GCEC) provides quantitatively and site-specifically acetylated
material. The incorporation is possible at any position of the protein and also
double- or multi-acetylated proteins can be generated. The deficiencies of mimics
and analogs are avoided and the lysine-acetylated material can even be used to
assess the validity of indispensable mimics/analogs. This is especially valuable
when it comes to in vivo experiments since the application of Q/R-mimics is still
the easiest/established/prevalent way to study lysine acetylation in cells. However,
over the last decade the GCEC was already extended to yeast, D.melanogaster,
C.elegans and mammals/mammalian cells (Bianco et al., 2012; Greiss and Chin,
2011; Hancock et al., 2010; Kang et al., 2013; Wang et al., 2007).
Genetic code expansion is the artificial extension of the genetic code by one ore
more codons to co-translationally incorporate non-proteinogenic amino acids at
specific positions of a protein. Several prerequisites have to be fulfilled in order to
make use of the GCEC:
• The amino acid to incorporate must not be among the encoded proteinogenic
amino acids of the target organism.
• An unused codon has to be available to encode the desired amino acid.
Often rare stop-codons or four-base codons (in combination with evolved
ribosomes) are used. The amber codon (UAG), for example, is the least
used codon in E.coli and therefore predestined for GCEC.
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• The orthogonal tRNA has to specically recognize the target codon.
• An orthogonal tRNA-synthetase to load the speci c tRNA with the arti cial
amino acid has to be introduced.
Most importantly, the orthogonal tRNA-synthetase/tRNA-pair must not cross-
talk with endogenous tRNAs/tRNA-synthetases by still being functional with the
endogenous translation machinery (e.g. ribosomes). The modi ed amino acid
has to be provided to enable the incorporation, otherwise the translation stops
at the corresponding codon. Often the endogenous transport machinery can be
utilized to import the supplied amino acid from the culture medium. However,
in the case of acetyl-lysine it is still unknown how the amino acid is taken up by
E.coli. Alternatively, a biosynthetic pathway can be engineered or incorporated
to produce the residue (Da Silva and Sheppard, 2015). Figure 1.18 illustrates the
incorporation of acetyl-lysine into a recombinant protein in E.coli.
AA-tRNA-Synthetase
tRNATAG
AcK
site-specifically
acetylated Ran
aa-tRNA-
Synthetase
5‘ 3‘UAG
CUA
CUA
AcK
AcK
AcK
Ribosome
Figure 1.18: Genetic-code expansion concept.Schematic presentation of
the incorporation of acetyl-lysine by expansion of the genetic code. Acetyl-lysine
(AcK) is supplemented to the medium and taken up by E.coli. The orthogonal
tRNA is charged with AcK by the orthogonal acyl-lysyl-tRNA-synthetase. The
incorporation of the acely-lysine in response to the introduced amber-codon
occurs co-translationally, resulting in a site-speci cally acetylated protein.
In 2008, Neumann et al. presented an orthogonal N-( )-acetyl-lysyl-tRNA-synthe-
tase/tRNACUA-pair for the incorporation of acetyl-lysine in E.coli (Neumann
et al., 2008). The synthetase and its cognate suppressor tRNA were derived
from the pyrrolysyl-tRNA-synthethase from Methanosarcina barkeri. Based on
the crystal structure of the homologous enzyme from M.mazei promising residues
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of the active site were chosen for several rounds of selection for acetyl-lysine instead
of pyrro-lysine. The proof of principle was provided one year later by successful
acetylation of histone H3 at lysine K56 (Neumann et al., 2009). Furthermore, in
2010 Lammers et al. could solve the first crystal structure of a lysine-acetylated
protein, CypA, and its complexes with HIV-1 capsid and cyclosporin (Lammers
et al., 2010). This study demonstrated that this technique has the capacity to
provide high yields of homogeneously acetylated protein, suitable for biophysical
characterization and X-ray crystallography.
1.4 Acetylation of Ran
In 2009 the global human lysine acetylome was analyzed by high-resolution mass
spectrometry (Choudhary et al., 2009). In three different human cell lines a sum of
3600 lysine acetylation sites on 1750 proteins were identified by a typical shotgun
(bottom-up) approach. Furthermore, the effect of two deacetylase inhibitors on
the acetylome was investigated/quantified. Metabolic labeling (SILAC) was used
to enable quantification. After tryptic digest acetylated peptides were enriched
with specific AcK-antibodies and isoelectric focussing was applied as an additional
fractionation step.
The small G-protein Ran was found to be acetylated at five (out of eighteen)
lysines: K37, K60, K71, K99 and K159. Close inspection of available crystal
structures of Ran and Ran-complexes suggested a strong impact of acetylation
on protein function or protein-protein interaction for several of the lysines. Two
of the modified lysines, namely K37 and K71, are part of switch I and switch
II, respectively, and thus located at the binding interface of Ran-effectors and
-regulators (RCC1 and RanGAP). Especially K71 of Ran might be of major im-
portance, since it is located in the switch II region of the G-domain of Ran. Due to
the close proximity to Q69 (Q61 in Ras), which is important for positioning of the
catalytic water molecule essential for GTP hydrolysis, acetylation may influence
the hydrolysis of GTP by changing the orientation of Q69. Furthermore, steric
effects or induced conformational changes could block the access to GDP/GTP.
In addition, lysine 71 forms two essential salt bridges to D92 and D94 of NTF2.
It is reported that disruption of these salt bridge abolishes NTF2-binding (Kent
et al., 1999; Stewart et al., 1998).
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Figure 1.19: Ran acetylation sites and possible effects.Cartoon-
presentation of Ran (yellow) with GppNHp (blue) bound (PDB: 1K5D). The
switch regions are highlighted in green (switch I ligth-green, switch II dark-
green) and the five reported acetylated lysines are shown as sticks (red). Possi-
bly affected interactions/processes are named for each acetylation site.
As visible from the crystal structure of Ran and Importin-β (PDB:1IBR), ly-
sine 159 interacts with a negatively charged, acidic patch of the import receptor.
Acetylation of that residue could directly impact on the interaction and conse-
quently influence thermodynamic or kinetic parameters of the interaction. Lysine
99 of Ran forms a salt bridge with D128 of RCC1, which might be influenced by
electrostatic quenching upon acetylation.
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1.5 Aim of this thesis
Ran was shown to be acetylated at five distinct lysines (K37, K60, K71, K99
and K159) in human cell lines. However, the physiological relevance of this post-
translational modification of Ran is unclear. In order to judge the significance of
Ran-acetylation in the biological context, the following questions regarding molec-
ular effects, stoichiometry and regulation of Ran-acetylation had to be answered.
1. How does Ran-acetylation impact on Ran-function and -interactions?
I used the genetic code expansion concept to produce Ran site-specifically acety-
lated at each of the five identified acetylation sites. All acetylated Ran variants
(AcKs) were compared to unmodified Ran (Ran wt) regarding intrinsic prop-
erties (stability, nucleotide binding), protein functionality (nucleotide exchange/-
hydrolysis) and the interaction with Ran-interacting proteins in vitro. The RanGEF
RCC1, the major import receptor Importin-β and the Ran-shuttling protein NTF2
were analyzed, since an effect of Ran-acetylation on these interactions was likely,
as judged by available structural data. Protein-protein interactions were charac-
terized by isothermal titration calorimetry (ITC) to obtain binding affinities and
thermodynamic parameters (enthalpy, entropy, stoichiometry and free energy).
Stopped-flow fluorescence spectroscopy was used to determine association kinetics
for the Importin-β-Ran association and to compare the RCC1-catalyzed nucleotide
exchange on Ran wt and all five Ran AcKs. Cell culture experiments with acetyla-
tion mimics (Q and R) provided information on acetylation-dependent alterations
in Ran localization.
2. How abundant is this PTM of Ran in mammalian cells and under
which conditions is up- or downregulation taking place?
The acetylation of Ran had to be verified on protein level by immunodetection
after isolation from mammalian cell lysate. Either acetyl-lysine or Ran was used
as target for affinity enrichment by specific antibodies (against acetyl-lysine) or
Ran-specific binding proteins (RCC1). Another aim was the estimation of the
stoichiometry of Ran-acetylation in mammalian cells and the influence of stress-
or growth-conditions with on the acetylation dynamics.
3. How is this modification regulated on the cellular level?
Finally, I wanted to identify Ran-specific acetyltransferases and deacetylases to
gain insight into the regulation of Ran-acetylation.

Chapter 2
Material and Methods
2.1 Materials
2.1.1 Primer
Table 2.1: Cloning primer
Name sequence (length) Enzyme
GEXRanflfoB CGGGATCCATGGCTGCGCAGGGAG (24) BamHI
RanflrevE CGGAATTCCGTTACAGGTCATCATCCTC (28) EcoRI
GEXRan8foB CGGGATCCCAGGTCCAGTTCAAAC (24) BamHI
RSFRan1foB CGCGGATCCCGGAATGGCT GCGCAGGGAGAGC (32) BamHI
RSFRan8foB CGCGGATCCCGGACAGG TCCAGTTCAAAC (29) BamHI
Ran213revE CGGAATTCCGTTAATCCTCATCCGGGAGAGC (31) EcoRI
Ran177revE CGGAATTCCGTTAAACAAATTCCAAGTTAG (30) EcoRI
RSFRan1foB CGCGGATCCCGGAATGGCTGCGCAGGGAGAGC (32) BamHI
RSFRan8foB CGCGGATCCCGGACAGGTCCAGTTCAAAC (29) BamHI
EGFPRan1foE CCGGAATTCCATGGCTGCGCAGGGAGAGCC (30) EcoRI
EGFPRan216revB CGCGGATCCCAGGTCATCATCCTCATCCGGG (31) BamHI
GEXImp1foB CGCGATCCATGGAGCTGATCACCATTC (28) BamHI
GEXImp862revN TTTAGCGGCCGCATTCTTATTTAAGCTTGGTTCTTCAGTTTC (42) NotI
GEXRCC149foB CGGGATCCAAGGTCTCACACAGGTCC (26) BamHI
GEXRCC1444revX CCGCTCGAGCGGTTATTCTTTGTCCTTGAC (39) XhoI
GEXNTF2revX CCGCTCGAGCGGTCAGCCAAAGTTGTGC (28) XhoI
GEXNTF2foE CCGGAATTCCGGATGGGAGACAAGCC (26) EcoRI
39
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Table 2.2: Quick change primer
QCRan37amber GGTGAATTTGAGTAGAAGTATGTAGCCACCTTGGG 35
QCRanK37Q GGTGAATTTGAGCAGAAGTATGTAGCCACCTTGGG 35
QCRanK37R GGTGAATTTGAGAGGAAGTATGTAGCCACCTTGGG 35
QCRanK60amber CAACAGAGGACCTATTTAGTTCAATGTATGGGAC 34
QCRanK60Q CAACAGAGGACCTATTCAGTTCAATGTATGGGAC 34
QCRanK60R CAACAGAGGACCTATTAGGTTCAATGTATGGGAC 34
QCRanK71amber CACAGCCGGCCAGGAGTAGTTCGGTGGACTGAGAG 35
QCRanK71Q CACAGCCGGCCAGGAGCAATTCGGTGGACTGAGAG 35
QCRanK71R CACAGCCGGCCAGGAGAGATTCGGTGGACTGAGAG 35
QCRanK99amber GAGAGTTACTTACTAGAATGTGCCTAACTGG 31
QCRanK99Q GAGAGTTACTTACCAGAATGTGCCTAACTGG 31
QCRanK99R GAGAGTTACTTACAGGAATGTGCCTAACTGG 31
QCRanK159amber GTAACTACAACTTTGAATAGCCCTTCCTCTGGCTTGC 37
QCRanK159Q GTAACTACAACTTTGAACAGCCCTTCCTCTGGCTTGC 37
QCRanK159R GTAACTACAATTTGAAAGGCCCTTCCTCTGGCTTGC 37
2.1.2 Vectors
The expression vector for GST-tagged protein expression, pGEX4T5 TEV, is
based on the commercially available pGEX4T1 (GE healthcare). However, a TEV
(tobacco etch virus) protease cleavage site was inserted between the Thrombin
cleavage site and the first restriction site of the multiple cloning site (MCS). The
Thrombin cleavage site as well as the reading frame were not affected by the
insertion.
The commercially available pRSF-Duet-1 (Novagen) was modified as follows (refer
to Appendix...): The evolved acetyl-lysyl-tRNA-synthethase AcKRS-3 (AcKRS of
M.barkeri with mutations: L266M, L270I, Y271F, L274A, C313F) was cloned
under the control of an glnS promoter/terminator using SphI (Neumann et al.,
2008). It also contains the PylT gene under the control of an lpp promoter and
a rrnC terminator. For additional information on the sequence and cloning of
the synthetase/tRNA please refer to Appendix A.1. Furthermore, the His6-tag
sequence was modified (MGSSH6- to MPSSH6-) by Quickchange PCR to prevent
α-N-6 phosphogluconoylation of the tag (Referenz, Geoghegan 1999). Target pro-
tein genes (Ran AcKs) carrying the amber codon were cloned with BamHI/EcoRI,
utilizing MCS I and II.
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2.1.3 Buffers and solutions
GSH-affinity chromatography
Buffer GST I 25 mM Tris/HCl, pH 8.0
500 mM NaCl
5 mM MgCl2
5 mM β-ME
100µM PMSF
Buffer GST II 25 mM Tris/HCl, pH 8.0
250 mM NaCl
5 mM MgCl2
5 mM β-ME
Buffer GST III 25 mM Tris/HCl, pH 8.0
100 mM NaCl
5 mM MgCl2
5 mM β-ME
Buffer GST IV 25 mM Tris/HCl, pH 8.0
100 mM NaCl
5 mM MgCl2
5 mM β-ME
30 mM GSH
Ni-affinity chromatography
Buffer His I 25 mM Tris/HCl, pH 8.0
500 mM NaCl
5 mM MgCl2
10 mM Imidazole
2 mM β-ME
100µM PMSF
Buffer His II 25 mM Tris/HCl, pH 8.0
1 M NaCl
5 mM MgCl2
10 mM Imidazole
2 mM β-ME
Buffer His III 25 mM Tris/HCl, pH 8.0
300 mM NaCl
5 mM MgCl2
10 mM Imidazole
2 mM β-ME
Buffer His IV 25 mM Tris/HCl, pH 8.0
300 mM NaCl
5 mM MgCl2
500 mM Imidazole
2 mM β-ME
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Buffer V 50 mM Tris/HCl, pH 7.5
(size-exclusion chromatography) 100 mM NaCl
5 mM MgCl2
2 mM β-ME
Assay-buffers
Phosphate buffer 30 mM KPi
(measurement buffer) 5 mM MgCl2
2 mM β-ME
HPLC-buffer 100 mM KPi, pH 6.4
10 mM TBAB
2% (v/v) Acetonitrile
(20% (v/v) Acetonitrile for mant-nucleotides)
KDAC-assay buffer 25 mM Tris/HCl, pH 8.0
137 mM NaCl
2.7 mM KCl
1 mM MgCl2
0.1 mg/ml BSA
0.5 mM NAD+
KAT-assay buffer 50 mM Tris/HCl, pH 7.3
50 mM KCl
0.1 mM EDTA
1 mM DTT
5% (v/v) Glycerol
SDS-PAGE and immunoblotting
SDS-PAGE Running buffer 25 mM Tris/HCl, pH 8.3
192 mM Glycine
2% (w/v) SDS
Sample buffer 50 mM Tris/HCl, pH 6.8
50% (v/v) Glycerol
500 mM DTE
10% /w/v) SDS
0.5% (w/v) Bromphenolblue
Staining solution 40% (v/v) Methanol
10% (v/v) Acetic acid
0.4% (w/v) Coomassie blilliant blue R-250
0.4% (w/v) Coomassie blilliant blue G-250
Destaining solution 20 % (v/v) Ethanol
10% (v/v) Acetic acid
Transfer buffer 25 mM Tris, base
(semi-dry) 150 mM Glycine
10% (v/v) Methanol
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Media, Antibiotics, Inhibitors
LB-medium (1l) 10 g NaCl
10 g Tryptone
5 g Yeast extract
stock end concentration
Ampicillin 100 mg/ml 0.1 mg/ml
Kanamycine 25 mg/ml 0.025 mg/ml
PMSF 100 mM 0.1 mM
Trichostatin A (TSA) 5 mM 1µM
SAHA 10 mM 2µM
Butyrate 1 M 1 mM
Nicotinamide 2 M 10 mM
2.2 Biomolecular methods
2.2.1 Cloning
Fragments were amplified with Phusion Polymerase (NEB) using the manufactur-
ers protocol. The used oligonucleotide-primers provided the neccessary consensus
sequence for the restriction enzymes (Table 2.1). Inserts were amplified by PCR,
purified by gel extraction (QIAquick Gel Extraction Kit), digested according to
the manufacturers protocol (NEB) and subsequently purified by PCR-purification
(QIAquick PCR purification Kit). Vector DNA was digested and furthermore de-
phosphorylated prior to purification. After ligation by T4 DNA Ligase (NEB),
plasmids were transformed into NEB5α cells (NEB). The identification of posi-
tive clones was done by analytical PCR (colony PCR) using 5 Prime Mastermix
(5Prime), scraped cells of the colony as template and primers specific for the target
vector. The amplified fragment was separated by agarose gelelectrophoresis and
stained with SybrSafe (ThermoScientific).
2.2.2 Purification of DNA
Plasmid-DNA was purified using commercially available kits from Qiagene. Either
the QIAprep Spin Miniprep kit or the QIAGEN Plasmid Midi kit was used.
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2.2.3 Transformation
100 µl of chemocompetent E. coli cells (NEB5α or BL21 (DE3)) were incubated
with 20-100 ng Plasmid-DNA or 10-20µl ligation mix for 30 min on ice. Following
a heatshock for 2 min at 42 ◦C, 800µl LB-medium were added and the cells were
allowed to recover for 45 min at 37 ◦C. Cells were pelleted and plated on agar plates
containing the selection-antibiotics.
2.3 Biochemical methods
2.3.1 Preparative expression of recombinant proteins
Four to five colonies were picked from the agar plate and transfered to 200 ml LB-
medium containing the appropriate antibiotic. After growth over night at 37 ◦C
and 140 rpm, this pre-culture was used to inoculate 10 l of LB medium at a ratio
of 1:100. The expression culture was grown at 37 ◦C and 160 rpm until the optical
density at 600 nm (OD600) reached 0.5 and 0.8 for expression of acetylated and
unacetylated proteins, respectively.
For unacetylated (GST-tagged) proteins the protein expression was induced by
addition of 100µM IPTG to the culture at an OD600 of 0.8. To incorporate
acetyllysine into the target protein, the temperature was decreased to 20 ◦C at an
OD600 of 0.5 and 10 mM of N-()-acetyl-L-lysine (Chem-Impex Int.) and 20 mM
nicotinamide (AppliChem) were added to the culture. After 30 min protein
expression was induced with 100 M IPTG. After induction both cultures were
grown over night at a reduced temperature of 20 ◦C and pelleted at 4000 x g for
20 min. The pellet was resuspendet in 150 ml of buffer I and stored at -80 ◦C.
2.3.2 Lysis of cells
The resuspended pellet was thawed and cells were lysed by sonicating 3 x 2 min.
A Branson Sonifier 250 was used with 60% duty cycle and micro tip limit 8. The
lysate was cleared from unsoluble components and cell debris by centrifugation at
50000 x g for 45 min.
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2.3.3 Purification of recombinant proteins
To purify recombinant proteins A¨KTApurifier systems (GE healthcare) were used,
providing constant flow and pressure conditions. The systems furthermore recorded
the absorptions at 220 nm and 280 nm, which facilitates the monitoring of the pu-
rification procedure and the identification of elution fractions containing protein.
All purification steps were carried out at 4 ◦C.
Table 2.4: Purification strategies for recombinant proteins
Protein Vector Resistance Column MWCO Superdex
Ran wt pGEX4T5 TEV Amp GST 10 kDa S 75
Ran KxQ/R pGEX4T5 TEV Amp GST 10 kDa S 75
NTF2 pGEX4T5 TEV Amp GST 3 kDa S 75
RCC1 49-444 pGEX4T5 TEV Amp GST 30 kDa S 200
Importin-β pGEX4T5 TEV Amp GST 30 kDa S 200
Ran KxAcK pRSFDuet Kan Ni-NTA 10 kDa S 75
GSH-affinity chromatography
The cleared lysate was applied to a buffer-equilibrated GSH-column (buffer GST
I), packed with 40 - 60 ml of PureCube Glutathion Agarose (Cube Biotech) ma-
terial. The column-bound protein was washed with 5-10 column volumes (CV)
wash buffer (buffer GST II), followed by 2 CV TEV-cleavage buffer (buffer III).
TEV-protease was added and circulated over night at 4 ◦C. The cleaved protein
was eluted with buffer GST III. Depletion of the His-tagged TEV-protease was
achieved by affinity capture using Ni-Sepharose 6 Fast Flow (GE healthcare).
The protein was concentrated by ultrafiltration with AmiconUltra centrifugal fil-
ter devices with appropriate pore sizes (molecular weight cut-off 3, 10 or 30 kDa).
Subsequently a size-exclusion chromatography (Superdex S75 or S200, GE health-
care) was carried out with buffer V. The pure protein was concentrated again,
flash frozen in adequate aliquots and stored at -80 ◦C.
Ni-affinity chromatography
The cleared lysate was applied to a buffer-equilibrated Ni-NTA column (buffer His
I), packed with 40 - 60 ml of Ni-Sepharose 6 Fast Flow (GE healthcare) material.
The column-bound protein was washed with 5-10 column volumes (CV) high salt
buffer (buffer His II) followed by 2 CV buffer His III. To elute the protein from
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the column a gradient from 10 mM to 500 mM imidazole (buffer His III to IV)
over 10 CVs was applied and the eluate collected in 4 ml-fractions. The fractions
containing the target protein were identified by SDS-PAGE and pooled for ultrafil-
tration. Subsequently a size-exclusion chromatography was carried out with buffer
V. The pure protein was concentrated again, flash frozen in adequate aliquots and
stored at -80 ◦C.
Regeneration of column material
GSH-columns were flushed with 2 CV GSH-containing buffer (buffer GST IV) to
elute the TEV-cleaved GST and uncleaved GST-fusion protein, still bound to the
column. A sample of this step was also applied to SDS-PAGE to quantify the
cleavage efficiency. The column was furthermore flushed with 3 CV water, 2 CV
guanidinium hydrochloride and finally 5 CV water.
Ni-NTA columns were treated with 1 CV 3 M Imidazole, followed by 3 CV wa-
ter, 2 CV guanidinium hydrochloride and 5 CV water. For long term storage all
columns were equilibrated with 20% (v/v) ethanol.
2.3.4 Analytical size-exclusion chromatography
150µM protein (Ran wt/AcK71/K71Q and NTF2) in phosphate buffer was applied
to a Superdex S75 10/300 column at a flow-rate of 0.6 ml/min. Eluting protein was
detected by absorption at 280 nm. Equimolar mixtures (Ran wt/AcK71/K71Q-
NTF2) were incubated on ice for 30 min to allow complex formation prior to size
exclusion chromatography.
2.3.5 Determination of protein concentration
To determine protein concentrations the absorption at 280 nm was measured and
the Lambert-Beer law was applied.
A =  · c · l (2.1)
with the absorbance A, the absorption coefficient  (M−1cm−1), the protein con-
centration c (M) and the path length l (cm).
Due to the absorption of the bound nucleotide at 280 nm, the concentration of
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Ran could not be determined by the Lambert-Beer law. Instead the Bradfor-
dUltra assay (Expedeon) was used. In this assay the colorimetric reaction of
Coomassie brilliant blue G-250 with amino acid side chains is used as a read-out
at 595 nm. The quantification was based on standard curves with bovine serum
albumin (BSA).
2.3.6 SDS-Polyacrylamide gelelectrophoresis (SDS-PAGE)
Denaturing, discontinuous SDS-polyacrylamide gelelectrophoresis according to Laemmli
was used to separate protein mixtures. Tris-Glycine gels with 5% stacking gel and
12-15% separation gel were run for 45 - 60 min at 200 V. All proteins were stained
with staining solution and destained with an ethanol/acetic acid mixture (see
buffers).
2.3.7 Western blotting and immunodetection
Following SDS-PAGE, protein transfer onto a methanol-activated PVDF mem-
brane (GE Healthcare) was achieved by semidry electrotransfer in transfer buffer
at 150 mA for 45 min. 3% (w/v) milk powder in PBST was used as blocking solu-
tion (30 min). Primary antibodies were diluted in blocking solution according to
the manufacturers protocol and incubated with the membrane over night at 4 ◦C
(Table 2.5). The membrane was washed three times 10 min with PBST. HRP-
coupled secondary antibodies were used as 1:10000 dilution in blocking solution
and incubated with the membrane for 30 - 60 min at room temperature. After
three washes with PBST, 5 min each, signal development was done with RotiLu-
min (Roth) in the darkroom.
To strip the PVDF-membrane of antibodies for subsequent detection with a dif-
ferent antibody, 0.2 M NaOH was applied for 2 x 10 min. After three washing steps
with PBST, the immunodetection procedure was repeated, starting with the block-
ing step. Used PVDF membranes could be stored in a dried state and reactivated
by a short incubation in methanol.
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Table 2.5: Antibodies
Antigen Catalog nr. Species Dilution
Ran ab4781 rabbit 1:2500
AcK ab21623 rabbit 1:1500
His6-tag ab18184 mouse 1:2000
NTF2 ab137192 rabbit 1:1500
Sirt2 ab75436 rabbit 1:500
Myc ab24740 rabbit 1:1000
GST 71097 (Novagen) mouse 1:1000
rabbit-IgG (HRP) ab6721 goat 1:10000
mouse-IgG (HRP) ab6728 rabbit 1:10000
2.3.8 Nucleotide exchange on Ran protein
Nucleotide exchange on the small GTPase Ran was done in buffer V. 3 - 10 mg
protein were incubated with a 5-fold molar excess of nucleotide (GTP, GppNHp,
GTPγS and mant-labelled nucleotides) in the presence of catalytic amounts of
GST-RCC1. If a non-hydrolyzable nucleotide was to be loaded, 1µl of calf intesti-
nal phosphatase (CIP, NEB) was added to the reaction to hydrolyze GDP/GTP.
GST-RCC1 was removed with Glutathion-Agarose beads and Ran was separated
from excess nucleotide by size-exclusion chromatography. All nucleotides were
purchased from Jena Biosciences. Alternatively, the nucleotide was exchanged by
addition of a 2-fold molar excess of EDTA in the presence of desired nucleotide
(similar ratios as for RCC1-method). After 2 h on ice, a 1.5-fold molar excess of
MgCl2 over the EDTA-concentration was added to stabilize the nucleotide bind-
ing. In analogy to the other method, Ran was separated from excess nucleotide
by size-exclusion chromatography.
2.3.9 High pressure liquid chromatography (HPLC)
The identity of bound nucleotides was determined by reversed-phase high pressure
liquid chromatography (RP-HPLC) with buffer containing tetrabutylammonium
bromide (TBAB, Sigma ) at a flowrate of 2 ml/min. As solid phase a Chromolith-
Performance RP-18e 100 - 4.6 mm column (Merck) was used. The protein (30µl)
was denatured at 95 ◦C for 5 min and subsequently pelleted at 13,000 x g. The
supernatant was applied to the RP-HPLC. TBAB interacts with phophates and
thereby increases the hydrophobicity of nucleotides dependent on the number of
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available phosphates. Consequently GDP elutes earlier than GTP. Eluting nu-
cleotides were detected by absorption at 254 nm. 20% (v/v) acetonitrile (instead
of 2%) were used for mant-labeled nucleotides since these are more hydrophobic
and do not elute from the column with 2% (v/v) acetonitrile. The column was
washed and stored in 20% (v/v) acetonitrile.
2.3.10 Activity Test for Deacetylases
Deacetylases were purchased from Biomol or Sigma (Table 2.6). All deacetylases
were recombinantly expressed either in E.coli (sirtuins 1 - 5) or in a baculovirus
expression system (HDACs 1 - 11, sirtuins 6 and 7). 1000 pmol Fluor-de-Lys sub-
strate (fluorogenic HDAC substrate 2a or 3, Biomol, see Table 2.6) were incubated
with buffer (background) or HDAC 1 - 11 in triplicates for 30 min at 37 ◦C. Devel-
oping solution (trypsin, Sigma) was added and after incubation for 10 min at RT
the fluorescence intensities were determined (exc. 350 nm, em. 450 nm). For the
sirtuin activity assay 250 pmol fluorogenic Sirt2 substrate (Sigma) were used. The
amount of enzyme per well corresponded to a turnover of 1000 pmol/h (HDACs)
and 250 pmol/h (sirtuins), as specified by the manufacturer.
2.3.11 KDAC-Screen
The KDAC-screen was done in KDAC-assay buffer. 100 pmol recombinant Ran
(wt or AcK) was incubated with deacetylase or buffer (negative control) for 3 h
at 25 ◦C. Each condition was set up as triplicates in 20µl in a 96-well-plate. As
read-out, a dot-blot procedure with 1µl per well on a nitrocellulose membrane
was performed, followed by immunodetection with the anti-acetyl-lysine antibody
(AcK, see Table 2.5). Equal loading was verified by immunodetection of the His6-
tag of Ran. The AcK-fluorescence intensities were normalized based on the His-
background. The amounts of enzyme used for the screen were adjusted based
on the enzymatic activity determined in the preceding activity test: amount was
normalized to correspond to 40-fold intensity increase over the background. This
experiment was conducted together with P.Knyphausen.
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Table 2.6: Human KDACs
KDAC Construct Affinity-tag Activity Conc.
(Biomol) (pmol / min /µg) (mg/ml)
HDAC1 full-length C-term. His/Flag-tag 460 0.56
HDAC2 full-length C-term. His-tag 675 0.75
HDAC3 full-length C-term. His-tag 3000 1.1
HDAC4 627 - 1084 N-term.GST-,C-term.His-tag 103255 0.24
HDAC5 657 - 1123 C-term. His-tag 2521 1.65
HDAC6 full-length N-term. GST-tag 219 1.5
HDAC7 518 - end N-term. GST-tag 26437 0.04
HDAC8 full-length C-term. His-tag 298 1.56
HDAC9 604 - 1066 C-term. His-tag 3137 1.76
HDAC10 1 - 481 N-term.GST-, C-term.His-tag 2.4 0.13
HDAC11 full-length N-term. GST-tag 3.7 0.09
Sirt1 193 - 741 N-term. GST-tag 30.1 0.2
Sirt2 50 - 356 C-term. His-tag 1 0.26
Sirt3 102 - 399 N-term. GST-tag 6.5 0.07
Sirt4 25 - 314 N-term. GST-tag - 0.32
Sirt5 full-length N-term. GST-tag 3.6 0.94
(Sigma) (RLU/min/ng)
Sirt6 full-length His-tag 120 0.1
Sirt7 full-length His-tag 140 0.1
2.3.12 Deacetylase (KDAC)-Assays
Deacetylase assays were done in KDAC-assay buffer. 100 pmol of acetylated Ran
were incubated with catalytic amounts of KDACs (refer to respective figure leg-
ends) for the indicated time at 25 ◦C. The reaction was stopped by adding sample
buffer and heating the samples for 5 min at 95 ◦C. Acetylation was detected by
western blotting and immunodetection with an acetyl-lysine specific anibody (Ta-
ble 2.5). This experiment was conducted together with P.Knyphausen.
2.3.13 Acetyltransferase (KAT)-Assays
120 pmol Ran were incubated with 1µl recombinant acetyltransferase purchased
from Biomol: full length CBP, Gcn5 and Tip60, as well as p300 (aa 965-1810) and
pCAF (165 aa from HAT domain). Except for CBP (mouse), all enzymes were of
human origin. The KAT-assays were done in KAT-assay buffer supplemented with
Material and Methods 51
100µM acetyl-CoA. The reaction was stopped by adding sample buffer and heating
the samples for 5 min at 95 ◦C. The enzyme activities were tested using known
histone substrates (recombinant, BPS Bioscience), namely 0.75 g H3 (for p300,
CBP and Gcn5) and 7.5µg H4 (for pCAF and Tip60). Acetylation was detected
by western blotting and immunodetection. For analysis by mass spectrometry
10µg Ran wt (10µM in 40µl) were incubated with 1µl transferase in KAT-buffer
for 4 h at 25 ◦C.
2.3.14 Pull-down of endogenous Ran
All centrifugation steps with GSH-agarose beads were conducted with max. 500 x g.
GSH-Agarose beads (100µl slurry per condition/sample) were washed three times
with buffer V and subsequently incubated with purified, recombinant GST-RCC1
(0.5 mg/condition) for 30 min at 4 ◦C. Unbound GST-RCC1 was removed by three
washing steps with buffer V. In a fourth washing step buffer V supplemented with
KDAC-inhibitors (buffer V+I) was used. Cells were lysed by sonication (3 x 30 sec,
duty cycle 4%, tip limit 2) in buffer V+I. The lysate was cleared by centrifugation
(1000 x g, 10 min) and the supernatant was incubated with 100µl RCC1-loaded
GSH-beads (rotating, 1 h, 4 ◦C). The beads were pelleted and the supernatant
(lysate after incubation) removed. The beads were washed three times with 1 ml
buffer V+I. Finally, protein was eluted by three subsequent incubations (5 min
each) with 100 - 150µl buffer V+I supplemented with 30 mM GSH. The three elu-
ates were pooled and concentrated with centrifugal concentrators (Vivaspin500,
MWCO 10 kDa, SartoriusStedim) at 15000 x g. At a final volume of 25 -40µl sam-
ple buffer was added and the samples were analyzed by western blotting and
immunodetection for acetyl-lysine and Ran.
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2.4 Cell culture
2.4.1 Cultivation of cell lines
HeLa cells were cultivated at 37 ◦C and 5% CO2 in DMEM (Gibco) supplied with
10% (v/v) fetal calf serum (PAN) Biotech, 1% (v/v) Penicillin/Streptomycin and
1% (v/v) non-essential amino acids (both Gibco). Cells were split by trypsination
(0.25% trypsin-EDTA-solution, Sigma) at a confluency of more than 70%. Cells
were stored at 80 ◦C in culture medium supplied with 10% (v/v) DMSO.
2.4.2 Transfection
For transfection approx. 40000 cells were seeded on cover slips in a 24-well plate.
After 20 h cells were transfected with 0.25 g DNA (Ran-acetylation mimetics with
N-terminal EGFP) using Lipofectamine LTX Plus (Invitrogen) according to the
manufacturers protocol.
2.4.3 Immunocytochemistry
HeLa cells transfected with EGFP constructs on cover slips were fixed with 3%
(w/v) Paraformaldehyde for 20 min at room temperature. After three washes with
ice cold PBS, DNA was stained by incubation with DAPI. for 30 - 60 min. After
three washing steps cover slips were embedded in ProLongGold antifade reagent
(Invitrogen) on microscope slides. The cover slips were sealed with varnish 24 h
later and stored in the dark at 8 ◦C. Images were taken on a Zeiss Meta 510
Confocal Laser Scanning Microscope. Images were processed with ImageJ.
2.4.4 Pull-down of His6-tagged Ran (in vivo KAT assay)
For pull-down of His6-tagged Ran, HEK293T cells grown in 15 cm dishes were
transfected with 10µg of the respective KAT plasmid (all pCMV-C-Myc except
for pTriEx-2-Tip60) and with 10µg pcDNA3.1CnoK-Ran (from which all lysine
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codons in the tag-region had been mutated to arginine codons) using Lipofec-
tamine 2000 (Invitrogen). 16 h after transfection cells were harvested and soni-
cated in 1.8 ml lysis buffer (10 mM Tris pH 8.0, 100 mM NaH2PO4, 300 mM NaCl,
2 mM β-Mercaptoethanol, 0.05% (v/v) Tween 20, 8 M Urea, and 10 mM Imida-
zole). Lysates were cleared by centrifugation for 10 min at 17500 x g and a 50µl
input sample was taken. Lysates were then incubated with 50µl Ni2+-NTA mag-
netic beads (5 Prime) over night at 4 ◦C with agitation. Beads were washed three
times for 5 min with wash buffer (lysis buffer + 20 mM imidazole) and His6-tagged
proteins were eluted with 50µl binding buffer containing 250 mM imidazole for
20 min at room temperature.
2.5 Biophysical methods
2.5.1 Mass spectrometry
Sample preparation and digestion
Samples of in vitro KAT-assays and pull-downs of His6-tagged Ran from HEK cells
transfected with KAT-plasmids were digested with trypsin based on a filter-aided
sample preparation (FASP) protocol (Wisniewski et al., 2009).
UHPLC and Mass Spectrometry
Peptides were separated using a binary buffer system of A (0.1% (v/v) formic
acid in H20) and B (0.1% (v/v) formic acid in acetonitrile) on an Easy nano-flow
LC 1000 system (Thermo Fisher Scientific). A linear gradient from 4 to 30 %
B in 40 min followed by 95% B for 10 min and re-equilibration to 5% B within
5 min on a 50 cm column (75µm ID) in-house packed with C18 1.8µm diameter
resin. The flow rate was set to 250 nL/min. To control the column temperature
we used an in-house made column oven at 45 ◦C. The UHPLC was coupled via a
nano-electrospray ionization source (Thermo Fisher Scientific) to the quadrupole
based mass spectrometer QExactive Plus (Thermo Fisher Scientific). MS spectra
were acquired using 3·e6 as an AGC target at a resolution of 70,000 (200 m/z) in a
mass range of 350-1650 m/z. The maximum injection time was set to 60 ms for ion
accumulation. In a data dependent mode MS/MS events were measured for the ten
most abundant peaks (Top10 method) in the high mass accuracy Orbitrap after
HCD (Higher energy C-Trap Dissociation) fragmentation at 25 collision energy in
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a 100-1650 m/z mass range. The resolution was set to 35,000 at 200 m/z combined
with an injection time of 120 ms and an AGC target of 5·e5.
Data analysis
All raw files were processed with MaxQuant (version 1.5.2.8) using the imple-
mented Andromeda search engine (Referenzen). For protein assignment ESI-
MS/MS fragmentation spectra were correlated with the Uniprot E.coli database
(for the in vitro assay) or the H.sapiens database (for pull-down from HEK cells)
including the respective Ran-sequence (from pRSF-Duet for in vitro, from pcDNA
for in vivo assay) and a list of common contaminants. Searches were performed
with trypsin specificity allowing two missed cleavages and a mass tolerance of
4.5 ppm for MS and 6 ppm for MS/MS spectra. Carbamidomethyl at cysteine
residues was set as a fixed modification. Acetylation at lysine residues, oxidation
at methionine and acetylation at the N-terminus were defined as variable modifi-
cations. The minimal peptide length was set to 7 and false discovery rate (FDR)
for proteins and peptides to 1 %. FDR for site modifications was calculated seper-
ately using the revert algorithm in MaxQuant. The minimal peptide score cut-off
was set to 0 and the minimal delta score to 0 and 6 for unmodified and modified
peptides, respectively.
Data presentation
The peptide intensities originating from the MaxQuant search were processed for
data visualization. To enable comparability intensities of acetylated peptides were
normalized to correspond to a total-protein intensity (sum of all unmodified pep-
tides) of 1·1011 in all samples tested. Factors were determined based on the raw
intensities (in vitro KAT assay) and LFQ (label-free quantification) intensities (in
vivo KAT assay). For heat map presentation, normalized peptide intensities of
two independent experiments were averaged.
Hierarchical clustering
Hierarchical clustering was done by Hendrik Nolte using heatmap.2 function. Dis-
tance was calculated by Euclidian method and linkage was performed in complete
mode. Data are represented as raw intensities and missing values are shown in
grey.
Random imputation of missing values for Volcano plot
In vitro KAT assays with CBP and without (-KAT) as a control, led to the iden-
tification of several acetylation sites. However missing values are a prominent
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problem due to very low abundance or absence of acetylation sites. To overcome
this problem and make sites accessible to statistical test, we imputated random
data according to a 0.75 down-shifted Gaussian distribution (in log2 scale) with
the standard deviation of all measured sites (e.g. 1.7 in log2 scale). Two sided
t-test was utilized for calculation of p-values assuming equal variance. To estimate
the FDR we repeated the resampling step 500 times and the averaged values for
log2 fold change and log10 p value were used. Visualization and calculations were
performed by Hendrik Nolte using statistical environment R.
2.5.2 Isothermal titration calorimetry (ITC)
Isothermal titration calorimetry was used to characterize protein-protein inter-
actions thermodynamically and to determine binding affinities (Wiseman et al.,
1989). This calorimetric method is based on the fact that every reaction is accom-
panied by a change in reaction enthalpy. A binding partner is titrated stepwise
into the measurement cell filled with the protein of interest. The release (neg-
ative ∆H, exothermic) or uptake (positive ∆H, endothermic) of heat during the
interaction is determined indirectly by monitoring the power necessary to keep the
measurement cell at the same temperature as the water-filled reference cell (power
compensation mode). This heating power per injection is plotted as a function of
time until binding saturation is obtained. The binding isotherms are fitted to a
one-site-binding model to determine the equilibrium association constant KA, the
stoichiometry and the reaction enthalpy ∆H directly. Based on the correlation
∆G = ∆H − T∆S = −RTlnKA (2.2)
the reaction entropy ∆S and the Gibbs free energy ∆G of the protein-protein
interaction can be derived.
We used an ITC200 (Malvern Instruments). For a typical experiment 2 - 3µl of
protein in the syringe (0.1 - 0.3µM) was injected into the cell containing protein
B in concentrations of 10 - 50µM depending on the interaction analysed. The
standard measurement temperature was 25 ◦C and all measurements were con-
ducted in phosphate buffer. Furthermore, a differential power (DP) of 6, initial
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delay and spacing of 120 sec (Importin-β 180 sec) and a stirring speed of 1000 rpm
(Importin-β 700 rpm) were set for all experiments. For applied concentrations
and measurement temperatures of individual measurements please refer to the
corresponding figure legends.
We used the standard EDTA-CaCl2 sample tests as described by MicroCal to
assess the statistical significance of individual observations. These gave values
within the manufacturers tolerances of ± 20% for KA values and ± 10% in ∆H.
The data analysis was done with the software provided by the manufacturer.
2.5.3 Fluorescence spectroscopy
Fluorescence spectroscopy takes advantage of the fact that the fluorescence of a
fluorophore depends primarily on its environment. This is based on fluorescence
quenching: fluorescence energy is transmitted from the fluorophore to molecules in
close proximity (for example solvent molecules such as H2O) and is subsequently
released by radiationless transitions, such as translation- or rotation-processes. For
an interaction (protein-protein, protein-ligand) quenching results in an increase or
decrease of fluorescence intensity when the environment of the fluorophore becomes
more hydrophobic or hydrophilic, respectively.
For the characterization of interactions of the Ran protein mant-labeled nucleotides
were used as fluorophors. The mant-(2‘/3‘-O-(N-Methyl-anthraniloyl)-fluorophor
is coupled to the ribose moiety of GDP or GppNHp (see Figure 2.1). The Ran
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Figure 2.1: Structure of 2‘/3‘-O-(N-Methyl-anthraniloyl)-GppNHp
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protein is loaded with labeled nucleotids by nucleotide exchange. Due to its spec-
troscopic properties the mant-group can either be excited directly at 355 nm or an
indirect excitation by FRET (fluorescence resonance energy transfer) from tryp-
tophanes is employed. Accordingly, either the change of the fluorescence signal of
the tryptophanes (which is quenched by FRET) or the emission of the man-group
can be used as reaction read-out.
Stopped-flow kinetics
Fast interaction kinetics were characterized by stopped-flow. The technique is suit-
able to record the fluorescence signal of a reaction down to a microsecond-timescale
(dead time approx. 2 - 3 msec.). Two solutions containing the interaction partners
are shot into the reaction chamber. As the solution fills the stopping syringe, the
plunger hits a block, causing the flow to be stopped instantaneously. Stopped-
flow experiments were done in phosphate buffer at 25 ◦C using an SX20 Applied
Photophysics spectrometer (Leatherhead, UK). The photomultiplier voltage was
adjusted to the respective experimental condition. For a reaction of two interaction
partners (A and B) forming a complex (AB)
A+B 
 AB (2.3)
the rate of complex formation is given by
d[AB]
dt
= kon[A][B]− koff [AB] (2.4)
Assuming that the concentration of one reaction partner A is constant, due to
a high excess over the other, pseudo-first-order conditions are fulfilled and the
second-order reaction v = k[A][B] can be handled as v = kobs[B].
d[AB]
dt
= kobs[B]− koff [AB] (2.5)
with kobs = kon[A]. The solution of the differential equation yields
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[AB] =
kobs[B]0
kobs + koff
− kobs[B]0
kobs + koff
· e−t(kobs+koff ) (2.6)
The fit of the primary traces to an exponential function provides kobs which, under
the assumption of a pseudo-first-order reaction, is given by
kobs = kon[A] + koff (2.7)
The plot of kobs over the concentration of A results in a linear curve with the slope
kon and the intercept koff . However, the dissociation rate constants determined by
this method are often inaccurate and should be verified by direct determination.
GraFit 7.0 was used for data analysis.
The association of Ran∗mantGppNHp and Importin-β was monitored by using
an excitation of 350 nm and an emission cut-off filter of 420 nm, thus monitor-
ing the mant fluorescence directly. 200 nM (final 100 nM) of Ran∗mantGppNHp
were titrated with increasing concentrations of Importin-β (1 - 8µM; final 0.5 -
4µM). The increase in fluorescence was monitored over time and fitted to a single-
exponential function to give the observed rates (kobs). The plot of the kobs-values
(3 - 5 individual time courses per Importin-β concentration) over the Importin-β
concentration resulted in a linear curve. All data points were fitted to a linear func-
tion applying explicit (user defined) weighting based on the error of the primary
exponential fit of every individual trace.
To determine RCC1-catalyzed nucleotide exchange rates, mant-labeled Ran was
excited at 295 nm and the fluorescence energy transfer from tryptophane to the
mant-group was measured by using a 420 nm cut-off filter. A constant concentra-
tion of 1µM (final 500 nM) Ran∗mantGDP was titrated with increasing concen-
trations of RCC1 (0.039 - 80µM; final: 0.0195 - 40µM) in the presence of excess
GTP (50µM; final: 25µM). The fluorescence signal was plotted over time and
fitted to a single-exponential function to give the observed rates (kobs) for each
RCC1-concentration. The plot of the kobs-values (3 - 5 individual time courses per
RCC1 concentration) over the RCC1 concentration resulted in a hyperbolic curve.
By fitting to a hyperbolic function (Equation 2.8) the maximal rate of nucleotide
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dissociation from the ternary complex, k−2, and the equilibrium constant of the
Ran∗mGDP-RCC1 interaction, K1, were obtained.
kobs =
k−2K−1[RCC1]
K−1[RCC1] + 1
(2.8)
2.5.4 Data visualization
Images were processed using ImageJ and Adobe Photophop CS5.1. Figures were
created with Abobe Illustrator CS 5.1. For the presentation of structural data
based on crystallography Pymol was used.

Chapter 3
Experimental results
3.1 Protein purification and identification
Until now, five out of eighteen lysine residues of Ran were found to be acety-
lated in human samples. In mouse and rat even up to eleven lysines were found
do be modified. To gain a fundamental understanding of the impact of lysine
acetylation on the protein integrity and function, a site-specific characterization
of the acetylated protein is inevitable. The use of the genetic code expansion
concept circumvents most of the shortcomings of acetylation mimetics, chemical
modification or synthetic peptides. I therefore used this method to incorporate
acetyl-lysine co-translationally and site-specifically into the recombinant Ran pro-
tein. After purification and quality control (SDS-PAGE, immunoblotting, mass
spectrometry), the proteins were used to study the acetylation sites separately in
vitro. All unacetylated proteins (namely Ran wt and Q/R-mutants, RCC1, NTF2
and Importin-β) were expressed as GST-fusion proteins. This strategy is less time
consuming and provides high yields of pure protein. The GST-tag is furthermore
beneficial for the stabilization of proteins that tend to aggregate during expres-
sion. However, for the incorporation of acetyl-lysine a His6-tag proved beneficial,
resulting in higher yields.
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3.1.1 Purification of acetylated Ran
Acetylated Ran was expressed in E.coli transformed with an expression vector car-
rying the mutated Ran-(amber)-sequence, the evolved acetyl-lysyl-tRNA-synthe-
thase and the corresponding amber-tRNA. The bacteria were grown at 37 ◦C up to
an OD600 of 0.6. At that point 10 mM N-()-acetyl-lysine and 20 mM nicotinamide
were added and cells were grown for another 30 min at 20 ◦C before induction.
The addition of acetyl-lysine is crucial to prevent translation stops due to the
lack of modified amino acid. If no acetyl-lysine is added, the translation stops at
the amber stop codon, yielding shortened proteins/peptides specific for the incor-
poration site. We observed that, even without addition of acetyl-lysine, a small
proportion of protein is still expressed in full length and acetyl-lysine is incorpo-
rated. In this case the modified lysine probably originates from peptone or yeast
extract included in the luria broth. The supplemented nicotinamide inhibits the
single characterized E.coli deacetylase CobB. The addition of both components 30
minutes prior induction ensures sufficient uptake and minimizes the accumulation
of translation stop fragments. After induction the protein was expressed for 16
to 24 h at 20 ◦C, the cells were pelleted and lysed by sonication. The following
centrifugation step separated the soluble fraction from insoluble aggregates, cell
debris and intact cells. The supernatant was applied to a Nickel-affinity (Ni-NTA)
column to bind the His-tagged target protein. High salt buffer with 10 mM im-
idazole was applied to remove proteins binding unspecifically to either Ran or
the Ni-NTA-column. By applying a gradient of imidazole to elute the protein,
even stronger binding impurities were removed. Fractions containing recombi-
nant full length Ran were pooled and concentrated (MWCO 10 kDa) to a volume
appropriate for size exclusion chromatography (1-4 ml). After size exclusion chro-
matography Ran containing fractions were pooled, concentrated to approximately
20 mg/ml, flash frozen in liquid nitrogen and stored at -80◦C. An exemplary SDS-
PAGE with samples of all stages of the described procedure is shown in figure
3.1.
Recombinant Ran turned out to be very stable. Aggregation was neither observed
during the purification procedure, nor after thawing. Furthermore, in only few
cases we detected Ran in the exclusion peak of the size exclusion chromatography,
which would indicate protein aggregation. By applying the described method
yields of 8 mg to up to 60 mg of recombinant, acetylated Ran were obtained.
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Figure 3.1: Purification of Ran AcKs. An exemplary purification of Ran
AcK37 is shown. (a) Flow-scheme of the His6-tag-based purification proce-
dure.(b) Coomassie-stained SDS-PAGE of the purification showing marker(M),
lysates prior/after induction (prior/after I.), flow-through (f.t.), eluted fractions
of the imidazole-gradient and Ran AcK prio/after size-exclusion chromatogra-
phy (prior/after SE). (c) Elution profile of the imidazole-gradient. Samples
for SDS-PAGE were taken as indicated. (d) Chromatogram of the final size-
exclusion chromatography using a Superdex S75 (26/60). Peak A corresponds
to the exclusion volume, peak B contains the purified Ran AcK.
3.1.2 Quality control of acetylated Ran
All purified Ran variants exhibit a high degree of purity. The SDS-PAGE in figure
3.2 shows Ran wt and all five acetylated variants of Ran. In each lane 5µg of
protein were loaded. All protein bands are well defined and migrate in accordance
with the molecular weight of full length Ran (24.6 kDa for Ran wt and 26 kDa for
Ran AcK). The difference in molecular weight and migration behavior between
Ran wt and the acetylated proteins is due to the absence of the His6-tag in the
case of Ran wt. Apart from the Ran band only minor impurities or degradation
bands are visible on the gel, therefore a purity of > 95 % can be assumed. For
immunodetection 250 ng of protein were blotted onto a PVDF membrane and
acetyl-lysine as well as Ran was detected using specific antibodies. The anti-Ran
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Figure 3.2: Incorporation of acetyl-lysine into recombinant Ran.(a)
Coomassie-stained SDS-PAGE (CMB) and immunoblots (IB) probed with anti-
AcK and anti-Ran antibodies for recombinant Ran-variants (wt and acety-
lated). (b) Quantitative incorporation of N-()-acetyl-lysine into recombinant
His-tagged Ran was verified by ESI-mass spectrometry. The calculated mass is
26043,6 Da
antibody detects one specific band for all Ran variants. No degradation products
are detected. The immunodetection of acetyl-lysine confirms the incorporation of
acetyl-lysine into the recombinant Ran protein. All five acetylated Ran variants are
stained with the AcK-specific antibody. This blot also illustrates the specificity
and selectivity of the used antibody. The unacetylated Ran wt, serving as a
negative control, is not detected. Interestingly, the signal intensities of the five
acetylated samples differ substantially, which indicates an epitope selectivity of
the polyclonal primary antibody. An acetyl-lysine incorporated in position 71 of
Ran results in a much stronger signal than the same modification at lysine 99.
The incorporation of acetyl-lysine was also confirmed by molecular mass determi-
nation by ESI-MS. Figure 3.2.b shows the ESI-MS spectrum of Ran AcK37, for the
complete list refer to Appendix A.2. The detected mass of 26044 Da corresponds
to the His-tagged full length Ran lacking the start-methionine and carrying one
single acetyl-moiety.
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3.1.3 Purification of Ran-interaction partners
For all unacetylated proteins ( Ran wt, Ran Q/R, RCC1, NTF2 and Importin-β)
the purification based on the GST-tag was favored. The GST-tag can be ben-
eficial for the expression of demanding proteins, such as the 95 kDa Importin-β.
The purification yields highly pure protein, even before size exclusion chromatog-
raphy, and it can optionally be conducted as a batch purification. The use of the
pGEX4T5 TEV vector, furthermore, allows for the easy cleavage of the GST-tag
thereby providing a tag-free purification product.
GST-tagged proteins were expressed in E.coli. After induction at an OD600 of
0.8, cells were grown at 20 ◦C over night and harvested by centrifugation. The
standard procedure for a GST-based purification is illustrated in the flowchart in
figure 3.3.a. Following sonication, the cell lysate was cleared by centrifugation
and applied to Glutathion-agarose/sepharose for protein binding. An extensive
washing step with salt-rich buffer eliminated unspecifically bound proteins. The
proteolytic cleavage of the column-bound GST-fusion protein by TEV-protease
was done over night in buffer GST III. The cleaved target protein was depleted
of TEV-protease by a short incubation with Ni-beads and concentrated to 1 - 4 ml
prior to size exclusion chromatography. The protein specific peak fractions were
pooled, concentrated to approx. 20 mg/ml and flash frozen in liquid nitrogen.
Protein specific molecular weight cut-off sizes (MWCO) and achieved yields are
listed in table 3.1.
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Figure 3.3: Purification of Ran-binding proteins. (a) Flow-scheme of
the GST-tag-based purification procedure. (b) Exemplary SDS-PAGE of sub-
steps of the purification of RCC1. (c) SDS-PAGE of the purified Ran-binding
proteins used in this project, namely NTF2, RCC1 and Importin-β.
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Table 3.1: Parameters for the purification of Ran-binding proteins
Protein MW (kDa) MWCO (kDa) Yield (mg/l)
Ran (wt/Q/R) 24.6 10 2 - 10
RCC1 42.5 30 22
Importin-β 97.5 30 2.5
NTF2 15 3 1.4
To determine the cleavage efficiency and to recover uncleaved fusion protein, GSH-
buffer was applied to the column to elute bound GST. The recombinant Ran-
binding proteins have purities > 95 % and SDS-PAGE (see figure 3.3.c) as well as
size exclusion chromatography indicate homogeneity of the proteins. The obtained
yields are protein dependent but sufficient for extensive biophysical characteriza-
tion.
3.1.4 Nucleotide exchange on Ran
Ran-binding proteins distinguish between the different nucleotide-dependent con-
formational states of Ran. In contrast to effector proteins such as Importin-β,
NTF2 binds predominantly to Ran∗GDP. Since the nucleotide exchange factor
RCC1 catalyzes nucleotide release to bind the nucleotide-free Ran with high affin-
ity, it interacts with GDP- and GTP-bound Ran.
Recombinant Ran is purified from E.coli in the GDP-bound form. To be able to
characterize the interactions of Ran∗GTP and to introduce fluorescently-labeled
nucleotides, GDP was exchanged for GTP, GppNHp or mant-nucleotides (mant-
GDP, mantGppNHp). The nucleotide exchange was done after the purification.
Either EDTA or catalytic amounts of RCC1 were used to accelerate the exchange
reaction. EDTA acts as a chelator for the essential magnesium ion of Ran. With-
drawal of the ion results in a decrease of affinity and consequently release of the
bound nucleotide (GDP). The re-addition of an excess of Mg2+ in the presence of
an excess of nucleotide (GTP, GppNHp, mant-nucleotides) restores the nucleotide
binding capability of Ran. Consequently, GDP and the nucleotide of interest are
bound in the same ratio they were added. If a non-hydrolyzable nucleotide ana-
log is to be exchanged, this ratio can be influenced by addition of calf intestine
phosphatase (CIP), since the binding affinity for GMP is 106-fold lower compared
to GDP/GTP (John et al., 1990; Rensland et al., 1995). As an alternative to
the EDTA-method, catalytic amounts of GST-RCC1 were used in the presence of
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Figure 3.4: Nucleotide exchange on Ran. (a) Exemplary chromatogram
of the size-exclusion chromatography (Superdex S75 10/300) after nucleotide
exchange. Protein and nucleotide absorb at the detected wavelength of 280 nm.
Ran elutes in one peak after 12 ml, whereas the excess of nucleotide elutes after
19 ml. (b) Chromatograms of Ran AcK37 prior (GDP) and after nucleotide
exchange (GTP, GppNHp). The nucleotides absorb at 254 nm and elute after
characteristic retention times, dependent on the number of phosphates.
excess of nucleotide and, if applicable, CIP. After one hour at room temperature
GST-RCC1 was removed with buffer-equilibrated GSH-beads. After every nu-
cleotide exchange a size-exclusion chromatography was done to remove unbound
nucleotide. One exemplary chromatogram is shown in Figure 3.4.a. The free nu-
cleotide, which also absorbs at 280 nm and 254 nm, elutes after Ran (Ran 12 ml,
GXP 19 ml) and due to the small size close to the total column volume (24 ml).
The elution behavior of Ran reflects the high quality of the purified protein. Ran
elutes in one single, symmetrical peak and no protein is detected in the exclusion
volume (8 ml), hence neither aggregates nor major impurities are present.
The efficiency of the exchange reaction was verified by reversed phase (RP)-HPLC
with TBAB as mobile phase component (Tucker et al., 1986). TBAB interacts with
phosphates and influences the elution from the used RP-column dependent on the
number of phosphates. The elution is detected by absorption at 254 nm. The col-
umn was calibrated with nucleotide standards. The exemplary chromatogramms
(Ran AcK37 after nucleotide-exchange) in Figure 3.4.b show that the retention
time increases with the number of phosphates present in the analyzed nucleotide.
The (early-eluting) additional peak for GppNHp originates from a heat-induced
degradation product, which is also observed for GppNHp-standards after heating
for 5 min at 95 ◦C.
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3.2 Biophysical studies on the effect of Ran acety-
lation
To characterize the effect of the five different acetylation sites in vitro, three Ran
interacting proteins were selected. NTF2 binds specifically to Ran∗GDP and is
essential for the nucleocytoplasmic transport cycle. RCC1 is the guanine nu-
cleotide exchange factor (GEF) for Ran and allows for the existence of the crucial
Ran∗GDP - Ran∗GTP gradient. Hence, RCC1 plays an important role in mitosis
and nucleocytoplasmic transport. Importin-β was chosen as the third interac-
tion partner. It is the best-known import receptor and by binding exclusively to
Ran∗GTP Importin-β is a true effector of Ran. Furthermore, the interaction with
RanGAP (Ran GTPase activation protein), RanBP1 (Ran binding protein 1) and
the major export receptor CRM1 was characterized by Philipp Knyphausen. All
these proteins are pivotal for proper Ran function- especially in nucleocytoplasmic
transport. The in vitro characterization of the effect of Ran acetylation on these
proteins should indicate/point out/suggest the possible physiological relevance of
this modification.
3.2.1 Effect of Ran-acetylation on NTF2 interaction
The binding of wildtype and acetylated Ran versions to NTF2 was investigated
by ITC. Diminished binding could severely disrupt the cellular Ran gradient in
interphase cells, since Ran∗GDP would not be shuttled back into the nucleus,
where nucleotide exchange would take place. The consequence would be a cytoso-
lic accumulation of Ran∗GDP and finally the arrest of Ran-dependent transport
processes. The crystal structure of the Ran∗NTF2-complex indicates such a con-
sequence for the acetylation of lysine 71, since an essential salt bridge could no
longer be formed (Figure 3.8).
All ITCs with NTF2 were measured in phosphate buffer at 25 ◦C. The chosen
standard concentrations were 300µM Ran in the syringe and 30µM NTF2 in the
cell. The monitored power over molar ratio (syringe/cell) was fitted based on
a single binding model. The determined binding affinities are in the nanomolar
range and stoichiometries indicate one to one binding (Table 3.2). Please refer
to Appendix A.3 for original ITC-curves and fitting results. While acetylation at
four lysines have no effect on the binding of Ran and NTF2, Ran acetylated at
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Table 3.2: Characterization of the Ran-NTF2 interaction by ITC
∆G ∆H -T∆S N KD
(kcal/mol) (kcal/mol) (kcal/mol) (nM)
Ran∗GDP WT -9.0 -3.7± 0.035 -5.3 1.0 260± 29
(300µM) AcK37 -8.6 -4.2± 0.040 -4.4 0.9 490± 46
NTF2 AcK60 -8.6 -5.8± 0.14 -2.8 1.1 500± 110
(30µM) AcK71 n.b. n.b.
AcK99 -9.0 -5.0± 0.037 -4.0 0.9 250± 23
AcK159 -9.1 -3.9± 0.043 -5.2 0.8 230± 31
K71R -7.4 -2.2± 0.066 -5.2 1.4 4000± 660
K71Q n.b. n.b.
K99Q -9.0 -3.5± 0.034 -5.5 0.7 240± 28
K99R -8.9 -3.2± 0.031 -5.7 1.1 280± 35
lysine 71 (Ran AcK71) shows no binding heat when titrated to NTF2. Since the
reaction enthalpy is temperature dependent, the measurement was repeated at
10 ◦C and 30 ◦C. However, in contrast to Ran wt and the other acetylated versions
of Ran, no binding can be detected for Ran AcK71 and NTF2 using ITC in the
temperature range of 10 ◦C to 30 ◦C.
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Figure 3.5: ITC of NTF2 and Ran wt/AcK71/K71Q. Representative
ITC-titrations of 300µM Ran (wt/AcK71/K71Q) to 30µM NTF2. Ran wt
binds NTF2 with a middle nanomolar affinity (KD=260 nm ± 29 nm), no bind-
ing is detectable for Ran AcK71 and K71Q.
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To confirm that NTF2 and Ran AcK71 do not form a complex, analytical gelfiltra-
tion runs were carried out, using the NTF2∗Ran wt complex as a reference. With
a binding affinity in the nanomolar range, the complex is sufficiently stable to be
separated from the monomeric fractions containing only Ran or NTF2. The ana-
lytical gelfiltration was done with a Superdex S75 10/300 column and phosphate
buffer as mobile phase. The elution volumes of Ran wt, Ran AcK71 and NTF2
were determined in separate runs. Then mixtures of NTF2 with Ran wt and Ran
AcK71 were preincubated on ice to allow complex formation and applied to the
column. Figure 3.6 shows the chromatograms (absorption at 280 nm over elution
volume) for all runs. The NTF2∗Ran wt complex elutes earlier than NTF2 and
Ran wt alone and is well separated from the other elution peaks. A small shoulder
in the chromatogram corresponds to unbound NTF2/Ran wt. In contrast, the
elution profile of NTF2∗Ran AcK71 fully superposes with the peaks of NTF2 and
Ran AcK71 and does not exhibit a smaller retention volume. This clearly confirms
that acetylated Ran at lysine 71 is not able to bind do NTF2.
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Figure 3.6: Analytical size-exclusion chromatography of Ran-NTF2-
complexes. (a) The elution behavior of Ran wt, NTF2 and the preformed
complex was analyzed by size-exclusion chromatography. 150µM protein or the
equimolar complex was applied to a Superdex S75 10/300 column at a flow-rate
of 0.6 ml/min. Protein was detected by absorption at 280 nm. (b) The same
procedure as described in (a) was applied to Ran AcK71.
In interphase cells, around 90 % of the endogenous Ran is localized in the nucleus
(Ren et al., 1993). The fact that Ran AcK71 is not binding to NTF2 should
result in the cytosolic accumulation of Ran. To test this hypothesis in vivo, HeLa
cells were transfected with EGFP-constructs of the acetylation mimetics glutamine
(Q) and arginine (R). The mimetics for lysine 71 were first evaluated regarding
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Figure 3.7: Subcellular localization of acetylation mimetics. (a) HeLa
cells were transfected with Ran K to Q and K to R mutants with C-terminal
EGFP-tag and additionally stained with DAPI. Cytosolic accumulation was ob-
served for Ran K71Q/R and K99R. Scale bar 10µm (b) Quantification of sub-
cellular localization of Ran-EGFP-constructs. The ratio of nuclear to cytosolic
EGFP-intensity was determined for at least 20 cells per condition. Shown is the
mean ± s.d. relative to Ran wt.
their validity and applicability. Ran K71Q turned out to mimic the acetylated
Ran in regard to NTF2 interaction, since ITC measurements as well as analytical
gelfiltration verified the inability of complex formation. In contrast, Ran K71R
still exhibits binding to NTF2, even though with a reduced affinity.
For the localization studies, HeLa cells were grown on cover slips and transfected
with the C-terminal EGFP-constructs of Ran wt and all five acetylation sites.
The ratios of the cytosolic and nuclear fluorescence signal were determined. As
seen in figure 3.7.a, the C-terminal EGFP-tag does not interfere with the nuclear
localization of Ran in interphase cells. Furthermore, the majority of acetylation
mimetics (except for K71Q, K71R and K99R) also show a nuclear localization
similar to the wildtype protein. This observation corresponds well to the affini-
ties determined by ITC, which indicated normal NTF2 binding behaviour for all
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Figure 3.8: Ran in comlex with NTF2. (a) Ribbon-presentation of Ran
(yellow) in complex with NTF2 (green) with the ve acetylation-sites studied
here (red sticks) (PDB:1A2K). (b) Close-up of the binding interface with the
two essential salt-bridges and corresponding interaction distances.
acetylated Ran versions except for AcK71. In agreement with the in vitro data
Ran K71Q accumulates in the cytosol and is almost depleted from the nucleus,
since it is restricted to enter the nucleus by di usion. Ran K71R, however, is
almost evenly distributed between nucleus and cytosol, which is probably due to
the reduced binding a nity of Ran K71R towards NTF2. The altered localization
of Ran K99R has to be attributed to a disturbed process independent from NTF2-
binding, since the determined a nity is similar to Ran wt. Acetylation of the other
three lysine residues does neither a ect the binding a nities towards NTF2 nor
the subcellular localization of the corresponding EGFP-constructs. The described
ndings t well to the available structural data of the NTF2  Ran wt complex
(pdb:1A2K)(Stewart et al., 1998)). Two of the major intermolecular contacts are
two salt bridges formed between lysine 71 of Ran and aspartic acid residues 92 and
94 of NTF2 (see Figure 3.8). The disruption of the salt bridges by acetylation of
the lysine side chain leads to the loss of binding, as shown by ITC and analytical
gel ltration. Glutamine, mimicking the neutral charge of an acetylated lysine, is
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not able to restore the salt bridges and consequently exhibits the same phenotype
as Ran AcK71. The arginine substitution, in contrast, retains the charge charac-
teristics of an unmodified lysine by simultaneously mimicking the steric features of
acetylated lysine. This combination preserves the salt bridges and NTF2 binding,
albeit with lower affinity due to steric reasons.
The characterization of the interaction of site-specifically acetylated Ran and
NTF2 revealed that acetylated Ran at lysine 71 is not able to bind to NTF2.
Since Ran AcK71 is then restricted to enter the nucleus by diffusion, it accumu-
lates in the cytosol. Depending on the ratio/abundance of this acetylation this
could severely derogate the nucleocytoplasmic transport machinery, by diminish-
ing the level of actively cycling Ran.
3.2.2 Effect of Ran-acetylation on RCC1-interaction and
nucleotide exchange
The existence of the Ran gradient is a prerequisite for several cellular processes,
including mitotic spindle formation and nucleocytoplasmic transport. The slow
intrinsic nucleotide exchange rate of Ran is accelerated by a Ran-specific guanine
nucleotide exchange factor (RanGEF), namely RCC1. RCC1 is associated with
chromatin and binds Ran∗GDP and Ran∗GTP likewise. The acetylation of Ran
could influence the interaction of Ran and RCC1 or the catalyzed nucleotide ex-
change reaction. Both processes were analyzed separately. The binding affinities
and interaction thermodynamics were determined by ITC, whereas the exchange
reaction was monitored by stopped-flow.
Binding affinities determined by ITC
The binding affinities of RCC1 and Ran∗GDP and Ran∗GppNHp were determined
by ITC. GppNHp was used as a non-hydrolyzable GTP-analog, to investigate the
triphosphate state without disturbances by nucleotide hydrolysis. The nucleotide
exchange was done with either catalytic amounts of RCC1-GST or by applying the
EDTA-method. ITC measurements were done in phosphate buffer at 1000 rpm,
differential power 6, 120 s initial delay and spacing and 2µl injections. The stan-
dard setup comprised 293µM Ran in the syringe and 37µM RCC1 in the cell
at 25 ◦C. Concentrations and measurement temperature were adjusted whenever
necessary and changes are stated in the corresponding text.
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Figure 3.9: Signature plots of the interaction of Ran and
RCC1.Signature plots showing free energy (∆G), reaction enthalpy (∆H) and
reaction entropy (-T∆S) of the interaction of Ran (wt and AcKs) and RCC1
determined by ITC in KPi at 25
◦C. Determined KD-values and stoichiometries
are given in the upper panel. (a) Ran∗GDP (180µM) was titrated to RCC1
(22µM). (b) Ran∗GppNHp (300µM) was titrated to RCC1 (37µM).
Binding affinities of Ran wt as well as acetylated Ran towards RCC1 are in the
medium nanomolar range (in phosphate buffer). Please refer to Appendix A.4 and
A.5 for original ITC-curves and fitting results. All interactions are characterized
by a favourable (exothermic) reaction enthalpy and a favourable reaction entropy.
The resulting free energy (∆G) is comparable for all interactions of Ran wt and
acetylated Ran with RCC1. For Ran wt and most AcKs the bound nucleotide
(GDP or GppNHp) does only marginally affect the binding affinities measured
by ITC (see Figure 3.9). This observation is in agreement with the accepted
binding model, suggesting a tight Ran-RCC1 complex after nucleotide release
from a loose ternary Ran-GXP-RCC1 complex. Thus, RCC1 does not distiguish
between the active (GTP) or inactive (GDP) nucleotide state of Ran and direc-
tionality of nucleotide exchange is rather dependent on prevailing concentrations.
The determined affinities for RCC1 are 560 nM and 550 nM for Ran-GDP and
Ran∗GppNHp, respectively. Taking the manufacturers tolerance of ± 20% for KA
into account, the determined binding affinities of AcK37∗GDP, and AcK159∗(GDP
and GppNHp) are similar/comparable to the wildtype. Ran AcK60 binds RCC1
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with a roughtly 2-fold reduced affinity which is also nucleotide-independent. In-
terestingly, the Ran AcK37 interactions are dependent on the bound nucleotide.
Ran AcK37∗GDP binds with 390 nM, whereas the active, GppNHp-loaded pro-
tein binds with a 5-fold higher affinity (100 nM). However, how AcK37 mediates
this effect on the molecular level is unclear. Acetylation on lysine 71 resulted
in the most prominent alteration, increasing the RCC1-affinity 6- and 20-fold for
AcK71∗GDP and -GppNHp, respectively.
The comparison of the thermodynamic profiles of all interactions sets Ran AcK99
apart from the other Ran AcKs. The interaction of AcK99 in both nucleotide
states is characterized by a distinctly lower reaction enthalpy which is only partially
compensated by a slightly higher entropic contribution. Due to the resulting weak
heat signal, the measurement had to be conducted at 30 ◦C instead of 25 ◦C in the
case of AcK99∗GDP. This clear difference in the thermodynamic profile indicates
a different binding mechanism for this interaction.
RCC1-catalyzed nucleotide exchange reaction characterized by stopped-
flow
The effects of Ran-acetylation on the RCC1-catalyzed nucleotide-exchange reac-
tion were investigated by stopped-flow measurements (original traces and fits in
Appendix A.6). The Ran-protein was loaded with fluorescently-labeled mantGDP
and subsequently titrated with increasing concentrations of RCC1 in the presence
of unlabeled GTP. The decrease in fluorescence was plotted against time and fitted
to a single-exponential function to give the observed rates (kobs) for each RCC1-
concentration. The plot of the observed rates against the RCC1-concentration
resulted in a hyperbolic curve (Figure 3.10.a). Fitting to equation 2.8 determined
the maximal rate of nucleotide dissociation (k−2) and the affinity constant for the
binding of RCC1 to Ran∗mGDP (K−1)(Figure 3.10.b). For further details refer to
Chapter 2.5.3.
For the reaction of Ran wt and RCC1 an affinity constant of 1.1µM and a max-
imal nucleotide dissociation rate of 12.8 s−1 were determined. The dissociation
constant is similar to published values also determined by stopped flow, namely
0.9 - 1.3µM (Klebe et al., 1995b). The dissociation rate deviates noticeably from
the published value (21 s−1), however, this is probably due to differences in the
experimental setup (exchange for GTP instead of GDP, slightly different Ran con-
struct). Since the main focus of this investigation is the direct comparison of Ran
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Figure 3.10: RCC1-catalyzed nucleotide exchange measured by
stopped-flow.Ran∗mantGDP (1µM) was titrated with RCC1 (0.039 - 80µM)
in the presence of GTP (50µ). Tryptophanes were excited at 295 nm and mant-
fluorescence was detected using a 420 nm-cut off filter. (a) Reaction scheme
and hyperbolic plot of kobs over the RCC1-concentration. (b) Determined
nucleotide-dissociation rates (k−2) and affinity constants (1/K1) of RCC1 and
Ran∗mantGDP.
wt with the acetylated Ran variants, these minor deviations are negligible/accept-
able. Acetylation of Ran on lysines 60 and 159 results in a slight increase of the
RCC1-catalyzed nucleotide dissociation rate and RCC1 affinities (KD) similar to
Ran wt. Ran AcK37, on the other hand, exhibits a slightly decreased dissociation
rate in combination with a lower equilibrium dissociation constant (1/K−1). The
fact that these three Ran variants show only minor deviations from the Ran wt be-
havior, corresponds well to the thermodynamic binding characterization by ITC.
In contrast acetylation of Ran at lysine 71 or 99 affects the RCC1-catalyzed re-
action drastically. Ran AcK71 has a 2-fold decreased nucleotide dissociation rate,
which could be due to the drastic increase in binding affinity (nucleotide-dependent
6- to 20-fold) as determined by ITC. However, the strongest impairment of the ex-
change reaction is exerted/caused by Ran-acetylation at lysine 99. The nucleotide
dissociation is reduced by a factor of ten, whereas the RCC1 affinity is comparable
to Ran wt.
Structure-based discussion of results
The crystal structure of the Ran-RCC1 complex (PDB: 1I2M) locates the Ran-
binding site opposite to the chromatin binding site of the seven-bladed β-propeller
of RCC1. The RCC1-structure does not change much upon Ran-binding, except
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Figure 3.11: Ran in comlex with RCC1.(a) Ribbon-presentation of Ran
(yellow) in complex with RCC1 (blue) with the ve acetylation-sites studied
here (red sticks) (pdb:1I2M). (b) Close-up of the binding interface with the
Ran lysines 71 and 99 as well as the RCC1 residues in interaction distance (blue
sticks).
for a prominently protruding/exposed -sheet in blade three (146 - 153), the so
called -wedge. In contrast, the Ran structure shows structural di erences in
switch II, helices 3/ 4 and the 121NKxD125 nucleotide base binding motif. The
two acetylation sites with the strongest impairment of the RCC1-catalyzed ex-
change reaction, lysines 71 and 99, are both located in the binding interface of
Ran and RCC1 (see gure 3.11.a and b). Lysine 71 is part of switch II, which re-
arranges upon RCC1-binding and interacts with N268 and H304 of RCC1. Lysine
71 is also in interaction distance of lysine 18 in the P-loop of Ran. Mutational
studies in the past pointed towards K71 and F72 of Ran as very important for the
interaction with RCC1 (Renault et al., 2001). This study shows that acetylation
of K71 drastically increases the a nity towards RCC1, presumably by forming
additional contacts. Furthermore, the nucleotide dissociation rate of Ran AcK71
is lowered by a factor of two compared to Ran wt. Since switch II is not directly
involved in the nucleotide exchange reaction, this e ect is more likely due to the
altered binding a nity. Acetylated Ran at lysine 99 exhibited a tenfold reduced
RCC1-catalyzed nucleotide dissociation rate in combination with a changed ther-
modynamic interaction pro le determined by ITC. This is not surprising, given
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that lysine 99 is located in helix α3, which forms the most extensive interactions
with RCC1. Especially Ran lysine 99 relocates upon binding to be buried in a
pocket close to the central tunnel of the RCC1-propeller structure. It furthermore
interacts with D128 and N181 of RCC1. Acetylation of this residue results in
a reduced reaction enthalpy, indicating a loss of hydrogen bonds, salt bridges or
van-der-Waals interactions. The observed effects could either be due to drastically
altered binding kinetics or an indirect structural interference with the nucleotide
exchange reaction. Notably, the RCC1 mutations D182A and H304A significantly
affect the kkat of RCC1 (Renault et al., 2001). Structural data based on a complex
of Ran AcK71 or AcK99 and RCC1 would provide valuable information regarding
the molecular mechanisms of the acetylation effects. All crystallization attempts
with recombinant Ran AcK 71/99 and RCC1 in different construct lengths failed,
though.
3.2.3 Effect of Ran-acetylation on Importin-β interaction
In the nucleocytoplasmic transport cycle, Ran∗GTP binds to transport receptors
to facilitate cargo-binding (export receptors) or -release (import receptors) in the
nucleus. Importin-β, the classical import receptor, was chosen to investigate the
effect of Ran-acetylation on import receptor binding. The binding affinities and
thermodynamic parameters of the interaction were determined by ITC (Figure
3.12 and Appendix A.7). Furthermore, the association kinetics were analyzed by
stopped-flow measurements. Due to the extremely low koff rate for the high-
affinity Ran-Importinβ-complex and protein stability issues, we desisted from an-
alyzing the dissociation reaction, but derived them from the KD and kon values
instead.
Since Importin-β does exclusively bind Ran∗GTP, ITC measurements were done
with GppNHp-loaded Ran. For a standard binding experiment 268µM Importin-β
was titrated to 40µM Ran∗GppNHp in 2.5µl injection-steps. The titration was
done at 25 ◦C in phosphate buffer at 800 rpm, differential power 6, 180 s initial
delay and spacing.
Importin-β binds with an affinity of 160 nM to Ran wt∗GppNHp in phosphate
buffer. In contrast, published affinities ,determined indirectly by competition as-
says or fluorescence-based determination of the kinetic constants, are in the low
nanomolar to picomolar range (Go¨rlich et al., 1996; Villa Braslavsky et al., 2000).
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Figure 3.12: Thermodynamic characterization of the Importin-β
- Ran interaction. (a) Representative ITC titrations of Ran∗GppNHp
(40muM) to Importin-β (268muM) in KPi at 25
◦C. (b) Signature plot show-
ing free energy (∆G), reaction enthalpy (∆H) and reaction entropy (-T∆S) of
Ran wt and AcKs. Determined KD-values and stoichiometries are given in the
upper panel.
This variance is due to the influence of the used interaction buffer, especially
the salt-content. In Tris- and phosphate-buffer containing 150 mM salt the bind-
ing affinity of Ran wt to Importin-β is increased to sub-nanomolar levels (data
not shown), hence to the detection limit of ITC. To still be able to compare the
interaction of Importin-β with Ran wt and the Ran AcKs using ITC, we took
advantage of the reduced affinities in the phosphate buffer system (without salt).
Ran wt and all Ran AcKs bound to Importin-β in an exothermic reaction with
almost identical values for the free energy (∆G)(Figure 3.12.b). All reactions are
enthalpy-driven and exhibit enthalpy-entropy-compensation, which can often be
observed for protein-protein- and protein-ligand interactions (Frisch et al., 1997;
King et al., 2012). In comparison to Ran wt, Ran AcK99 and AcK159 have a
higher reaction entropy contributing to binding, which is compensated by a lower
enthalpic contribution. In the case of Ran AcK71 binding to Importin-β a slightly
unfavorable reaction entropy was measured, which is counteracted by an increased
favorable enthalpy. The KD-values determined for the acetylated Ran variants are
in the low nanomolar range and indicate strong binding. Ran AcK60 and AcK71
bind with comparable, or slightly higher affinity to Importin-β compared to Ran
wt. Acetylation on lysines 37, 99 or 159, however, results in a 8 - 14-fold stronger
binding to the import receptor.
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Figure 3.13: Association of Importin-β and Ran measured by
stopped-flow.Ran∗mantGppNHp (200 nM) was titrated with Importin-β (1 -
8µM) in KPi at 25
◦C. The increase in fluorescence of the mant-fluorophor (λex:
320 nm, λem: 450 nm) was monitored. (a) Original traces and single-exponential
fits for Ran wt. (b) Plot of kobs over the Importin-β concentration and linear
fit to determine kon for Ran wt. (c) Determined kon rates for Ran wt and all
AcKs. (d) Affinity constants (ITC), kon rates (stopped-flow) and resulting koff
rates (calculated).
The association kinetics of the interaction were analyzed by stopped-flow (Figure
3.13). To this end, 200 nM mantGppNHp-labeled Ran was mixed with 1 - 8µM
Importin-β in potassium phosphate buffer at 25 ◦C. The increase in fluorescence
of the mant-fluorophor (λex: 320 nm, λem: 450 nm) was monitored over time and
fitted to a single-exponential function to give the observed rates (kobs). The plot
of the kobs-values over the Importin-β concentration resulted in a linear curve with
the slope kon (see Appendix A.8 and A.9 for original traces and linear fits). The
association rate for Ran wt and Importin-β was determined as 1.5·10−4M−1s−1,
which is in accordance with the published value of 1.3·10−4M−1s−1 in HEPES
buffer at 20 ◦C (Villa Braslavsky et al., 2000).
The majority of acetylated Ran variants (namely AcK 60, 71, 99 and 159) only
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marginally affects the association rate. In contrast, acetylation of lysine 37 results
in a 3-fold increase of the association rate to Importin-β. Since all experiments
(ITC, stopped-flow) were conducted under the same conditions (25 ◦C, KPi) the
Ran∗mGppNHp-Importin-β dissociation rate (koff ) can be determined from the
measured equilibrium dissociation constant (KD) and the association rate (kon).
The calculated dissociation rate (koff ) for all Ran AcKs is slower than for Ran
wt, ranging from a 2-fold decrease for Ran AcK71 to a 24-fold reduction for Ran
AcK99. Taken together, the interaction studies revealed that acetylation of Ran
at different lysine residues may increase the binding affinity by altering the asso-
ciation and dissociation rates likewise.
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3.3 Regulation of Ran acetylation
3.3.1 Ran acetylation in vivo
Several mass-spectrometry based screens in different species and under different
conditions identified up to eleven acetylation sites in Ran. However, the stoi-
chiometry of these acetylation events was neither the major focus of these studies,
nor were/are the techniques for stoichiometry determination in these large-scale
bottom-up screens advanced enough. Therefore, it is unclear whether lysine acety-
lation of Ran ranks among a low-stoichiometry background or exists with relevant
abundance. I wanted to address this question with a top-down approach, detect-
ing the acetylation on the full-length protein level by immunoblotting of isolated
endogenous Ran.
The first technique was based on an anti-acetyl-lysine-antibody coupled to agarose-
beads (ImmuneChem). These beads were also used by Choudhary et al. to en-
rich acetylated peptides prior to mass-spectrometrical analysis (Choudhary et al.,
2009). Immunodetection of Ran after affinity-pull-down combined with detection
of acetyl-lysine with a different antibody would have been a reliable readout for
Ran-acetylation. However, this approach proved unsuitable. Tests with recombi-
nant Ran (wt and acetylated) showed that Ran binds unspecifically to the agarose
beads. Furthermore, it could not be ruled out, that Ran is pulled-out indirectly
due to binding to histone-associated RCC1 or other acetylated proteins.
As an alternative endogenous Ran was isolated from cell lysate with GST-RCC1,
the GEF of Ran. Owing to the extensive characterization of the interaction be-
tween RCC1 and the Ran AcKs (see section 3.2.2) it can be excluded, that single-
acetylation at either of the studied sites prevents RCC1-binding. The determined
affinities of 30 nM to 1.4µM should allow efficient pull-down of all Ran AcKs. In
fact, the pull-down with RCC1 worked quantitatively. Lysates of several cell lines
(HeLa, MV4-11, NB4) under different growth- and stress-conditions (interphase,
mitosis, osmotic stress) were used for the pull-down (Table 3.3). Immunoblot-
ting of the eluates for Ran and AcK demonstrated successful isolation of Ran
but no acetylation was detected (data not shown). Thus, a low stoichiometry of
Ran-acetylation has to be assumed for the conditions tested.
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Table 3.3: Cell lines and conditions (all ± Inhibitors) used for the pull-down
with RCC1
Cell line Interphase Mitosis Osmotic Stress 24 h Inhibitors
HeLaB x x x x
NB4 x - - -
MV4-11 x - - -
LoVo x - - -
HEK293 x - - -
3.3.2 Regulation by specific deacetylases
The availability of natively-folded, site-specifically acetylated Ran provided the
opportunity to test all human deacetylases for activity against each of the exam-
ined acetylation-sites. To this end all human KDACs (HDAC1-11 and Sirtuins
1-7) were purchased as recombinantly purified, active proteins (see Table 2.6). All
enzymes were tested regarding their deacetylase-activity by using commercially
available Fluor-de-Lys substrates in a fluorescence-based deacetylation-assay. In
this assay all KDACs were applied according to the specific activity given by the
manufacturer. Thus, identical levels of deacetylation were expected under iden-
tical assay conditions. However, as shown in Figure 3.14 strong variations were
observed. Since all reactions were performed in parallel (HDACs and Sirtuins sep-
arately) the different deacetylation levels are probably due to deviating enzyme
activities under the used assay conditions. In the case of Sirt6 the low activity
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Figure 3.14: Verification of enzymatic activity for all KDACs.Fluor-
de-Lys substrate was incubated with recombinant KDACs according to the en-
zymatic activity given by the manufacturer. After cleavage with trypsin, fluo-
rescence intensities were determined (λexc 350 nm, λem 450 nm). (a) 1000 pmol
HDAC substrates 2a or 3 were used. (b) 250 pmol Sirt2 substrate was used.
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can be explained by its preference to remove long-chain fatty acyl-chains, such
as myristoyl, from lysine residues (Jiang et al., 2013). For Sirt7 no deacetylase
activity could be shown for peptides, apart from H3K18, in vitro so far, suggest-
ing a high specificity. To provide comparable conditions in the subsequent KDAC
screen, the amount of enzyme was normalized to correspond to a 40 % increase
of intensity over the background in the initial activity assay. Hence more enzyme
was used in the case of HDAC 1, 3, 5, 7 and 11 and less for HDAC 2, 4, 6, 8, 9
and 10. For the sirtuin assay all enzyme amount were increased except for Sirt2.
The KDAC-screen was set up as a dot-blot of triplicates for every acetylation-
site with and without the respective enzyme after incubation for 3 h at 25 ◦C.
The sequential detection of acetyl-lysine and Ran (loading control) was done by
imunoblotting. The histogram in figure 3.15 shows the mean relative fluorescence
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Figure 3.15: Deacetylation of recombinant Ran AcKs by classical
KDACs and Sirtuins.Recombinant Ran AcKs (100 pmol) were incubated in
triplicates with/without deacetylases. Amounts of enzymes were adjusted to
correspond to 40 % fold intensity in the initial activity assay (Fig. 3.14). Acety-
lation was detected by dot-blot and subsequent immunoblotting with the anti-
AcK antibody and anti-Ran for loading control. AcK-signals were normalized to
Ran-loading. The mean± s.d. of triplicates is shown. (a) All classical HDACs
and (b) human sirtuins 1, 2, 3, 6 and 7 were tested for activity against the five
Ran acetylation sites.
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intensity with standard deviation for every combination tested. For none of the
tested human HDACs a substantial deacetylation activity against the tested Ran
AcKs was observable under the assay conditions. However, three sirtuins (Sirt1 -3)
exhibited activity against Ran AcKs, resulting in a more than 50 % reduction of
the AcK-specic uorescence signal.
In vitro assays followed by immunoblotting veri ed, that sirtuins 1, 2, and 3
deacetylate Ran AcK37, whereas Ran AcK71 is speci cally deacetylated by Sirt2
only (Figure 3.16.a). As expected for sirtuin-catalyzed reactions, deacetylation is
NAD+-dependent and can be inhibited by nicotinamide (NAM).
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IB:  AcK
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IB:  AcK
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Figure 3.16: Ran is deacetylated by sirtuins 1, 2 and 3.(a) 3  g re-
combinant Ran AcK were incubated with sirtuins 1, 2 and 3 (0.6  g, 0.2  g
and 0.55  g) for 2 h at room temperature. Shown are immunoblots using the
anti-AcK antibody, Coomassie-blue staining (CMB) for Ran-loading and anti-
His/anti-GST as input-control for the enzymes used. (b) Time-course experi-
ment with 25  g Ran AcK37 and AcK71 and 1.5  g Sirt2. Signal detection by
immunoblotting with anti-AcK antibody, SDS-PAGE as loading control for Ran
and Sirt2. Both experiments were conducted by P. Knyphausen.
The time-course experiment with AcK37 and Ran AcK71 in gure 3.16.b reveals
that the deacetylation rate of Sirt2 is much higher for AcK37 than for AcK71.
Thus, the acetylated lysine 37 of Ran, located in the relatively exible switch I
region, seems to be an excellent substrate for Sirt1, Sirt2 and even the mitochon-
drial Sirt3. In contrast, deacetylation of AcK71, which is also located in a exible
region (switch II), is highly speci c for Sirt2, albeit with a slower rate.
Interestingly, both Sirt2-target sites are located in the essential switch regions of
Ran. Lysine 37 is located in switch I, whereas lysine 71 is situated in switch II.
Both exible loops interact with the bound nucleotide and change conformation
dependent on the nucleotide state. This conformational shift is the basis for the
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discrimination between active GTP-bound- and inactive GDP-bound-Ran by Ran-
effector proteins. As a consequence, the switch regions, and hence lysines 37 and
71, are often/usually part of the binding interface with Ran-binding proteins.
To test, whether Sirt2-catalyzed deacetylation is dependent on the nucleotide-
state or complex-formation of Ran, time-course experiments were conducted. So
far, all deacetylation experiments used Ran∗GDP AcKs as substrates. In this
experiment Ran∗GppNHp AcK37 and 71 as well as the Ran∗GDP-NTF2-complex
and the, theoretically nucleotide-free, Ran-RCC1-complex of AcK37/71 were used
as Sirt2 substrates (Figure 3.17). Ran∗GppNHp was chosen instead of Ran∗GTP
to circumvent interference by the intrinsic nucleotide-hydrolysis.
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Figure 3.17: Dependence of Sirt2 deacetylation on complex-formation
and nucleotide-state.65µg recombinant Ran were incubated with Sirt2 at
25 ◦C and samples taken after the indicated time points. Immunodetection
with anti-AcK antibody and corresponding quantification with ImageJ is shown.
Coomassie-blue staining (CMB) serves as Ran-loading control. Input was de-
tected with anti-Ran, anti-Sirt2, anti-NTF2 and CMB for RCC1 (far-right
panel). (a) 1µg Sirt2 was used for Ran AcK37. (b) 3.7µg Sirt2 were used
for Ran AcK71.
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In the case of Ran AcK37 no substantial difference between the two nucleotide
states was observed. However, NTF2-binding to Ran decreased the deacetyla-
tion rate, whereas RCC1-interaction led to a faster deacetylation. In contrast
to lysine 71, which forms two salt bridges with NTF2, lysine 37 is not directly
involved in NTF2-binding and steric hindrance is not apparent from the crystal
structure. The accelerating effect of RCC1 on the deacetylation rate of AcK37
is not surprising, since lysine 37 adopts a more solvent-exposed conformation in
the RCC1-complex crystal structure compared to Ran∗GDP (Figure 3.11.b).The
analogous experiment was conducted with Ran AcK71, however, to compensate
for the slower deacetylation rate of Sirt2 four times more enzyme was used. The
deacetylation rate of Ran∗GDP AcK71 is unaffected by NTF2. This result is
in agreement with the inability of complex-formation between Ran AcK71 and
NTF2, shown in section 3.2.1. RCC1, on the other hand, prevents deacetylation of
AcK71. This effect is most likely due to the inaccessibility of lysine 71 in the Ran-
RCC1-complex, which is completely burried in the binding interface. Unexpect-
edly, Sirt2-catalyzed deacetylation of Ran AcK71 is strongly nucleotide dependent.
Ran∗GppNHp AcK71 is deacetylated considerably faster than Ran∗GDP AcK71.
Lysine 71 is located in the switch II loop, which adopts a rigid conformation in
the GppNHp-bound state but exhibits a high degree if flexibility in Ran∗GDP.
In other words, the deacetylation of AcK71 by Sirt2 is faster when switch II has
a fixed conformation. This effect could indicate that, apart from a consensus se-
quence, additional structural features are required for substrate recognition and
efficient deacetylation at lysine 71 by Sirt2.
In the literature, Sirt2 is widely regarded as a deacetylase preferentially acting
in unstructured regions with a rather low specificity (Khan and Lewis, 2005;
Mart´ınez-Redondo and Vaquero, 2013). We took advantage of the availability/p-
resence of another lysine residue adjacent to lysine 37 to test this assumption. The
recombinant Ran AcK38 served as a control for the specificity of Sirt2. Contra-
dictory to the prevailing opinion Sirt2 clearly discriminates between lysine 37 and
38. Despite the almost identical structural context, AcK38 is deacetylated with a
drastically reduced rate (Figure 3.18).
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Figure 3.18: Sirt2 distinguishes between Ran AcK37 and AcK38.The
deacetylation of Ran AcK38 is considerably slower than the deacetylation of
the adjacent position AcK37. 65µg recombinant Ran were incubated with Sirt2
at 25 ◦C and samples taken after the indicated time points. Immunodetec-
tion with anti-AcK antibody and corresponding quantification with ImageJ is
shown. Coomassie-blue staining (CMB) serves as Ran-loading control. Input
was detected with anti-Ran, anti-Sirt2, anti-NTF2 and CMB for RCC1 (far-
right panel).
3.3.3 Regulation by acetyl-transferases
In vitro KAT assays analyzed by immunoblotting
Commercially available acetyl-transferases were used to acetylate recombinant Ran
wt in vitro. The two closely related KATs p300 and CBP represent the p300/CBP-
family of KATs. They are the most prominent KATs in the literature. Further-
more Gcn5 and pCAF were chosen as representatives of the Gcn5/pCAF family
and Tip60 as a member of the MYST-family. The enzymatic activity of the
KATs was verified by in vitro acetylation of known histone-substrates. For p300,
CBP and Gcn5 the histone H3 was used, whereas H4 was chosen for pCAF and
Tip60. The histones were recombinantly expressed and purified from E.coli and,
thus, unacetylated. Incubation with the respective KATs in KAT-buffer contain-
ing acetyl-CoA yielded acetylated histones, as verified by immunoblotting against
acetyl-lysine (Figure 3.19.a). Gcn5 exhibited a noticeably weaker acetylation ac-
tivity than the other KATs. For pCAF and Tip60 more H4 substrate had to be
used to obtain a decent acetylation signal, probably due to weaker recognition of
the H4-acetylation sites by the used AcK-antibody.
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Figure 3.19: Acetylation of Ran by CBP in vitro.(a) KAT activities were
tested with histone substrates. 0.75µg H3 and 7.5µg H4 were incubated with
1µl commercially available lysine-acetyltransferase in KAT-buffer. Immunode-
tection with anti-AcK and anti-His (loading) is shown. (b) In vitro transferase
assay with Ran wt as substrate. Immunoblotting for AcK reveals acetylation of
Ran by p300 and CBP. Immunoblotting for Ran serves as loading control. (c)
Specificity of Ran-acetylation by CBP. Negative controls (without Ran, CBP or
Acetyl-CoA)
For the in vitro KAT assay, recombinant Ran wt was incubated with the KATs
in KAT-buffer containing 100µM acetyl-CoA. A sample with Ran wt and acetyl-
CoA without transferase served as negative control. After 4 h at 25 ◦C samples
were processed by SDS-PAGE and subsequent immunoblotting for acetyl-lysine.
Due to autoacetylation all KATs are visible on the blot. Since autoacetylation is
beneficial for all KATs tested here, the appearance of the autoacetylation-signals
is also a good indication for enzymatic activity under the assay conditions used.
The negative control shows no acetylation signal. After incubation with p300 and
CBP, however, a weak acetylation signal could be observed which corresponds to
the molecular weigth of Ran (Figure 3.19.b). Several controls confirmed the speci-
ficity of the Ran-acetylation, as shown in Figure 3.19.c. Again, incubation of Ran
with CBP and acetyl-CoA (+) resulted in a decent acetylation-signal. In contrast,
no acetylation was detectable at this height when Ran was absent. In the sample
without CBP (still containing Ran and acetyl-CoA) neither Ran-acetylation nor
the autoacetylation of CBP was detectable. This control also excludes an unspe-
cific, chemical acetylation of Ran under these specific assay conditions with a pH
of 7.3. This intentionally chosen pH reflects the cytosolic/nuclear pH-conditions
(Llopis et al., 1998). A more basic pH would increase the reactivity of the lysine
side chains and thereby facilitate chemical acetylation. This effect is postulated
for the mitochondrial matrix showing a slightly more basic pH (pH≈ 8). The last
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control in Figure 3.19.c, without acetyl-CoA, confirmed the dependence of the
CBP-catalyzed reaction on the cofactor acetyl-CoA. The weak autoacetylation
signal, even in the absence of acetyl-CoA, suggests that CBP is already partially
acetylated after purification of the enzyme.
Taken together, the in vitro KAT assays with Ran wt and five representative KATs
indicate that Ran is acetylated by p300 and CBP in an acetyl-CoA-dependent
manner/reaction. Furthermore, no unspecific, chemical acetylation was observed
under cytosolic/nuclear pH-conditions in vitro.
In vitro KAT assays analyzed by mass-spectrometry
To verify the results from the in vitro KAT assays by a more sensitive method and
to determine the exact acetyl-acceptor-lysines, mass-spectrometry was used as a
second, independent detection method. To this end, 10µg Ran wt was incubated
with 1µl KATs in the presence of acetyl-CoA for 4 h at 25 ◦C. The samples were
digested with trypsin and finally peptides were analyzed by mass-spectrometry
(for a detailed description refer to Chapter 2). The raw data was processed with
MaxQuant using the implemented Andromeda search engine. To enable compara-
bility all determined peptide intensities were normalized to correspond to a total
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Figure 3.20: MS/MS spectrum of the AcK142-peptide.Annotated
MS/MS spectrum of the modified peptide corresponding to AcK-site 142 in
Ran. Fragments are assigned and color-coded and detected masses are given
for every fragment. The immonium-ions at m/z 126 and 143 are marker ions
for peptides containing -N-acetyl-lysine. Corresponding spectra for AcK37 and
AcK134 are shown in Appendix A.10
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protein intensity of 1·1011. A representative MS/MS spectrum is shown in Figure
3.20. In this case the two marker immonium ions with m/z 126 and 143 were
fragmented (Trelle and Jensen, 2008).
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Figure 3.21: Mass-spectrometrical analysis of Ran-acetylation in
vitro.(a) Heat-map with hierarchical clustering of identified acetylation-sites.
The mean intensities of two independent in vitro KAT-assays are shown with
missing values in grey (b) Volcano-plot of three independent in vitro KAT-assays
with Ran and CBP. The Ran lysines 37, 134 and 142 were identified as the most
significant acetylation sites (p-value< 0.05).
Two independent experiments were averaged for the heat-map in Figure 3.21.a.
The mean normalized intensities of the identified acetylated Ran peptides (n=2)
are shown for the control (Ctrl, no KAT) and the five KATs. Missing values
(peptide not detected) are shown in grey. In the control experiment four out of
eleven acetylated peptides were detected. Compared to the control, the samples
with pCAF, p300 and Gcn5 exhibited only marginal upregulation of acetylation.
Few additional acetylated peptides were detected and, in the case of Gcn5 and
p300, the peptides AcK 134, 142 and 37 had slightly higher intensities. However,
for Tip60 and CBP a strong upregulation of Ran acetylation was determined. In
agreement with the immunodetection, the CBP-treated samples had the maxi-
mum number of acetylated peptides (11) and the highest intensities. The peptide
acetylated at lysine 134 was detected with the highest intensity, followed by AcK
142 and AcK37. A similar pattern was observed for Tip60, but only nine out of
eleven peptides were detected. Three independent KAT assays with Ran wt and
CBP were analyzed by mass-spectrometry and data presented in a volcano-plot
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(Figure 3.21.c). Every data point corresponds to one specific acetylated peptide.
The majority of acetylated peptides are characterized by a low statistical signifi-
cance (low -log10 p-value) and a small log2-fold change of the intensity compared
to the control without transferase. Four peptides stand apart from this cluster of
low significance/low magnitude fold change, of which AcKs 37, 134 and 142 are
characterized by a p-value below 0.05 and a decent intensity change compared to
the control.
The interpretation of both experiments/approaches/analysis indicates that CBP
and Tip60 are Ran-specific acetyl-transferases, in vitro. The mass-spectrometrical
approach furthermore identified the lysines 37, 134 and 142 as the major acetyl-
acceptors.
In vivo KAT assays analyzed by mass-spectrometry
In the cell, KATs are tightly regulated and often exert their activity as part of
large multimeric complexes. The in vitro assays are incapable/unsuitable to take
necessary, yet unknown, cofactors and regulators of the KATs into account. To
provide a more physiological background for the KAT reaction, a human cell line
was transiently transfected with the respective acetyl-transferases. This experi-
ment was conducted by Philipp Knyphausen.
His6-Ran was co-expressed with Myc-tagged KATs (His6-Tip60) in HEK293T cells.
Cells were lysed, Ran was pulled-down with Ni-NTA-beads and subsequently pro-
cessed for mass-spectrometrical analysis. Immunoblotting of the input of the pull-
down confirms the overexpression of the transfected KATs. In addition to the five
KATs used in the in vitro assay, the α-tubulin-specific acetyl-transferase α-TAT
was included in this assay. In contrast to the in vitro data, were raw unnor-
malized peptide intensities were used for analysis, I used the intensities of the
label-free quantification (LFQ) for the in vivo data. Hence, the peptide intensities
were normalized to the protein background present after the pull-down procedure.
Intensities of acetylated peptides were normalized to a total protein intensity of
1·1011, averaged over two independent experiments and presented/depicted in the
heat-map in Figure 3.22.b.
In contrast to the in vitro KAT assay with eleven acetylated peptides, only three
acetylated peptides were identified in the in vivo assay. The control sample with-
out overexpression of KAT already contained the peptides corresponding to AcK
134 and 142. The strongest intensity increase was observed for AcK134 in the
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Figure 3.22: Ran-acetylation by KAT-overexpression in vivo.(a) Co-
transfection of His6-Ran and Myc-tagged KATs (His6-Tip60) in HEK293T cells
and subsequent Ni-pulldown of Ran. Successful transfection of KATs was ver-
ified by immunoblotting against Myc-tag (His6-tag for Tip60). Experiment
conducted by P. Knyphausen.(b) Heat-map with hierarchical clustering of iden-
tified acetylation-sites after in vivo acetylation. The mean intensities of two
independent pulldowns are shown with missing values in grey
Tip60-sample, followed by CBP and p300 which led to an approximately 2-fold
increase in intensity for this peptide. The acetylation of lysine 134 by Tip60 and
CBP is in agreement with the in vitro assay (Figure 3.21.b), whereas almost no
upregulation of AcK142 was detected here. The detected acetylation activity of
p300 on Ran supports our initial observation by immunoblotting (Figure 3.19.b).
Interestingly, α-TAT seems to acetylate Ran exclusively at lysine 152, which would
indicate a high degree of specificity. However this observation is so far not verified
by another independent assay. In the sample with Gcn5 overexpressed no acety-
lated peptide was detected, although the presence of transferase was confirmed by
immunoblotting and mass-spectrometry.

Chapter 4
Discussion
4.1 Summary of results
Effects on Ran-function and Ran-interactions
Five Ran acetylation sites were identified in an acetylome screen of human cell
lysates by the group of Choudhary et al., which were confirmed - and comple-
mented by additional sites- by subsequent screens in different organisms.(Choudhary
et al., 2009). In the course of this study, site-specifically acetylated Ran was pro-
duced by recombinant expression from E.coli. To introduce the amino acid acetyl-
lysine into the protein, the genetic-code expansion concept was used, which is based
on an evolved acetyl-lysyl-tRNA synthethase/tRNACUA -pair from Methanosarcina
barkeri(Neumann et al., 2008). The incorporation as well as the subsequent purifi-
cation was highly efficient, yielding pure protein in quantities suitable for biophys-
ical characterization. Furthermore, Ran-binding proteins, namely NTF2, RCC1
and Importin-β, were successfully purified from E.coli. The interactions of the
binding-proteins with Ran wt were in agreement with published data and con-
firmed the activity of the recombinant proteins. The produced acetylated Ran
variants exhibited no noticeable difference in intrinsic properties compared to each
other or Ran wt. Ran wt and all AcKs were highly stable in the used buffer sys-
tem and the nucleotide binding ability was unaffected by acetylation, as judged
by nucleotide exchange reactions and fluorescence assays (data not shown). The
observed identical elution behavior from size exclusion chromatography also indi-
cated similar protein conformations and oligomerization states.
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Regarding the interaction with Ran-binding proteins, several Ran AcKs show dis-
tinct deviations from the Ran wt behavior. Acetylation at lysine 71 of Ran com-
pletely abolishes binding to NTF2, whereas acetylation of the other four lysines
do not affect this interaction in vitro. Ran AcK71, furthermore, drastically in-
creases the RCC1-binding affinity 6- to 20-fold, depending on the nucleotide state,
and decelerates the RCC1-catalyzed nucleotide exchange observed by stopped-flow
measurements. Acetylation of lysine 99 results in an even stronger impairment of
the RCC1-catalyzed nucleotide exchange, reducing the nucleotide dissociation rate
by a factor of ten. This effect is accompanied by an altered binding mechanism,
which becomes apparent by different binding thermodynamics of the interaction
of RCC1 and Ran AcK99 compared to Ran wt. Regarding the interaction with
the import receptor Importin-β, Ran acetylation impacts on the binding affinities
and the interaction kinetics. Three Ran AcKs exhibit higher binding affinities
for Importin-β (AcK37, AcK99 and AcK159). In the case of Ran AcK37 the
tighter binding is due to a 4-fold accelerated association rate in combination with
a reduced dissociation rate. For Ran AcK99 and AcK159 a reduction of the dis-
sociation rate appears to be the main reason for the higher affinity constants.
Abundance and regulation of Ran-acetylation
The pull-down of endogenous Ran from cell lysates combined with the specific
detection of acetylated lysines by immunoblotting was a major goal of this the-
sis. Different techniques for the isolation of Ran were tested. A pull-down with
GST-RCC1 was chosen, since it proved quantitative and is not interfering with
the subsequent specific detection of acetyl-lysine. Different cell lines and growth-
/stress-conditions were tested for Ran acetylation. Nevertheless, no acetylated
Ran was detected by immunoblotting.
In the absence of direct evidence for the physiological relevance of Ran-acetylation,
the identification of enzymes regulating the acetylation of Ran provides indirect
evidence. An extensive screening procedure with all human deacetylases (clas-
sical HDACs and sirtuins) identified Sirt1, -2 and -3 as deacetylating enzymes
for lysine 37 in Ran. Furthermore, Sirt2 specifically removes the acetyl-group
from lysine 71. Both lysines (37 and 71) are located in the flexible switch re-
gions of Ran, which adopt different nucleotide-dependent conformations. Interest-
ingly, the Sirt2-catalyzed deacetylation is accelerated in the GppNHp-bound state
(compared to the GDP-state) for both positions, but more pronounced for Ran
AcK71∗GppNHp.
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The enzymatic acetylation of Ran was shown by immunoblotting. Incubation of
Ran wt with the human lysine-acetyltransferases p300 and CBP results in a Ran-
specific acetylation signal. The acetylation is dependent on the KAT co-factor
acetyl-CoA and chemical acetylation (without transferase) could be excluded by
several control experiments. No acetylation signal was detected for the trans-
ferases Tip60, pCAF and Gcn5. Mass-spectrometrical analysis of all in vitro
KAT-assays (-KAT, p300, CBP, Tip60, pCAF and Gcn5) detected eleven acety-
lated peptides, predominantly in the samples treated with CBP and Tip60. Three
independent experiments with CBP identified the lysines 37, 134 and 142 as the
major acetyl-acceptors with considerable upregulation and statistical significance
(p-value< 0.05) over all three measurements. In vivo acetylation of Ran by over-
expression of the respective transferases supports this result. Again, Tip60 as well
as CBP and p300 lead to an increase in acetylation, primarily at lysine 134. No-
tably, in contrast to the in vitro KAT-assays, only three acetylated peptides were
detected. The in vivo KAT assay, furthermore, indicates acetyltransferase activity
of α-TAT at lysine 152 of Ran.
4.2 Implications for the biological relevance of
Ran acetylation
This study demonstrates the broad regulatory spectrum of lysine acetylation as a
post-translational modification. For the small GTPase Ran the effects of acetyla-
tion range from catalytic inactivity or loss-of function due to disruption of protein-
protein interactions to fine-regulation by slightly altered binding kinetics.
Acetylation of lysine 71 in switch II
Acetylation at lysine 71 of Ran completely abolishes binding to NTF2, the protein
responsible for Ran-relocation to the nuclear compartment. The loss of this inter-
action restricts Ran relocation to diffusion, which, for Ran-sized proteins, is slowed
down more than 500-fold by the permeability barrier of the NPC (Ribbeck and
Go¨rlich, 2001). This ultimately results in a cytosolic accumulation of Ran∗GDP
AcK71. The disruption of NTF2-binding is not surprising for acetylation of this
specific lysine, since it abolishes the formation of two essential salt-bridges. In
addition to the NTF2-mediated effect, a dominant negative effect of AcK71 on
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RCC1 was observed, resulting from a much slower RCC1-catalyzed nucleotide ex-
change process and a stronger binding affinity. The same effect is observed for the
T24N mutation in Ran (Dasso1994). If acetylation of lysine 71 accumulates to
quantitative levels, both effects ultimately disrupt the Ran∗GDP/GTP-gradient
crucial for nucleocytoplasmic transport in interphase cells. The high affinity for
RCC1 in combination with the decelerated nucleotide exchange results in a pro-
longed residence time of Ran AcK71 in the nucleus and, consequently, in much
slower Ran-cycling and less cargo-transport. The cytosolic accumulation due to
diffusion-restricted reentry into the nucleus would almost completely arrest nucleo-
cytoplasmic transport. The role of NTF2 during mitosis is unknown, thus the effect
of prevention of NTF2-binding by AcK71 under mitotic conditions needs further
investigation.Assuming that only a minor proportion of Ran is acetylated at lysine
71, this modification could modify the Ran-gradient or the Ran-localization in a
regulated manner. In response to a certain stimulus (e.g. radicals, osmotic stress,
hormone) Ran acetylation at lysine 71 could be up-regulated (refer to subsection
4.2) to either slow-down the transport machinery or to make more Ran∗GDP
available for a, yet unknown, cytosolic function. The specific deacetylation by
the cytosolic Sirt2 would terminate this temporary state and restore the original
Ran-gradient.
Acetylation of lysine 99 (loss-of-function)
The loss-of-function acetylation of lysine 99 would result in a different phenotypical
scenario. Ran acetylated in that position binds RCC1 with affinities comparable
to Ran wt, but the catalyzed nucleotide exchange reaction is drastically slower.
As a consequence, the overall production of Ran∗GTP in the nucleus is inhib-
ited by the blockage of RCC1 by Ran AcK99. Dependent on the proportion of
AcK99 the phenotype could range from a slightly reduced transport rate to a dras-
tic reduction of Ran-cycling/transport due to nuclear accumulation of Ran∗GDP
AcK99. However, this tremendous regulatory spectrum requires regulatory tools,
in this case specific acetyltransferases and deacetylases. Enzymatic acetylation
of lysine 99 by acetyltransferases was detected in this study (CBP, Tip60, pCAF
and Gcn5), however the data do not allow for an explicit conclusion regarding the
KAT-regulation of that position. In fact, almost all acetylome screens published
to date prove the existence of Ran AcK99 (Figure 4.1) , either due to chemical
or enzymatic acetylation (Beli et al., 2012; Choudhary et al., 2009; Henriksen
et al., 2012; Lundby et al., 2012; Mertins et al., 2013; Sol et al., 2012; Weinert
et al., 2011). Either way, accumulation of Ran AcK99 would severely impact on
Discussion 99
all essential Ran-functions and has to be tightly regulated or the accumulation
has to be strictly prevented. Yet, in contrast to AcK71 we did not identify the
deacetylase specific for Ran AcK99 with our in vitro KDAC-screen, not ruling out
the regulation in vivo. Acetylation of other lysines Apart from the radical effects
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Figure 4.1: Ran acetylation sites detected in different MS-based
studies.Summary of all Ran acetylation sites identified in MS-based acetylome
screens in different species and by in vitro/in vivo KAT assays in the course of
this study.
of AcK71 and AcK99, Ran acetylation also has the potential for fine-regulation
of interaction processes, as observed for the Ran-Importinβ-interaction. Several
Ran AcKs impact on the binding kinetics and the equilibrium dissociation con-
stant. In the physiological context, such small changes could represent regulatory
screws to adjust Ran-Importin-β interactions and, consequently, transport-rates.
Please note, that the in vitro characterization of the effect of Ran-acetylation on
Importin-β-binding presented here does not satisfy the complexity of the physi-
ological interaction. Neither the presence of Importin-α nor a cargo protein was
taken into account in this study.
The strong regulation of the acetylation on lysine 37 by Sirt1, -2 and -3 and
the acetyltransferases Tip60 and CBP/p300 suggests an important function of
that specific acetylation site. From the data presented here, a direct effect of
AcK37 on RCC1- or NTF2-interaction can be excluded. Furthermore, the inter-
action with Crm1, Snurportin-1, RanGAP and RanBP1 , as well as the RanGAP-
catalyzed nucleotide-hydrolysis reaction are unaffected by acetylation of lysine
37 (P.Knyphausen, unpublished). However, Ran AcK37 has a clear effect on
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Importin-β-interaction, drastically increasing the association-rate and the bind-
ing affinity. How this impacts on the assembled import-complex (Importinβ-
Importinα-cargo) is unclear.
Apart from the five acetylation sites identified in the original screen, several more
sites have been reported over the last six years (Figure 4.1). According to our in
vivo and in vitro acetylation data three of these sites, namely K134, K142 and
K152, are dominant acetyl-acceptor lysines for some of the KATs tested and, thus,
of potential physiological relevance. Lysine 134 (K136 in yeast) is reported to be
essential for the interaction of Ran and the nucleotide release factor Mog1 in yeast
(Baker et al., 2001; Steggerda and Paschal, 2000). Initial interaction studies with
Ran AcK134 and Mog1 indeed suggest that K134-acetylation blocks Mog1-binding
(P.Knyphausen, unpublished). Since the function of Mog1 in the Ran-system it-
self is unknown, a prediction of the physiological consequences of the prevention
of Ran-interaction by acetylation of lysine 134 is not possible at that time. Lysine
152 is part of the SAK-motif (G5, Table 1.2) and, hence, involved in nucleotide
binding by contacting the guanine base. Thus, lysine acetylation in that position
might affect nucleotide binding. Based on available structural data one could,
furthermore, speculate about consequences of acetylation of K134/142/152 for nu-
clear import/export and the formation of RanBP1-complexes. The intramolecular
interaction of K152 with the acidic C-terminus (DEDDDL) in RanBP1-containing
complexes (Ran∗RanGAP∗RanBP1, PDB: 1K5D/G; Ran∗Crm1∗RanBP1, PDB:
4HB2), for example, might be disturbed. In the case of K152 and K134, electro-
static interactions with Crm1 would be lost upon acetylation (PDB: 3GJX, 4HB2)
and also K142 is involved in Crm1- and Importin-β-binding (PDB: 3GJX, 1IBR).
However, the actual effects of each of these acetylations on the mentioned inter-
actions would have to be investigated in detail before statements regarding the
physiological relevance are feasible.
Crosstalk of PTMs
The possibility of acetylation of more than one lysine in vivo impedes the predic-
tion of physiological consequences. Taking all eleven identified acetylation sites in
Ran into consideration, the number of possible combinations of lysine acetylation
is enormous. And even for the five sites studied here a prediction of the effect of
multi-acetylation is not possible, since the assumption of a simple additive effect
is not valid. However, in the case of AcK71 and AcK99 such an additive effect
regarding the RCC1-interaction and -catalysis is not unlikely. Both lysines are
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located in the binding interface and single-acetylation of either of them affects the
RCC1 binding affinity and results in the reduction of the nucleotide-dissociation
rate from the complex. The actual phenotype of this potential double-acetylation
(AcK71/99) needs further investigation.
The crosstalk of Ran acetylation with other post-translational modifications of
Ran is another topic, which was not adressed so far, yet might be of physiological
relevance. In contrast to many other small GTPases Ran was not found to be reg-
ulated by PTMs such as prenylation, phosphorylation or glycosylation. However,
proteomic screens identified several of the eighteen lysine residues as potential
ubiquitylation sites (Wagner et al., 2011, 2012). In fact all lysines found to be
acetylated, were also found to be ubiquitylated. Since this information is exclu-
sively based on mass-spectrometrical analysis, the actual extend as well as the
nature of the ubiquitin-modification (mono- or poly-ubiquitylation, sort of chain)
is unknown. Furthermore, insights into the functional relevance and the regula-
tion of Ran-ubiquitylation are missing. Even though little is known so far about
Ran acetylation and ubiquitylation, a crosstalk between both modifications is very
likely and demands further investigations.
This comprehensive study suggests the enormous regulatory potential of site-
specific acetylation of Ran. By targeting different lysines, Ran function can be
adjusted on different levels. We, furthermore, present strong evidence for the ex-
istence of specific regulating enzymes for some of the acetylation sites studied.
The attempts of detection and quantification of endogenous, acetylated Ran on
protein-level was not successful. Although endogenous Ran was isolated in high
quantities from different cell lines and under different growth-/stress-conditions,
no acetylated Ran was detected by immunoblotting in either of these samples.
To prevent rapid deacetylation upon cell lysis, all isolation steps were carried out
at 4 ◦C and in the presence of deacetylase inhibitors. Enzymatic deacetylation
under non-denaturing conditions could be one explanation for the absence of an
acetylation signal, however, isolation of acetylated Ran under denaturing condi-
tions (urea) also failed (personal communication with P. Knyphausen). These
results suggest a low stoichiometry of Ran acetylation under the conditions tested
in the different cell lines. Very low acetylation levels are difficult to detect by im-
munoblotting, especially in the case of the sites with a low epitope recognition by
the AcK-antibody. This holds true for the AcKs 37, 99 and 159, but is unknown
for all additional acetylation sites not studied here.
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The postulated low abundance of Ran-acetylation in the samples tested questions
a possible physiological relevance of this post-translational modification of Ran.
The modified peptides detected by mass-spectrometry could represent a low sto-
ichiometry background of acetylation, originating from non-enzymatic, chemical
acetylation or unspecific acetylation by transferases. This would be in line with
recent publications showing a low stoichiometry background for the majority of
proteins in yeast (Weinert et al., 2014). In the mitochondrial matrix, chemical
acetylation is an abundant modification event, due to a more basic pH and a high
acetyl-CoA-concentration (up to mM) in this cellular compartment. In this context
lysine deacetylases might act as detoxifying instead of regulating enzymes, hence
a lower substrate specificity is effectual and often observed for these enzymes. In
the cytosolic and nuclear compartment chemical acetylation is less likely, since
the side-chain reactivity of lysines is reduced at the lower pH (7.3 instead of 8
in mitochondria) and reactive acetyl-donors (acetyl-CoA) are less abundant. Im-
munoblotting detected no chemical acetylation of Ran in the in vitro assay system
mimicking cytosolic pH conditions (7.3) even at high concentrations of acetyl-
CoA. On the other hand, expression in E.coli results in unspecific acetylation of
random lysines. The level of these undesired modifications is very low, therefore
neither detectable by immunoblotting nor influencing the determination of the
correct molecular mass (ESI-MS). Acetylated peptides are only detected by high
sensitivity MS-MS measurements following tryptic digest.
Abundance and regulation of Ran-acetylation
[h] And in fact, in a scenario where only a minor proportion of the extensive Ran
pool is acetylated, only a gain-of-function modification or a cascade of acetylation
events would be of physiological relevance. A cascade, where several acetylations
result in the amplification of the final outcome, could be indicated by the fact that
several Ran-interacting proteins were also found to be acetylated (e.g. Importin-β,
RanGAP and RanBP1). In another scenario, Ran-acetylation is tightly regulated
by specific acetylating and deacetylating enzymes. The identification of the Ran-
specific acetyltransferases p300/CBP, Tip60 and, potentially, α-TAT as well as
the deacetylation of AcK37 and AcK71 by human sirtuins are strong arguments
for this scenario. Moreover, the analysis of tissue-specific acetylation patterns in
rodents by Lundby et al. (Figure 4.2) supports this hypothesis of conditional
acetylation of Ran (Lundby et al., 2012). Some tissues exhibit no Ran-acetylation
at all, whereas others show a broad spectrum of acetylation sites and -levels.
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Figure 4.2: The acetylation pattern of Ran is tissue-dependent (in
mouse/rat samples).Relative abundance of acetylated peptides detected by
MS in different tissues of rats/mice. Modified after (Lundby et al., 2012)
Acetylation of Ran could increase upon up-regulation of the specific KATs either
due to higher expression, increased activity or a change in KAT-localization. These
changes could be related to a specific tissue, an external stimulus, a metabolic
state as well as growth-/stress- or even disease-specific conditions. In prostate
cancer up-regulation of Tip60 as well as oncogenic potential of CBP/p300 was
reported (Fu et al., 2000; Halkidou et al., 2003). In hepatocallular carcinoma
high expression levels of p300 were identified as a biomarker for poor prognosis (Li
et al., 2011). Inversely, the downregulation of the deacetylases of Ran would result
in the accumulation of acetylation. This scenario is imaginable for several cancer
types. Sirt1-levels, for example, were found to be reduced in prostate and bladder
carcinoma, glioblastoma and ovarian cancer (Wang et al., 2008). Moreover, sirtuin-
levels (Sirt1, -2, -3, -5, -6 and -7) are decreased in head and neck squamous cell
carcinoma (Lai et al., 2013). Furthermore, several publications show interaction
and regulation of acetyltransferases with/by lysine-deacetylases and vice versa. A
functional cooperativity was shown for Tip60 and p300/CBP (Col et al., 2005;
Xiao et al., 2014). Deacetylation by Sirt2 inactivates p300, whereas acetylation of
Sirt2 by p300 inactivates, creating a feedback loop (Han et al., 2008).
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4.3 General implications for the investigation of
protein acetylation
Besides the Ran-related gain of knowledge/information described and discussed
above, several general conclusions can be drawn from this study. First of all,
the strong regulatory potential of lysine-acetylation as a post-translational mod-
ification has to be acknowledged. The analysis of only five acetylation sites
of Ran revealed a broad regulatory spectrum for this rather small modification
even without taking the crosstalk with other PTMs into account. Thus, protein
acetylation might approximate the importance of phosphorylation as a regula-
tory PTM, assuming that the majority of acetylation sites does not turn out as
low-stoichiometry background noise. In fact, this major challenge of the current
acetylome research also becomes apparent in this study. Despite detection of Ran-
acetylation by numerous MS-based acetylome screens, no detectable quantities of
acetylated Ran could be isolated from living cells on the protein level. This clearly
demonstrates, that the physiological abundance of every acetylation site/ acety-
lated protein detected by MS-based screens has to be verified by independent and
quantifiable methods such as immuno-precipitation (IP) and immunoblotting (IB)
(until reliable means of absolute quantification are available for proteomics). If
no acetylated protein can be isolated from cells and detected via IP and IB (as in
the case of Ran), either the high sensitivity of modern mass-spectrometers detects
traces of acetylated peptides or the acetylation is tightly regulated and restricted
to distinct conditions.
In contrast to classical approaches we used site-specifically acetylated, recombinant
proteins (based on the genetic-code expansion concept) for the in vitro character-
ization of every single acetylation site. The acetylated full-length proteins enable
the site-specific verification of acetyl-lysine mimics, the investigation of deacety-
lase reactions or bromodomain-interactions and even crystallization trials with the
latter. The KDAC-screen with the five Ran-acetylation sites identified deacety-
lase activity for Sirt-1, -2 and -3 against AcK37 and Sirt2-specificity for AcK71.
Remarkably, these activities were not detected in an acetylome peptide microar-
ray screening all human sirtuin isoforms for activity against 13-mer-peptides of
the acetylation sites identified by Choudhary et al.(Choudhary et al., 2009; Rauh
et al., 2013). Similar to Ran, also other published sirtuin substrates were not
identified in this screen (Figure 4.3). Either the immobilization of the peptide
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Figure 4.3: Sirtuin activity on published substrates as detected by
a microarray screen.An acetylome peptide microarray screen fails to detect
deacetylase activity for Ran AcKs and several published sirtuin substrates. The
bar charts show the weighted means of the signal ratios with error bars resulting
from three independent experiments (Rauh et al., 2013). (a) Signal ratios for
Ran AcK 37 and 71, which were shown to be sirtuin substrates of Sirt1-3 and
Sirt2, respectively. (b) Signal ratios for established sirtuin substrates. SMAD7
is deacetylated by Sirt1, Tubulin-α by Sirt2 and PDHA1 is a substrate of Sirt3
(Kume et al., 2007; North et al., 2003; Ozden et al., 2014).
affects the substrate recognition or one or two widely accepted assumptions of the
screen are not applicable: 1. 13-meric peptides (six residues N- and C-terminal of
the acetylation site) are sufficient for sirtuin substrate recognition, 2. A secondary
structure is not needed (or even obstructive) for substrate recognition (Cosgrove
et al., 2006; Khan and Lewis, 2005). In fact, there seems to be no defined consen-
sus sequence for sirtuin recognition, neither as a group nor for individual enzymes
(Mart´ınez-Redondo and Vaquero, 2013). Blander et al. even reported absence of
substrate specificity of Sirt1 on peptides in vitro and suggest a tertiary fold or
protein-protein interactions as determinants of specificity in vivo (Blander et al.,
2005).
Contradictory to these assumptions and reports regarding sirtuin substrate speci-
ficity, we observed a high degree of specificity for Sirt2 indicating dependence
of substrate recognition on protein structure and consensus sequence. Strikingly,
Sirt2 clearly distinguishes between AcK37 and AcK38 of Ran resulting in a consid-
erably reduced deacetylation rate of AcK38 compared to AcK37. The dependence
on structural features becomes apparent trough the fact that the Sirt2-catalyzed
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deacetylation rate of AcK71 is nucleotide-dependent. In other words, Sirt2 dis-
tinguishes between the (rigid, more structured) GTP-conformation and the (more
flexible) GDP-conformation of switch II, notably, in favor of the more structured
substrate AcK71∗GppNHp.
Finally, our approach provides the means to evaluate established tools which are
crucial to study protein acetylation, such as acetylation mimics and specific anti-
acetyl-lysine antibodies. The validity of the acetylation mimics, glutamine and
arginine, can be verified prior to cell culture experiments. The knowledge of which
is the better mimic (steric or charge) with regard to a specific interaction is cru-
cial for the interpretation of the experimental in vivo results. In the case of the
Ran∗NTF2 interaction, for example, glutamine was confirmed as a valid AcK71-
mimic (abolishes interaction), whereas K71R still binds to NTF2. Localization
experiments in cell culture showed the expected nuclear localization of Ran K71Q.
However, surprisingly Ran K99R exhibited a phenotype similar to Ran K71Q, al-
though the interaction of Ran AcK99 and NTF2 is unaffected. Either arginine is
no suitable mimic, neither for lysine nor for acetyl-lysine, or the observed effect is
caused by the manipulation of another, NTF2-independent, process. In this spe-
cific case, only the in vitro comparison of AcK99 and its Q/R-mimics regarding
NTF2-interaction enabled the correct interpretation of the observed result.
The evaluation of a well-established anti-acetyl-lysine antibody disclosed strong
variations in the detection specificity of different Ran AcKs, indicating a strong
dependence of the AcK-recognition on the residues flanking the acetyl-lysine. This
effect could be even more pronounced under native conditions, since structural
constraints might also influence the specificity. Consequently, detection limits
of recombinant Ran AcKs vary drastically. Since MS-based proteomic screens
rely on antibody-dependent affinity-enrichment of acetylated peptides, this site-
specific deviation in substrate recognition does directly influence the result of the
proteomic screen.
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4.4 Conclusion and outlook
In the course of this study five acetylation sites of the small G-protein Ran were
characterized regarding their impact on Ran and the Ran system. Ran acetylation
has the potential to influence all aspects of Ran-function, namely Ran localiza-
tion, Ran activation and -inactivation as well as import- and export processes.
Several attempts to isolate and detect acetylated full-length Ran from cells failed,
though, indicating a low-stoichiometry of Ran-acetylation under the conditions
tested. However, the fact that Ran-specific regulatory enzymes were identified
(Tip60, CBP/P300 and α-TAT as KATs and Sirt1/2/3 as KDACs) and no chem-
ical acetylation was observed at cytosolic pH-conditions even at high acetyl-CoA
concentrations, rather suggests a thight regulation of Ran-acetylation than an un-
specific low-level background acetylation. The development of reliable (absolute)
quantification methods for high-throughput acetylomics is essential to enable the
discrimination of biological relevant from irrelevant sites. An increasing number
of (quantified) cell-, tissue- and condition-specific acetylome datasets will provide
insight into the role and regulation of protein-acetylation. However, in vivo and
in vitro studies will remain indispensable to unravel the molecular mechanisms
underlying the observed effects of single acetylation sites. As shown here, GCEC
is a valuable tool for the investigation of the impact of lysine acetylation.
Due to the fact that several KATs and sirtuins also have acylation/ deacylation
activity, the comparison of acetylation and other forms of acylation will become
more important in the near future (Chen et al., 2007b; Liu et al., 2009). It will be
interesting to determine mechanistic differences between the different alkyl-chain
lengths and gain insight into the metabolic regulation of the different modification.
To judge this, more information about the regulation of KATs and KDACs is
needed, though.
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                        glnS-promoter        RNA-initiation           Shine  
 SphI           (-35)                     (-10)      sites                  Dalgarno 
GCATGCATGCCTCGGGTTGTCAGCCTGTCCCGCTTATAAGATCATACGCCGTTATACGTTGTTTACGCTTTGAGGAATCCCAT 
 
Translation                       acetyl-lysyl-tRNA synthetase coding sequence 
 Start                     
ATGATGGATAAAAAACCGCTGGATGTGCTGATTAGCGCGACCGGCCTGTGGATGAGCCGTACCGGCACCCTGCATAAAATCAA
ACATCATGAAGTGAGCCGCAGCAAAATCTATATTGAAATGGCGTGCGGCGATCATCTGGTGGTGAACAACAGCCGTAGCTGCC
GTACCGCGCGTGCGTTTCGTCATCATAAATACCGCAAAACCTGCAAACGTTGCCGTGTGAGCGGTGAAGATATCAACAACTTT
CTGACCCGTAGCACCGAAAGCAAAAACAGCGTGAAAGTGCGTGTGGTGAGCGCGCCGAAAGTGAAAAAAGCGATGCCGAAAAG
CGTGAGCCGTGCGCCGAAACCGCTGGAAAATAGCGTGAGCGCGAAAGCGAGCACCAACACCAGCCGTAGCGTTCCGAGCCCGG
CGAAnAGCACCCCGAACAGCAGCGTTCCGGCGTCTGCGCCGGCACCGAGCCTGACCCGCAGCCAGCTGGATCGTGTGGAAGCG
CTGCTGTCTCCGGAAGATAAAATTAGCCTGAACATGGCGAAACCGTTTCGTGAACTGGAACCGGAACTGGTGACCCGTCGTAA
AAACGATTTTCAGCGCCTGTATACCAACGATCGTGAAGATTATCTGGGCAAACTGGAACGTGATATCACCAAATTTTTTGTGG
ATCGCGGCTTTCTGGAAATTAAAAGCCCGATTCTGATTCCGGCGGAATATGTGGAACGTATGGGCATTAACAACGACACCGAA
CTGAGCAAACAAATTTTCCGCGTGGATAAAAACCTGTGCCTGCGTCCGATGATGGCTCCGACCATTTTTAACTATGCTCGTAA
ACTGGATCGTATTCTGCCGGGTCCGATCAAAATTTTTGAAGTGGGCCCGTGCTATCGCAAAGAAAGCGATGGCAAAGAACACC
TGGAAGAATTCACCATGGTTAACTTTTTTCAAATGGGCAGCGGCTGCACCCGTGAAAACCTGGAAGCGCTGATCAAAGAATTC
CTGGATTATCTGGAAATCGACTTCGAAATTGTGGGCGATAGCTGCATGGTGTATGGCGATACCCTGGATATTATGCATGGCGA
TCTGGAACTGAGCAGCGCGGTGGTGGGTCCGGTTAGCCTGGATCGTGAATGGGGCATTGATAAACCGTGGATTGGCGCGGGTT
TTGGCCTGGAACGTCTGCTGAAAGTGATGCATGGCTTCAAAAACATTAAACGTGCGAGCCGTAGCGAAAGCTACTATAACGGC
ATTAGCACGAACCTGTAA 
           Translation  
               Stopp 
 
CGTTTCAAACGCTAAATTGCCTGATGCGCTACGCTTATCAGGCCTACATGATCTCTGCAATATATTGAGTTTGCGTGCTTTTG
TAGGCCGGATAAGGCGTTCACGCCGCATCCGGCAAGAAACAGCAAACAATCCAAAACGCCGCGTTCAGCGGCGTTTTTTCTGC
TTTTCTTCGCGAATTAATTCCGCTTCGCACATGTGACATGCATGC            glnS terminator      RNA- 
termination                             SphI 
 sites 
 
glnS promoter:   glutaminyl-tRNA synthetase promoter 
glnS terminator: glutaminyl-tRNA synthetase terminator (Rho independent) 
Evolved Acetyl-Lysyl_tRNA-Synthetase: pAcKRS-3
(evolved from M.barkeri aminoacyl-tRNA-synthetase)
XbaI 
TCTAGAGTGGAGGTAATAATTGACGATATGATCATTTATTCTGCCTCCCAGAGCCTGATAAAAACGGT
TAGCGCTTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCG
GAACATAATGGTGCAGGGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGT
TGGGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGATA
GTCATGCCCCGCGCCCACCGGAAGGAGCTACCGGCAGCGGTGCGGACTGTTGTAACTCAGAATAAGAA
ATGAGGCCGCTCATGGCGTTCTGTTGCCCGTCTCACTGGTGAAAAGAAAAACAACCCTGGCGCCGCTT 
                                        lpp promoter 
CTTTGAGCGAACGATCAAAAATAAGTGGCGCCCCATCAAAAAAATATTCTCAACATAAAAAACTTTGT 
 
                BglII                     tRNACUA 
GTAATACTTGTAACGCTAGATCTGGGAACCTGATCATGTAGATCGAATGGACTCTAAATCCGTTCAGC 
 
                            SpeI          rrnC terminator 
CGGGTTAGATTCCCGGGGTTTCCGCCAACTAGTATCCTTAGCGAAAGCTAAGGATTTTTTTTAAGCTT 
GGCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTG
CAGCACATCCCCCTTTCGCCAGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGT
AGGTTGAGGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGCCCGAGATGCGCCGCGT
GCGGCTGCTGGAGATGGCGGACGCGATGGATATGTTCTGCCAAGGGTTGGTTTGCGCATTCACAGTTC
TCCGCAAGAATTGATTGGCTCCAATTCTTGGAGTGGTGAATCCGTTAGCGAGGTGCCGCCGGCTTCCA
TTCAGGTCGAGGTGGCCCGGCTCCATGCACCGCGACGCTCTAGA 
                                       XbaI 
lpp:  strong synthetic, constitutive promoter (lipoprotein promoter) 
rrnC: ribosomal RNA terminator (hairpin with poly-U;Rho-independent)!
pylT-gene for expression of tRNA:
Figure A.1: tRNA-synthetase/tRNA-pair used for GCEC.Sequence-
and cloning information for the used acetyl-lysyl-tRNA-synthetase (AcKRS3)
and the corresponding tRNA (pylT).
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Figure A.2: ESI-MS spectra of Ran wt and all AcKs. Quantitative in-
corporation of N-()-acetyl-lysine into recombinant His-tagged Ran was verified
by ESI-mass spectrometry. The calculated mass for the AcKs is 26043,6 Da.
Ran wt does not carry a His-tag and the calculated mass is 24624 Da.
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Figure A.3: Interaction of NTF2 and Ran wt/AcKs. The affinities and
thermodynamic interaction parameters of the interaction of NTF2 and Ran
wt/AcK/Q/R were determined by ITC.
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Figure A.4: Interaction of RCC1 and Ran∗GDP wt/AcKs. The affini-
ties and thermodynamic interaction parameters of the interaction of RCC1 and
Ran∗GDP wt/AcKs were determined by ITC.
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Figure A.5: Interaction of RCC1 and Ran∗GppNHp wt/AcKs. The
affinities and thermodynamic interaction parameters of the interaction of RCC1
and Ran∗GppNHp wt/AcKs were determined by ITC.
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Figure A.6: RCC1-catalyzed nucleotide exchange on Ran. The RCC1-
catalyzed nucleotide exchange on Ran wt/AcKs was determined by stopped-flow
measurements. Shown are original traces and fits.
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Figure A.7: Interaction of Importin-β and Ran wt/AcKs. The affinities
and thermodynamic interaction parameters of the interaction of Importin-β and
Ran wt/AcKs were determined by ITC.
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Figure A.8: Association of Importin-β and Ran wt/AcKs. Original
traces and primary fits of the stopped-flow measurements for the determination
of the association rate constant of Importin-β and Ran wt/AcKs
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Figure A.10: MS/MS spectra. MS/MS spectra of the pecific peptide for
(a) AcK134 and (b) AcK37.

Abbreviations
AcK Acetyl-lysine
Amp Ampicillin
CV Column volume
CMB Coomassie Blue
GAP GTPase-activating protein
GCEC Genetic-code expansion concept
GDP Guanosin 5-diphosphat
GEF Guanine-nucleotide exchange factor
GNBP Guanine-nucleotide binding protein
GppNHp 5’-Guanylyl imidodiphosphate
GTP Guanosin 5-triphosphat
IB Immunoblotting
IPTG Isopropyl -D-thiogalactosid
ITC Isothermal titration calorimetry
KAT Lysine-acetyltransferase
Kan Kanamycin
KDAC Lysine-deacetylase
MWCO Molecular-weight cut-off
MS Mass spectrometry
Ni-NTA Nickel-Nitrilotriacetic acid
NPC Nuclear pore complex
NTF2 Nuclear transport factor
RCC1 Regulator of chromosom condensation (RanGEF)
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